FedInvent Patent Applications

Patent Application Details for Thursday, July 15, 2021 

This page was updated on Thursday, July 15, 2021 at 11:40 PM GMT

Department of Health and Human Services (HHS) 

US 20210212293 Lhamon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) SIGNAL SOLUTIONS, LLC (Lexington, Kentucky)
ASSIGNEE(S)
INVENTOR(S) Michael E. Lhamon (Lexington, Kentucky);  Anuj Agarwal (Lexington, Kentucky)
ABSTRACT A rack system including a plurality of cages, wherein each cage comprises a respective plurality of outside surfaces, a plurality of housing areas, each housing area corresponding to a respective one cage of the plurality of cages, each housing area comprising a respective plurality of inside surfaces of the rack system and arranged to support at least a portion of one of the respective plurality of outside surfaces of its corresponding one cage, and a plurality of coaxial piezoelectric cables, each coaxial piezoelectric cable corresponding to a respective one cage of the plurality of cages and at least indirectly coupled to its corresponding one cage.
FILED Tuesday, March 09, 2021
APPL NO 17/195653
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 1/03 (20130101)
A01K 1/031 (20130101)
A01K 1/0035 (20130101)
A01K 1/0157 (20130101)
A01K 29/005 (20130101) Original (OR) Class

Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, or Fluid Pressure
G01L 1/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212571 Cheng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Ji-xin Cheng (Newton, Massachusetts);  Yingchun Cao (Natick, Massachusetts);  Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S)
INVENTOR(S) Ji-xin Cheng (Newton, Massachusetts);  Yingchun Cao (Natick, Massachusetts)
ABSTRACT An apparatus and method for converting localized laser absorption in lipid-rich biological tissue into ultrasonic waves through thermoelastic expansion to image the entire arterial wall with chemical selectivity and depth resolution. The apparatus including a sensitive quasi-collinear dual-mode photoacoustic/ultrasound catheter with elaborately selected sheath material.
FILED Thursday, May 16, 2019
APPL NO 17/055260
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0073 (20130101)
A61B 5/0084 (20130101)
A61B 5/0095 (20130101) Original (OR) Class
A61B 5/02007 (20130101)
A61B 5/6852 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212629 Li et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE MEDICAL COLLEGE OF WISCONSIN, INC. (MILWAUKEE, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) Shi-Jiang Li (Brookfield, Wisconsin);  Guangyu Chen (Brookfield, Wisconsin);  Gang Chen (Wauwatosa, Wisconsin)
ABSTRACT Systems and methods are described for computing a quantitative index that characterizes Alzheimer\'s disease (“AD”) risk events based on a temporally ordered sequence of biomarker events. In general, the systems and methods described here implement a modified event-based probabilistic (“EBP”) model to calculate the risk index from biomarker data.
FILED Thursday, December 15, 2016
APPL NO 16/062799
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0263 (20130101)
A61B 5/4088 (20130101) Original (OR) Class
A61B 5/4842 (20130101)
A61B 5/7275 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/4806 (20130101)
G01R 33/56341 (20130101)
G01R 33/56366 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 15/00 (20180101)
G16H 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212949 Xie et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (Lincoln, Nebraska)
ASSIGNEE(S)
INVENTOR(S) Jingwei Xie (Omaha, Nebraska);  Sunil Kumar Boda (Omaha, Nebraska)
ABSTRACT Nanofiber segments and nanofiber microspheres are provided as well as methods of use thereof and methods of making.
FILED Tuesday, April 23, 2019
APPL NO 17/044949
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101)
A61K 9/1641 (20130101)
A61K 9/1658 (20130101) Original (OR) Class

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/54 (20130101)
A61L 27/227 (20130101)
A61L 2400/12 (20130101)
A61L 2430/02 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212955 ZHENG et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE PENN STATE RESEARCH FOUNDATION (University Park, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Siyang ZHENG (State College, Pennsylvania);  Cheng GONG (Malden, Massachusetts)
ABSTRACT The present invention relates to compositions and methods for delivery of therapeutic agent. In certain aspects, the invention comprises a metal-organic framework nanoparticle encapsulating a protein. In some aspects, the metal-organic framework nanoparticle encapsulating a protein is coated with an extracellular vesicle membrane.
FILED Tuesday, May 28, 2019
APPL NO 17/058925
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5123 (20130101) Original (OR) Class
A61K 9/5176 (20130101)
A61K 9/5192 (20130101)
A61K 38/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212969 SU et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S)
INVENTOR(S) Bin SU (Cleveland, Ohio);  Monica M. MONTANO (Cleveland, Ohio)
ABSTRACT A method of inducing HEXIM1 expression in cells of a subject includes administering to the cells a compound having the formula, and pharmaceutically acceptable salts thereof.
FILED Tuesday, March 30, 2021
APPL NO 17/217084
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/16 (20130101)
A61K 31/18 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212987 TYAVANAGIMATT et al.
FUNDED BY
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) SIGA TECHNOLOGIES, INC. (Corvallis, Oregon)
ASSIGNEE(S) SIGA TECHNOLOGIES, INC. (Corvallis, Oregon)
INVENTOR(S) Shanthakumar R. TYAVANAGIMATT (Sammamish, Washington);  Kris HOLT (Colorado Springs, Colorado);  Ying TAN (Millbrae, California);  Melialani A.C.L.S. ANDERSON (Corvallis, Oregon);  Dennis E. HRUBY (Albany, Oregon)
ABSTRACT The present invention is directed to a dry suspension for reconstitution containing Tecovirimat (ST-246) powder and simethicone. The dry suspension is dispersed in water to provide an aqueous pharmaceutical suspension formulation for oral administration for treating orthopoxvirus infections and/or eczema vaccinatum. The suspension formulation exhibits excellent stability and good dissolution and has an improved taste and texture.
FILED Wednesday, February 15, 2017
APPL NO 16/071119
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/16 (20130101)
A61K 9/0053 (20130101)
A61K 9/0095 (20130101)
A61K 31/403 (20130101) Original (OR) Class
A61K 47/26 (20130101)
A61K 47/34 (20130101)
A61K 47/38 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212988 TUCKER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Actuate Therapeutics Inc. (Fort Worth, Texas)
ASSIGNEE(S)
INVENTOR(S) Torry A. TUCKER (Tyler, Texas);  Steven IDELL (Tyler, Texas)
ABSTRACT Pharmaceutical compositions and methods are described which rely upon glycogen synthase kinase 3 (form β; GSK 3β) inhibitors, most preferably 9-ING-41, to inhibit fibrotic pulmonary remodeling in vivo including proliferation and differentiation of myofibroblasts to fibrotic fibroblasts in several mouse models. Therapeutic targeting of GSK-3β with the clinically useful specific inhibitor, 9-ING-41, mitigates fibrotic pulmonary remodeling in vivo and provides a mode of therapy of human IPF by specific GSK-3β inhibition with 9-ING-41.
FILED Thursday, May 16, 2019
APPL NO 17/056238
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0073 (20130101)
A61K 31/407 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 11/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212989 Wandinger-Ness et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Mental Health (NIMH)
APPLICANT(S) UNM Rainforest Innovations (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Angela Wandinger-Ness (Albuquerque, New Mexico);  Laurie Hudson (Albuquerque, New Mexico);  Larry Sklar (Albuquerque, New Mexico);  Zurab Surviladze (Albuquerque, New Mexico);  Tudor Oprea (Albuquerque, New Mexico)
ABSTRACT The present invention relates to molecules which function as modulators (i.e., inhibitors and agonists) of the Ras-homologous (Rho) family of small GTPases (e.g. Rac, Cdc42 and Rho GTPases) and their use to treat diseases, including cancers (including solid tumors-medulloblastoma, ovarian, breast, head and neck, testicular, prostate among others and hematologic malignancies-B cell lymphoma, where these GTPases are overexpressed or hyperactivated), sporadic and genetic diseases where activation of Rho GTPases plays a pivotal role (Menkes disease, rheumatoid arthritis, atherosclerosis, diabetes (type 1), Huntington\'s disease and Alzheimer\'s disease) which are mediated through these proteins. Compounds according to the present invention may also be used as a therapy for the treatment of Entamoeba spp. or Acanthamoeba spp. infections, especially including Entamoeba histolytica.
FILED Wednesday, November 11, 2020
APPL NO 17/095399
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/403 (20130101)
A61K 31/407 (20130101) Original (OR) Class
A61K 31/415 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 231/06 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/573 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210212997 Varner et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Judith Varner (La Jolla, California);  Michael C. Schmid (West Kirby, United Kingdom)
ABSTRACT The present invention is based on the finding that CD11b signaling inhibits immune suppression, modulates neovascularization and promotes anti-tumor immune responses in models of murine and human cancer. As such, provided herein are methods of treating cancer using an antibody, protein or small molecule that modulates CD11b activity or expression. Also provided are methods of identifying cancer that is amenable to such treatment and/or increasing susceptibility of cancer cells to treatment with a chemotherapeutic agent.
FILED Thursday, May 30, 2019
APPL NO 17/058605
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/427 (20130101) Original (OR) Class
A61K 31/7068 (20130101)
A61K 39/3955 (20130101)
A61K 49/0008 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1138 (20130101)
C12N 2310/141 (20130101)
C12N 2320/31 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/158 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213022 Strum et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) G1 Therapeutics, Inc. (Research Triangle Park, North Carolina)
ASSIGNEE(S) G1 Therapeutics, Inc. (Research Triangle Park, North Carolina)
INVENTOR(S) Jay Copeland Strum (Hillsborough, North Carolina);  John Emerson Bisi (Chapel Hill, North Carolina);  Patrick Joseph Roberts (Durham, North Carolina);  Francis X. Tavares (Durham, North Carolina)
ABSTRACT This invention is in the area of improved compounds for and methods of treating selected RB-positive cancers and other Rb-positive abnormal cellular proliferative disorders while minimizing the deleterious effects on healthy cells, for example healthy Hematopoietic Stem Cells and Progenitor Cells (HSPCs), associated with current treatment modalities. In one aspect, improved treatment of select RB-positive cancers is disclosed using specific compounds disclosed herein. In certain embodiments, the compounds described herein act as highly selective and, in certain embodiments, short, transiently-acting cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors when administered to subjects.
FILED Monday, February 22, 2021
APPL NO 17/181638
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0053 (20130101)
A61K 31/519 (20130101)
A61K 31/527 (20130101) Original (OR) Class
A61K 31/555 (20130101)
A61K 31/5377 (20130101)
A61K 31/7048 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 35/04 (20180101)

Heterocyclic Compounds
C07D 487/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213023 Gendelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Board of Regents of the University of Nebraska (Lincoln, Nebraska)
ASSIGNEE(S)
INVENTOR(S) Howard Gendelman (Omaha, Nebraska);  Benson Edagwa (Omaha, Nebraska)
ABSTRACT The present invention provides prodrugs and methods of use thereof.
FILED Monday, March 22, 2021
APPL NO 17/301030
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/1641 (20130101)
A61K 31/5365 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/18 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213031 Boss et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Regents of the University of California (Oakland, California);  The Regents of the University of Colorado (Denver, Colorado)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  The Regents of the university of Colorado (Denver, Colorado)
INVENTOR(S) Gerard Boss (La Jolla, California);  Adriano Chan (La Jolla, California);  Matthew Brenner (La Jolla, California);  Sari Brenner Mahon (La Jolla, California);  Vikhyat Bebarta (Denver, Colorado)
ABSTRACT Methods and compositions for treating cyanide, sulfide, or methane-thiol exposure in a subject. The compositions may include one or more cobinamide compounds, such as an amino-tetrazole-cobinamide and/or a di-(amino-tetrazole)-cobinamide.
FILED Tuesday, June 04, 2019
APPL NO 15/734254
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 31/555 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 39/02 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213041 Ting et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Science Foundation (NSF)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts);  Icahn School of Medicine at Mount Sinai (New York, New York)
ASSIGNEE(S)
INVENTOR(S) David T. Ting (Dover, Massachusetts);  Miguel N. Rivera (Belmont, Massachusetts);  Vikram Deshpande (Belmont, Massachusetts);  Kshitij Arora (North Quincy, Massachusetts);  Benjamin Dylan Greenbaum (New York, New York);  Alexander V. Solovyov (New York, New York)
ABSTRACT Methods for predicting response to immunotherapy and selecting immunotherapy for treating cancer, e.g., cancer of epithelial origin, in a subject.
FILED Wednesday, February 06, 2019
APPL NO 16/967497
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7105 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/122 (20130101)
C12N 2310/141 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213055 Weissman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Irving L. Weissman (Stanford, California);  Amira A. Barkal (Stanford, California)
ABSTRACT Methods and compositions are provided for inducing phagocytosis of a target cell in an individual, by blocking the interaction between CD24 on a target cell and Siglec10 on a phagocytic cell.
FILED Wednesday, June 12, 2019
APPL NO 15/734470
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/15 (20130101) Original (OR) Class
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)

Peptides
C07K 16/30 (20130101)
C07K 16/2803 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57492 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213059 GEORGIOU et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
ASSIGNEE(S)
INVENTOR(S) George GEORGIOU (Austin, Texas);  Everett STONE (Austin, Texas)
ABSTRACT Methods and compositions related to the use of a protein with kynureninase activity are described. For example, in certain aspects there may be disclosed a modified kynureninase capable of degrading kynurenine. Furthermore, certain aspects of the invention provide compositions and methods for the treatment of cancer with kynurenine depletion using the disclosed proteins or nucleic acids.
FILED Tuesday, August 18, 2020
APPL NO 16/996806
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101) Original (OR) Class
A61K 38/00 (20130101)
A61K 38/46 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/14 (20130101)

Enzymes
C12Y 307/01003 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213067 Shi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Yufang Shi (Belle Mead, New Jersey);  Guangwen Ren (Piscataway, New Jersey);  Liying Zhang (Belle Mead, New Jersey)
ABSTRACT The present invention provides methods or kits with inflammatory cytokines to pretreat 1-ISCs to augment their immune modulatory effect, in prevention and treatment of various diseases such as multiple sclerosis, arthritis, lupus, sepsis, hepatitis, cirrhosis, Parkinson\'s disease, chronic infections, and GvHD. The present invention relates to novel methods for enhancing the immunosuppressive or the immune stimulatory activities of mesenchymal stem cells (JvfSCs).
FILED Friday, January 15, 2021
APPL NO 17/150457
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101) Original (OR) Class
A61K 38/191 (20130101)
A61K 38/217 (20130101)
A61K 38/2006 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 37/02 (20180101)

Peptides
C07K 14/50 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0018 (20130101)
C12N 5/0607 (20130101)
C12N 5/0662 (20130101)
C12N 5/0663 (20130101)
C12N 5/0665 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213074 RUVKUN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
ASSIGNEE(S) THE GENERAL HOSPITAL CORPORATION (Boston, Massachusetts)
INVENTOR(S) Gary RUVKUN (Newton, Massachusetts);  J. Amaranath GOVINDAN (Somerville, Massachusetts);  Elamparithi JAYAMANI (Boston, Massachusetts)
ABSTRACT Provided herein are methods and compositions comprising a bacterium or a metabolite thereof for enhancing mitochondrial and/or peroxisomal function.
FILED Tuesday, March 09, 2021
APPL NO 17/196271
CURRENT CPC
Fodder
A23K 10/18 (20160501)

Foods, Foodstuffs, or Non-alcoholic Beverages, Not Covered by Subclasses A23B - A23J; Their Preparation or Treatment, e.g Cooking, Modification of Nutritive Qualities, Physical Treatment; Preservation of Foods or Foodstuffs, in General
A23L 2/52 (20130101)
A23L 33/135 (20160801)

Indexing Scheme Relating to Foods, Foodstuffs or Non-alcoholic Beverages
A23V 2002/00 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0053 (20130101)
A61K 9/0056 (20130101)
A61K 35/74 (20130101) Original (OR) Class

Peptides
C07K 14/195 (20130101)
C07K 2319/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)
C12N 9/0006 (20130101)
C12N 9/0055 (20130101)
C12N 9/0057 (20130101)
C12N 2500/14 (20130101)
C12N 2500/16 (20130101)
C12N 2500/34 (20130101)

Enzymes
C12Y 101/99 (20130101)
C12Y 110/0301 (20130101)
C12Y 110/02002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213098 Yang
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Utah Research Foundation (Salt Lake City, Utah)
ASSIGNEE(S)
INVENTOR(S) Tianxin Yang (Salt Lake City, Utah)
ABSTRACT Disclosed are methods of treating obesity or an obesity-related condition comprising administering an effective amount of soluble (pro)renin receptor (sPRR) to a subject that is obese or having an obesity-related condition. In some instances, obesity-related conditions can be, but are not limited to, steatosis, hyperglycemia, insulin resistance, chronic renal disease. Disclosed are methods of reducing body weight comprising administering an effective amount of sPRR to a subject in need thereof. Disclosed are methods of treating fatty liver in a subject comprising administering an effective amount of sPRR to a subject in need thereof. Disclosed are methods of treating a fluid and electrolyte disorder comprising administering an effective amount of sPRR to a subject diagnosed with a fluid and electrolyte disorder.
FILED Wednesday, March 14, 2018
APPL NO 16/492457
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/177 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213101 Chen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) The Schepens Eye Research Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Dong Feng Chen (Newtonville, Massachusetts);  Chenying Guo (Malden, Massachusetts)
ABSTRACT Disclosed is a method of promoting neuronal growth by administering IGFBPL-1, or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need thereof, e.g., a subject in need of treating optic nerve degeneration.
FILED Wednesday, October 14, 2020
APPL NO 17/070596
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/352 (20130101)
A61K 31/708 (20130101)
A61K 31/711 (20130101)
A61K 31/713 (20130101)
A61K 31/7004 (20130101)
A61K 31/7088 (20130101)
A61K 31/7105 (20130101)
A61K 38/18 (20130101) Original (OR) Class
A61K 38/22 (20130101)
A61K 38/30 (20130101)
A61K 38/1738 (20130101)
A61K 38/1841 (20130101)
A61K 38/2278 (20130101)
A61K 45/06 (20130101)
A61K 49/0056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213110 Holers et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) The Regents of the University of Colorado, A Body Corporate (Denver, Colorado)
ASSIGNEE(S) The Regents of The University of Colorado, A Body Corporate (Denver, Colorado)
INVENTOR(S) V. Michael Holers (Denver, Colorado);  Nirmal Banda (Aurora, Colorado);  Liudmila Kulik (Denver, Colorado)
ABSTRACT The present invention provides delivery methods and constructs for treating inflammatory diseases in an individual. The targeted delivery approach utilizes an antibody that recognizes an epitope found to be present at sites of inflammation. The antibody is used to deliver a MAp44 polypeptide or fragment thereof to sites of inflammation, where it inhibits the lectin pathway of complement activation.
FILED Monday, December 07, 2020
APPL NO 17/113612
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/027 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 38/482 (20130101) Original (OR) Class

Peptides
C07K 16/18 (20130101)
C07K 16/44 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/6424 (20130101)
C12N 2710/10041 (20130101)

Enzymes
C12Y 304/21 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213126 Shalek et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The United States of America, as represented by The Secretary, Department of Health and Human Services (Bethesda, Maryland);  University of Pittsburgh - Of The Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Alexander K. Shalek (Cambridge, Massachusetts);  Travis Hughes (Cambridge, Massachusetts);  Marc H. Wadsworth (Cambridge, Massachusetts);  Robert Seder (Bethesda, Maryland);  Mario Roederer (Bethesda, Maryland);  Joanne L. Flynn (Pittsburgh, Pennsylvania);  Patricia Darrah (Bethesda, Maryland)
ABSTRACT Provided herein are compositions and methods for therapeutic and/or prophylactic treatment of an intracellular bacterial infection in a subject in need thereof, comprising one or more modulating agents, wherein the one or more modulating agents increase expression of IFNγ, IL-2, TNF, and/or IL-17 in systemic and/or lung T cells. In some embodiments, the increase of expression of IFNγ, IL-2, TNF, and/or IL-17 occurs in lung T cells. The lung T cells can be lung resident T cells or systemic T cells that are recruited to the lung. In some embodiments, the T cells are CD4+ and/or CD8+ T cells. In some embodiments, the intracellular bacterial infection is a Mycobacterium tuberculosis (MTB) infection.
FILED Wednesday, December 30, 2020
APPL NO 17/137481
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/04 (20130101) Original (OR) Class
A61K 2039/54 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/06 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213134 HEIFETZ et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) ORPRO THERAPEUTICS, INC. (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Peter B. HEIFETZ (San Diego, California);  Haim MOSKOWITZ (San Diego, California)
ABSTRACT The present invention is related to a drug delivery composition that includes a thioredoxin homologue protein having an N-terminal monocysteinic active site, with the cysteine residue of the active site in a reduced state and an active agent conjugated to the thioredoxin homologue protein and methods of making and using the composition.
FILED Friday, May 17, 2019
APPL NO 17/056151
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/337 (20130101)
A61K 31/407 (20130101)
A61K 31/427 (20130101)
A61K 31/431 (20130101)
A61K 31/475 (20130101)
A61K 31/496 (20130101)
A61K 31/546 (20130101)
A61K 31/665 (20130101)
A61K 31/675 (20130101)
A61K 31/704 (20130101)
A61K 31/5383 (20130101)
A61K 31/7036 (20130101)
A61K 31/7048 (20130101)
A61K 31/7068 (20130101)
A61K 33/243 (20190101)
A61K 38/07 (20130101)
A61K 38/12 (20130101)
A61K 38/13 (20130101)
A61K 38/14 (20130101)
A61K 47/64 (20170801) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213137 Ekker et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Stephen C. Ekker (Rochester, Minnesota);  Debabrata Mukhopadhyay (Jacksonville, Florida);  Priyabrata Mukherjee (Edmond, Oklahoma);  Victoria M. Bedell (Philadelphia, Pennsylvania);  Luke H. Hoeppner (Austin, Minnesota);  Stella P. Hartono (Houston, Texas)
ABSTRACT This document relates to materials and methods for administering (e.g., topically administering) one or more vascular endothelial growth factor (VEGF) inhibitors to reduce and/or treat ultraviolet (UV)-induced skin injury. For example, compositions including one or more VEGF inhibitors that can be administered (e.g., topically administered) to a mammal to reduce and/or treat UV-induced skin injury following UV exposure are provided.
FILED Wednesday, January 20, 2021
APPL NO 17/153565
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 47/6845 (20170801) Original (OR) Class
A61K 47/6929 (20170801)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 17/02 (20180101)
A61P 35/00 (20180101)

Peptides
C07K 16/22 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213139 Lu
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Quan Lu (Newton, Massachusetts)
ABSTRACT Methods, systems, compositions and strategies for the delivery of RNA into cells in vivo, ex vivo, or in vitro via ARMMs are provided. In some aspects, ARMMs containing fusion proteins of ARRDC1 fused to an RNA binding protein or an RNA binding protein fused to a WW domain are provided. In some aspects, ARMMs containing binding RNAs associated with cargo RNAs are provided. In other aspects, cargo RNAs associated with a binding RNA, such as a TAR element, are loaded into ARMMs via ARRDC1 fusion proteins containing an RNA binding protein, such as trans-activator of transcription (Tat) protein.
FILED Tuesday, October 03, 2017
APPL NO 16/338969
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5068 (20130101)
A61K 47/54 (20170801)
A61K 47/62 (20170801)
A61K 47/6901 (20170801) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/87 (20130101)
C12N 2740/16322 (20130101)
C12N 2795/10222 (20130101)
C12N 2795/10322 (20130101)
C12N 2795/18122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213170 Taboas et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Juan M. Taboas (Pittsburgh, Pennsylvania);  Alejandro Jose Almarza (Pittsburgh, Pennsylvania);  Jingming Chen (Chicago, Illinois)
ABSTRACT Biomaterials disclosed herein can comprise a hydrogel comprising PEG, gelatin, and a glycosaminoglycan with sulfated moiety; and chondrogenic, osteogenic, and immunomodulatory cytokines; wherein the biomaterial is capable of potentiating bone regeneration in a compromised wound while reducing inflammatory response. The glycosaminoglycan with sulfated moiety can comprise heparin, heparan sulfate, keratin sulfate, chondroitin sulfate, dermatan sulfate, and/or similar materials. The biomaterial can further comprise mesenchymal stem cells (MSCs), a crosslinking initiator, microparticles and nanoparticles, and or other materials. The biomaterial can be injectable into a wound, or the biomaterial can be loaded in, or further comprise a porous scaffold providing mechanical support for other components of the biomaterial, such that it can be implanted into a wound.
FILED Thursday, June 13, 2019
APPL NO 17/055046
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/52 (20130101)
A61L 27/54 (20130101)
A61L 27/3834 (20130101)
A61L 27/3847 (20130101) Original (OR) Class
A61L 2300/236 (20130101)
A61L 2300/252 (20130101)
A61L 2300/414 (20130101)
A61L 2300/426 (20130101)
A61L 2400/06 (20130101)
A61L 2430/02 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/19 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213171 CHEN et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Christopher S. CHEN (Newton, Massachusetts);  Jan D. BARANSKI (Philadelphia, Pennsylvania);  Ritika CHATURVEDI (Philadelphia, Pennsylvania);  Michael T. YANG (West Windsor, New Jersey);  Kelly R. STEVENS (Seattle, Washington);  Sangeeta N. BHATIA (Lexington, Massachusetts)
ABSTRACT The present disclosure provides patterned biomaterials having organized cords and extracellular matrix embedded in a 3D scaffold. According, the present disclosure provides compositions and applications for patterned biomaterials. Pre-patterning of these biomaterials can lead to enhanced integration of these materials into host organisms, providing a strategy for enhancing the viability of engineered tissues by promoting vascularization.
FILED Friday, March 26, 2021
APPL NO 17/213423
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/44 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/24 (20130101)
A61L 27/40 (20130101)
A61L 27/50 (20130101) Original (OR) Class
A61L 27/225 (20130101)
A61L 27/507 (20130101)
A61L 27/3604 (20130101)
A61L 27/3804 (20130101)
A61L 27/3808 (20130101)
A61L 27/3834 (20130101)
A61L 27/3839 (20130101)
A61L 27/3886 (20130101)
A61L 2430/20 (20130101)
A61L 2430/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213173 BHATIA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Sangeeta N. BHATIA (Lexington, Massachusetts);  Kelly R. STEVENS (Seattle, Washington);  Christopher S. CHEN (Newton, Massachusetts)
ABSTRACT Engineered human tissue seed constructs are provided that are suitable for implantation in subjects. Methods of making and using the engineered tissue seed constructs are provided.
FILED Friday, March 26, 2021
APPL NO 17/213436
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/52 (20130101) Original (OR) Class
A61L 27/225 (20130101)
A61L 27/3804 (20130101)
A61L 27/3808 (20130101)
A61L 27/3886 (20130101)
A61L 27/3891 (20130101)
A61L 2430/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213174 Spiller et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Drexel University (Philadelphia, Pennsylvania)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania)
INVENTOR(S) Kara Lorraine Spiller (Glenside, Pennsylvania);  Nathan Tessema Ersumo (Philadelphia, Pennsylvania)
ABSTRACT This application relates to biologically compatible porous cartilage templates for in vitro and in vivo generation of bone with enhanced structural characteristics. Provided herein are compositions having an internal structure desirable for the generation and regeneration of bone, along with methods of preparation and use.
FILED Friday, March 26, 2021
APPL NO 17/214159
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/44 (20130101)
A61F 2/46 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/52 (20130101)
A61L 27/54 (20130101)
A61L 27/56 (20130101) Original (OR) Class
A61L 27/222 (20130101)
A61L 27/3834 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 70/00 (20141201)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 11/04 (20130101)
C09D 11/101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213181 Khademhosseini et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Brigham and Women\'s Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Ali Khademhosseini (Cambridge, Massachusetts);  Guillermo Ulises Ruiz Esparza Herrera (Cambridge, Massachusetts);  Xichi Wang (Brighton, Massachusetts);  Su Ryon Shin (Brookline, Massachusetts);  Thomas Jozefiak (Belmont, Massachusetts)
ABSTRACT The present application relates to shear thinning hydrogel compositions which are useful for reducing and/or preventing tissue adhesion in a subject (e.g., a post-operative subject). Methods of using the compositions and kits comprising the compositions oar also provided.
FILED Wednesday, May 29, 2019
APPL NO 17/058224
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 33/06 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 31/128 (20130101)
A61L 31/145 (20130101) Original (OR) Class
A61L 2400/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213200 Raskin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) BETA BIONICS, INC. (Concord, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Edward B. Raskin (Irvine, California);  David Chi-Wai Lim (Irvine, California);  Michael J. Rosinko (Anaheim, California);  Firas H. El-Khatib (Allston, Massachusetts);  Edward R. Damiano (Acton, Massachusetts)
ABSTRACT An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.
FILED Thursday, March 25, 2021
APPL NO 17/212984
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/1723 (20130101) Original (OR) Class
A61M 2205/52 (20130101)
A61M 2230/201 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213203 Smith et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) iRenix Medical, Inc. (Palo Alto, California)
ASSIGNEE(S)
INVENTOR(S) Stephen J. Smith (Palo Alto, California);  Thomas W. Chalberg, JR. (Palo Alto, California)
ABSTRACT Therapeutic agent delivery devices are provided. Aspects of the devices include a syringe that is not surface sterilized, a tip that includes a sterile tissue contacting surface and a needle operably coupled to the syringe and the tip. Also provided are methods of using the devices.
FILED Thursday, June 27, 2019
APPL NO 17/254514
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/002 (20130101)
A61M 5/315 (20130101) Original (OR) Class
A61M 5/3202 (20130101)
A61M 2005/3126 (20130101)
A61M 2210/0612 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213306 Chalasani et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Salk Institute for Biological Studies (La Jolla, California)
ASSIGNEE(S) Salk Institute for Biological Studies (La Jolla, California)
INVENTOR(S) Sreekanth H. Chalasani (La Jolla, California);  Stuart Ibsen (La Jolla, California)
ABSTRACT The invention provides compositions featuring TRP-4 polypeptides and polynucleotides, methods for expressing such polypeptides and polynucleotides in a cell type of interest, and methods for inducing the activation of the TRP-4 polypeptide in neurons and other cell types using ultrasound.
FILED Wednesday, September 23, 2020
APPL NO 17/029143
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/00 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 41/0033 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 7/00 (20130101) Original (OR) Class

Peptides
C07K 14/705 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 13/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213329 Wechsler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute on Drug Abuse (NIDA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Trustees of Dartmouth College (Hanover, New Hampshire)
ASSIGNEE(S)
INVENTOR(S) Emily Wechsler (Dallas, Texas);  Ryan Halter (Lyme, New Hampshire);  John A. Batsis (Hanover, New Hampshire)
ABSTRACT Devices and methods are disclosed for remote clinical monitoring performance of exercises using an instrumented resistance device (100). An example device (100) includes a resistance band (120) having a first end (122) and a second end (124). A first handle (130) connected to the first end (122) and a second handle (140) connected to the second end (124) of the resistance band (120). The device (100) further includes a force sensing assembly (150) positioned between the first handle (130) and the first end (122). The force sensing assembly (150) includes a force sensor (156) connected to the resistance band (120), a microcontroller (182) connected to the force sensor (156) to receive a set of load force measurements from the force sensor (156), and a communication module (184) connected to the microcontroller (182) to transmit the set of load force measurements to a local data receiving device (170).
FILED Friday, May 17, 2019
APPL NO 17/055412
CURRENT CPC
Apparatus for Physical Training, Gymnastics, Swimming, Climbing, or Fencing; Ball Games; Training Equipment
A63B 21/00043 (20130101)
A63B 21/0552 (20130101)
A63B 21/4035 (20151001)
A63B 24/0062 (20130101) Original (OR) Class
A63B 2220/17 (20130101)
A63B 2220/51 (20130101)
A63B 2220/62 (20130101)
A63B 2220/833 (20130101)
A63B 2225/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213413 SALIGRAMA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Naresha SALIGRAMA (Stanford, California);  Ansuman SATPATHY (Stanford, California);  Howard Y. CHANG (Stanford, California);  Mark M. DAVIS (Stanford, California)
ABSTRACT Provided are systems and methods that can combine T cell receptor sequencing (TCRseq) and Assay for Transposase Accessible Chromatin using sequencing (ATAC-seq), and/or respective aspects thereof. Further provided are systems and methods that can combine ATAC-seq and perturbation sequencing (Perturb-seq), and/or respective aspects thereof.
FILED Wednesday, December 19, 2018
APPL NO 16/967402
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/0046 (20130101) Original (OR) Class
B01J 2219/00596 (20130101)
B01J 2219/00722 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1096 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6874 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213673 Benam et al.
FUNDED BY
Department of Health and Human Services (HHS)
Food and Drug Administration (FDA)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (Denver, Colorado)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (Denver, Colorado)
INVENTOR(S) Kambez Benam (Denver, Colorado);  Alexander Kaiser (Keenesburg, Colorado)
ABSTRACT A bioprinter for manufacturing an organomimetic device includes at least one extruder configured to extrude a material, a three-dimensional movement assembly, and a build-plate mounted to the three-dimensional movement assembly. The build-plate may be configured to support the organomimetic device being manufactured. The bioprinter may further include a controller operably coupled to and configured to control the at least one extruder, the three-dimensional movement assembly, and the build-plate. The at least one extruder may be non-movably fixed to the cabinet.
FILED Monday, February 11, 2019
APPL NO 16/967395
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/106 (20170801) Original (OR) Class
B29C 64/209 (20170801)
B29C 64/232 (20170801)
B29C 64/236 (20170801)
B29C 64/245 (20170801)
B29C 64/393 (20170801)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2031/753 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 30/00 (20141201)
B33Y 50/02 (20141201)
B33Y 70/00 (20141201)

Apparatus for Enzymology or Microbiology;
C12M 21/08 (20130101)
C12M 33/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214222 Kondiboyina et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Third Pole, Inc. (Waltham, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Vineel Kondiboyina (Somerville, Massachusetts);  Christopher Miles (Acton, Massachusetts);  Gregory W. Hall (Belmont, Massachusetts);  Simon E. Kozin (Lexington, Massachusetts);  Wolfgang Scholz (Beverly, Massachusetts);  Frank Heirtzler (Londonderry, New Hampshire)
ABSTRACT Systems, methods and devices for nitric oxide generation are provided for use with various ventilation and/or medical devices and having a humidity control system associated therewith. In some embodiments, a system for generating nitric oxide comprises at least one pair of electrodes configured to generate a product gas containing nitric oxide from a reactant gas, a scrubber configured to remove nitric dioxide NO2 from the product gas, and a humidity control device configured to alter a water content of at least one of the reactant gas and the product gas to control humidity within the system.
FILED Monday, January 11, 2021
APPL NO 17/146468
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 21/32 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214235 Ramachandran et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Roshini Ramachandran (West Hollywood, California);  Jessica K. Logan (Los Angeles, California);  Alexander M. Spokoyny (Los Angeles, California)
ABSTRACT A method of making boron oxide nanoparticles. The method can comprise sonochemically treating a composition comprising a boron oxide to form boron oxide nanoparticles. The method allows for the formation of these nanoparticles from non-toxic, inexpensive reagents and ambient reaction conditions. Additionally, the nanoparticles produced by the teachings described herein can be easily surface functionalized.
FILED Friday, May 31, 2019
APPL NO 15/734106
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 35/1027 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214348 Kamenecka et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) ASTRAZENECA AB (Sodertalje, Sweden);  EOLAS THERAPEUTICS, INC. (Carlsbad, California)
ASSIGNEE(S)
INVENTOR(S) Theodore M. Kamenecka (Palm Beach Gardens, Florida);  Jörg Holenz (Bolton, Massachusetts);  Steven Wesolowski (Natick, Massachusetts);  Yuanjun He (Palm Beach Gardens, Florida);  Roland Bürli (Hertfordshire, United Kingdom)
ABSTRACT The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
FILED Wednesday, December 09, 2020
APPL NO 17/116773
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/34 (20180101)

Heterocyclic Compounds
C07D 401/14 (20130101)
C07D 409/14 (20130101)
C07D 413/14 (20130101)
C07D 417/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214360 Petrukhin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Konstantin Petrukhin (New Windsor, New York);  Christopher Cioffi (Troy, New York);  Graham Johnson (Sanbornton, New Hampshire);  Rando Allikmets (Cornwall on Hudson, New York);  Emily Freeman (Voorheesville, New York);  Ping Chen (Slingerlands, New York);  Michael Conlon (Schenectady, New York);  Lei Zhu (Glenmont, New York)
ABSTRACT The present invention provides a compound having the structure:
    • wherein
    • R1, R2, R3, R4, and R5 are each independently H, halogen, CF3 or C1-C4 alkyl,
      • wherein two or more of R1, R2, R3, R4, or R5 are other than H;
    • R6 is H, OH, or halogen; and
    • B is a substituted or unsubstituted heterobicycle,
    • wherein when R1 is CF3, R2 is H, R3 is F, R4 is H, and R5 is H, or R1 is H, R2 is CF3, R3 is H, R4 is CF3, and R5 is H, or R1 is Cl, R2 is H, R3 is H, R4 is F, and R5 is H, or R1 is CF3, R2 is H, R3 is F, R4 is H, and R5 is H, or R1 is CF3, R2 is F, R3 is H, R4 is H, and R5 is H, or R1 is Cl, R2 is F, R3 is H, R4 is H, and R5 is H, then B is other than
or a pharmaceutically acceptable salt thereof.
FILED Monday, November 16, 2020
APPL NO 17/099231
CURRENT CPC
Heterocyclic Compounds
C07D 471/04 (20130101)
C07D 487/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214365 FISHER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) VIRGINIA COMMONWEALTH UNIVERSITY (Richmond, Virginia);  SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, California)
ASSIGNEE(S)
INVENTOR(S) Paul B. FISHER (Henrico, Virginia);  Maurizio PELLECCHIA (Riverside, California);  Swadesh K. DAS (Richmond, Virginia);  Timothy P. KEGELMAN (Richmond, Virginia);  Bainan WU (Richmond, Virginia);  Surya K. DE (Richmond, Virginia);  Jun WEI (La Jolla, California);  Mitchell E. MENEZES (Richmond, Virginia);  Luni EMDAD (Richmond, Virginia)
ABSTRACT Provided herein are, inter alia, compositions that bind to a PDZ1 domain of MDA-9/Syntenin (syndecan binding protein: SDCBP), thereby inhibiting MDA-9/Syntenin activity, and methods of use of same. The compositions and methods provided herein are useful for treating cancer and preventing cancer metastasis, particularly in cancers that have increased MDA-9/Syntenin expression.
FILED Thursday, January 14, 2021
APPL NO 17/148813
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/519 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Heterocyclic Compounds
C07D 487/04 (20130101) Original (OR) Class
C07D 495/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214368 Pluth et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Oregon (Eugene, Oregon)
ASSIGNEE(S) University of Oregon (Eugene, Oregon)
INVENTOR(S) Michael D. Pluth (Eugene, Oregon);  Yu Zhao (Springfield, Oregon);  Matthew M. Cerda (Berkeley, California)
ABSTRACT Disclosed herein are embodiments of a compound that is capable of releasing COS and/or H2S upon reaction with a thiol-containing compound. The compound embodiments also can produce a detectable signal (e.g., a fluorescent signal) substantially concomitantly with COS and/or H2S release and/or can release an active agent, such as a therapeutic agent. Methods of making and using the compound embodiments also are disclosed.
FILED Wednesday, January 30, 2019
APPL NO 15/733818
CURRENT CPC
Heterocyclic Compounds
C07D 285/01 (20130101)
C07D 493/10 (20130101) Original (OR) Class

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/06 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6486 (20130101)
G01N 33/0044 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214378 Holtzman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Michael J. Holtzman (St. Louis, Missouri);  Arthur G. Romero (Chesterfield, Missouri);  Benjamin J. Gerovac (St. Louis, Missouri);  Zhenfu Han (St. Louis, Missouri);  Shamus P. Keeler (University City, Missouri);  Kangyun Wu (St. Louis, Missouri)
ABSTRACT Compounds that inhibit mitogen-activated protein kinases (MAPKs) are disclosed. Some inhibitor compounds specifically target a single MAPK such as MAPK13, while others target multiple MAPKs such as MAPK13 and MAPK12. The compounds can be used therapeutically for a variety of diseases, including cancer and respiratory diseases. Methods of synthesis of the compounds are also disclosed.
FILED Thursday, May 30, 2019
APPL NO 17/059251
CURRENT CPC
Heterocyclic Compounds
C07D 213/75 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/0812 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214390 Liu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Jun Liu (Baltimore, Maryland);  Jingxin Wang (Baltimore, Maryland);  Zufeng Guo (Baltimore, Maryland)
ABSTRACT Compounds with the following structures and their analogs are provided. Compositions that include these structures can be used to inhibit glucose transporters and stop or decrease the proliferation of cancer, treat possible organ rejection and treat autoimmune disease.
FILED Friday, February 03, 2017
APPL NO 16/074300
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 31/12 (20130101)
A61K 31/167 (20130101)
A61K 31/235 (20130101)
A61K 31/353 (20130101)
A61K 31/407 (20130101)
A61K 31/4406 (20130101)
A61K 38/12 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 5/1008 (20130101) Original (OR) Class
C07K 5/1024 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214397 LY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
ASSIGNEE(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
INVENTOR(S) Danith H. LY (Pittsburgh, Pennsylvania);  Srinivas RAPIREDDY (Pittsburgh, Pennsylvania);  Bichismita SAHU (Pittsburgh, Pennsylvania)
ABSTRACT The present invention relates to γ-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
FILED Wednesday, August 26, 2020
APPL NO 17/003131
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/60 (20170801)

Acyclic or Carbocyclic Compounds
C07C 229/12 (20130101)
C07C 271/20 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101)
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101)

Peptides
C07K 1/04 (20130101)
C07K 1/08 (20130101)
C07K 14/003 (20130101) Original (OR) Class

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 69/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214413 Palmenberg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Ann Carol Palmenberg (Madison, Wisconsin);  Kelly Watters (Madison, Wisconsin)
ABSTRACT The present invention provides soluble truncated peptides of CDHR3, recombinant variants thereof and methods of making these peptides. The present invention also provide methods of inhibiting rhinovirus C infection and an in vitro assay for screening for anti-viral agents against rhinovirus C.
FILED Thursday, May 30, 2019
APPL NO 17/058934
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/705 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56983 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214415 Klebanoff et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (Bethesda, Maryland)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (Bethesda, Maryland)
INVENTOR(S) Christopher A. Klebanoff (New York, New York);  Tori N. Yamamoto (Bethesda, Maryland);  Nicholas P. Restifo (Bethesda, Maryland)
ABSTRACT The present disclosure provides methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to a cell comprising an antigen-recognizing receptor (e.g., a chimeric antigen receptor (CAR) or a T cell receptor (TCR)) and a dominant negative Fas polypeptide. In certain embodiments, the cells are antigen-directed and exhibit enhanced cell persistence, and enhanced anti-target treatment efficacy.
FILED Friday, March 26, 2021
APPL NO 17/214436
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/001112 (20180801)
A61K 2039/5156 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 37/04 (20180101)

Peptides
C07K 14/70521 (20130101)
C07K 14/70578 (20130101) Original (OR) Class
C07K 16/2803 (20130101)
C07K 16/2809 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/33 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214437 Weissman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Irving L. Weissman (Stanford, California);  Ravindra Majeti (Palo Alto, California);  Arash Ash Alizadeh (San Mateo, California);  Mark P. Chao (Mountain View, California)
ABSTRACT Methods are provided for treatment of hematologic cancers, particularly lymphomas and leukemias, including without limitation myelogenous and lymphocytic leukemias. A combination of antibodies specific for CD47; and specific for a cancer associated cell surface marker are administered to the patient, and provide for a synergistic decrease in cancer cell burden. The combination of antibodies may comprise a plurality of monospecific antibodies, or a bispecific or multispecific antibody. Markers of interest include without limitation, CD20, CD22, CD52, CD33; CD96; CD44; CD123; CD97; CD99; PTHR2; and HAVCR2.
FILED Friday, January 15, 2021
APPL NO 17/150881
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/39558 (20130101)
A61K 51/1093 (20130101)
A61K 2039/507 (20130101)

Peptides
C07K 16/2803 (20130101) Original (OR) Class
C07K 16/2887 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214442 BIGNER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) DUKE UNIVERSITY (Durham, North Carolina)
ASSIGNEE(S) DUKE UNIVERSITY (Durham, North Carolina)
INVENTOR(S) Darell BIGNER (Mebane, North Carolina);  Smita NAIR (Cary, North Carolina);  Vidyalakshmi CHANDRAMOHAN (Durham, North Carolina)
ABSTRACT Provided is a method of treating a tumor in an individual by neoadjuvant therapy, wherein the individual has not previously undergone a resection of the tumor, the method comprising administering an immunotoxin alone or an immune checkpoint inhibitor and an immunotoxin, such as D2C7-immunotoxin (D2C7-IT), followed by resection of the tumor. The method may further comprise administration of immune checkpoint inhibitor following resection.
FILED Thursday, May 16, 2019
APPL NO 17/055639
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 16/243 (20130101)
C07K 16/2818 (20130101) Original (OR) Class
C07K 16/2827 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214443 Ghosh et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Sankar Ghosh (New York, New York);  Yenkel Grinberg-Bleyer (New York, New York)
ABSTRACT Methods of treating a PD-1-resistant cancer are provided and comprise administering to a subject in need thereof a therapeutically effective amount of a c-Rel inhibitor and a therapeutically effective amount of a PD-1 inhibitor. A pharmaceutical combination comprising a therapeutically effective amount of a c-Rel inhibitor, and a therapeutically effective amount of a PD-1 inhibitor is also provided. Finally, methods of treating a cancer such as a CTLA-4-resistant cancer, a CD137-resistant cancer, and an OX-4-resistant cancer are provided and comprise administering to a subject in need thereof a therapeutically effective amount of a c-Rel inhibitor and a therapeutically effective amount of a CLTA-4, CD137 or OX-4 inhibitor, respectively.
FILED Tuesday, January 19, 2021
APPL NO 17/248308
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/522 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 16/2818 (20130101) Original (OR) Class
C07K 2317/76 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214558 Choi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts);  Northeastern University (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Hak Soo Choi (Needham, Massachusetts);  Jonghan Kim (Cambridge, Massachusetts);  Georges El Fakhri (Brookline, Massachusetts)
ABSTRACT Provided herein are compounds that are able to bind metal ions (e.g., free metal ions or metal ions bound to low affinity ligands) in a sample or subject. Also provided herein are methods of using the compounds for chelating metal ions and for the treatment of diseases associated with abnormal levels of metal ions. Methods of preparing the compounds and pharmaceutical compositions are also provided.
FILED Monday, December 21, 2020
APPL NO 17/129380
CURRENT CPC
Organic Dyes or Closely-related Compounds for Producing Dyes; Mordants; Lakes
C09B 23/0025 (20130101)
C09B 23/0033 (20130101)
C09B 23/0041 (20130101)
C09B 23/0066 (20130101) Original (OR) Class
C09B 69/105 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214673 Jovanovich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) S2 Genomics, Inc. (Livermore, California)
ASSIGNEE(S)
INVENTOR(S) Stevan Bogdan Jovanovich (Livermore, California);  Kaiwan Chear (Livermore, California);  Bruce Leisz (San Jose, California);  David Eberhart (Santa Clara, California);  John Bashkin (Fremont, California)
ABSTRACT A system, methods, and apparatus are described to collect and prepare single cells, nuclei, subcellular components, and biomolecules from specimens including tissues and in some embodiments use the single cells to form organoids or microtissues. The system can perform enzymatic and/or physical disruption of the tissue to dissociate it into single-cells and then use a hanging droplet method to form organoids or microtissues.
FILED Saturday, June 01, 2019
APPL NO 15/734128
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 41/12 (20130101)
C12M 45/02 (20130101) Original (OR) Class
C12M 45/06 (20130101)
C12M 45/09 (20130101)
C12M 45/20 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/31 (20130101)
G01N 1/286 (20130101)
G01N 1/4077 (20130101)
G01N 2001/4088 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214677 Lyons et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) University of Maryland, Baltimore (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) James Lyons (York, Pennsylvania);  Christopher Ward (Baltimore, Maryland);  Joseph Stains (Laurel, Maryland)
ABSTRACT The present invention relates to a fluid flow device. The device includes an elongate body having a proximal end, a distal end, and a length therebetween, at least one source fluid inflow port, at least one waste fluid outflow port, at least one well inlet port positioned at the distal end of the elongate body, at least one well outlet port positioned at the distal end of the elongate body, at least one conduit connecting the at least one source fluid inflow port to the at least one well inlet port, and at least one conduit connecting the at least one waste fluid outflow port to the at least one well outlet port.
FILED Thursday, January 21, 2021
APPL NO 17/154239
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50853 (20130101)
B01L 2200/026 (20130101)
B01L 2300/046 (20130101)
B01L 2300/0829 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 23/12 (20130101)
C12M 35/04 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/00 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/54366 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214701 DESAI et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Encodia, Inc. (San Diego, California)
ASSIGNEE(S) Encodia, Inc. (San Diego, California)
INVENTOR(S) Kevin DESAI (San Diego, California);  Kevin L. GUNDERSON (San Diego, California);  Robert C. JAMES (San Diego, California);  Lei SHI (San Diego, California);  Stephen VERESPY, III (San Diego, California)
ABSTRACT Provided herein are modified cleavases for removing amino acids from peptides, polypeptides, and proteins. Also provided are methods of using the modified cleavases for treating polypeptides, and kits comprising the modified cleavase. In some embodiments, the methods and the kits also include other components for macromolecule sequencing and/or analysis.
FILED Thursday, March 25, 2021
APPL NO 17/213169
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/485 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214708 BRANON et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Tess BRANON (Stanford, California);  Alice Y. TING (Stanford, California)
ABSTRACT Engineered promiscuous biotin ligases and methods of using them in proximity labeling are described. In particular, the invention provides novel biotin ligase variants having increased promiscuous biotinylation activity capable of proximity labeling of proteins in live cells in as little as 10 minutes.
FILED Friday, January 11, 2019
APPL NO 16/962792
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/93 (20130101) Original (OR) Class

Enzymes
C12Y 603/04015 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/58 (20130101)
G01N 33/6842 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214712 Pakhomova et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) OLD DOMINION UNIVERSITY RESEARCH FOUNDATION (Norfolk, Virginia)
ASSIGNEE(S)
INVENTOR(S) Olga Pakhomova (Norfolk, Virginia);  Andrei G. Pakhomov (Norfolk, Virginia)
ABSTRACT Systems and methods of enhancing membrane permeabilization in a cell are provided. An example method includes disposing the cell between a first electrode and a second electrode and applying a plurality of electrical pulses between the first electrode and the second electrode. In the systems and methods, the plurality of electrical pulses include at least two trains of pulses separated by an interval greater than about 10 s. Further, the amplitude of the electrical pulses is selected to be greater than about 0.2 kV/cm.
FILED Monday, March 29, 2021
APPL NO 17/215773
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/327 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 13/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214722 Shlomchik et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Mark Shlomchik (Pittsburgh, Pennsylvania);  Adriana Turqueti Neves (Olching, Germany);  Eduardo Schittler Neves (Olching, Germany);  Constantinos George Panousis (Pittsburgh, Pennsylvania);  Alexander McIntyre Rowe (Pittsburgh, Pennsylvania)
ABSTRACT This document provides methods and materials involved in cloning functional TCRs from single T cells. For example, methods and materials for obtaining nucleic acid encoding a TCR from a single T cell and arranging that nucleic acid to form nucleic acid vectors successfully designed to express a TCR, kits for obtaining nucleic acid encoding a TCR from a single T cell and arranging that nucleic acid to form nucleic acid vectors successfully designed to express a TCR, methods for making such kits, collections of nucleic acid primers designed to amplify the entire coding sequence of both variable regions for each expressed V segment for functional αβ or γδ TCRs of a particular mammalian species, methods for using such collections of nucleic acid primers to clone functional TCRs from single T cells, and kits containing such collections of nucleic acid primers to clone functional TCRs from single T cells are provided.
FILED Friday, December 18, 2020
APPL NO 17/127773
CURRENT CPC
Peptides
C07K 14/7051 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 15/1096 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/34 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214724 CHOUDHARY et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Army Research Office (ARO)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE BROAD INSTITUTE, INC. (Cambridge, Massachusetts);  THE BRIGHAM AND WOMEN\'S HOSPITAL, INC. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Amit CHOUDHARY (Boston, Massachusetts);  Donghyun LIM (Cambridge, Massachusetts);  Kurt COX (Cambridge, Massachusetts);  Soumyashree Ashok GANGOPADHYAY (Boston, Massachusetts)
ABSTRACT The present inventions generally relate to site-specific delivery of nucleic acid modifiers and includes novel DNA-binding proteins and effectors that can be rapidly programmed to make site-specific DNA modifications. The present inventions also provide a synthetic all-in-one genome editor (SAGE) systems comprising designer DNA sequence readers and a set of small molecules that induce double-strand breaks, enhance cellular permeability, inhibit NHEJ and activate HDR, as well as methods of using and delivering such systems.
FILED Tuesday, October 23, 2018
APPL NO 16/758840
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5153 (20130101)
A61K 31/18 (20130101)
A61K 31/336 (20130101)
A61K 31/655 (20130101)
A61K 31/7088 (20130101)
A61K 38/465 (20130101)
A61K 47/60 (20170801)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101)
C12N 15/11 (20130101) Original (OR) Class
C12N 15/902 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214731 Scadden et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) President and Fellows of Harvard College (Cambrigde, Washington)
ASSIGNEE(S)
INVENTOR(S) David T. Scadden (Weston, Massachusetts);  Cheuk-Him Man (Kowloon, China Hong Kong)
ABSTRACT Disclosed are methods for treating cancers (e.g., AML) having increased intracellular pH, including AML overexpressing MCT4. Also disclosed are methods of modulating cell growth by modulating intracellular pH.
FILED Wednesday, September 09, 2020
APPL NO 17/016209
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/192 (20130101)
A61K 31/551 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/02 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1138 (20130101) Original (OR) Class
C12N 2310/531 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214732 Close et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) 490 BioTech, Inc. (Knoxville, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Daniel Close (Knoxville, Tennessee);  Steven Ripp (Knoxville, Tennessee);  Gary Sayler (Blaine, Tennessee);  Michael Conway (Medford, Massachusetts)
ABSTRACT The present disclosure relates to cells, including stem cells, comprising an autobioluminescent phenotype, wherein the cells emit a luminescent signal in the absence of an exogenous luminescent stimulator. The luminescent signal may be constitutive, inducible, repressible, or tissue-specific. The cells express a synthetically engineered bacterial luciferase (lux) cassette, i.e., the luxCDABEfrp gene cassette. The cells may comprise luxA, luxB, luxC, luxD, luxE, and flavin reductase. The cells may each express a combined expression level of luxC, luxD, luxE, and flavin reductase that is from ten to forty times greater than a combined expression level of luxA and luxB. Further, methods of making and using the cells comprising an autobioluminescent phenotype are disclosed herein.
FILED Tuesday, March 23, 2021
APPL NO 17/210131
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0607 (20130101)
C12N 15/64 (20130101) Original (OR) Class
C12N 15/85 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/66 (20130101)

Enzymes
C12Y 105/0103 (20130101)
C12Y 114/14003 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5014 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214734 Mollapour et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Research Foundation for the State University of New York (Albany, New York)
ASSIGNEE(S)
INVENTOR(S) Mehdi Mollapour (Fayetteville, New York);  Giorgio Colombo (Pavia, Italy);  Mark Woodford (Baldwinsville, New York);  Gennady Bratslavsky (Fayetteville, New York);  Dimitra Bourboulia (Fayetteville, New York)
ABSTRACT The present disclosure relates to a method of identifying an agent-of-interest that alters binding or activity of a client protein to a chaperone, co-chaperone, or chaperone-co-chaperone complex, the method including: determining a three-dimensional (3D) structure of a client protein-of-interest; evaluating the 3D structure of the client protein-of-interest to identify an unstable substructure of the 3D structure of the client protein-of-interest; and determining an amino acid sequence of the unstable substructure of the 3D structure of the client protein-of-interest to identify an agent-of-interest that alters binding or activity of a client protein to a chaperone, co-chaperone, or chaperone-co-chaperone complex.
FILED Monday, November 16, 2020
APPL NO 17/099692
CURRENT CPC
Peptides
C07K 14/4702 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/62 (20130101)
C12N 15/70 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214751 Kaler
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Dept. of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Dept. of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Stephen G. Kaler (Bethesda, Maryland)
ABSTRACT Disclosed herein are codon-optimized nucleic acids encoding a reduced-size ATP7A protein. Also disclosed are vectors and recombinant viruses (such as recombinant adeno-associated viruses) including the codon-optimized nucleic acids encoding the reduced-size ATP7A protein and compositions including the disclosed vectors and viruses. Further disclosed herein are methods of treating copper transport disorders, for example by administering a disclosed nucleic acid, vector, or recombinant virus to a subject with a copper transport disorder, such as Menkes disease, occipital horn syndrome, or ATP7A-related distal motor neuropathy.
FILED Tuesday, March 30, 2021
APPL NO 17/217961
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 33/34 (20130101)
A61K 38/46 (20130101)
A61K 48/005 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 3/00 (20180101)
A61P 25/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/14 (20130101)
C12N 15/86 (20130101) Original (OR) Class
C12N 2800/22 (20130101)

Enzymes
C12Y 306/03004 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214758 CHATTOPADHYAY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) ID GENOMICS, INC. (Seattle, Washington)
ASSIGNEE(S)
INVENTOR(S) Sujay CHATTOPADHYAY (Kolkata, West Bengal, India);  Veronika TCHESNOKOVA (Seattle, Washington);  Elena RECHKINA (Seattle, Washington)
ABSTRACT The present disclosure provides methods and compositions for generating clonotypes from input nucleic acid sequences. Presently disclosed clonotype generating methods produce accurate and efficient indicators of genetic relatedness and diversity, including for example, of pathogenic organisms such as infectious bacteria. Also provided are primers, kits, and related methods for determining antibiotic susceptibility of a pathogenic organism, such as, for example, Klebsiella, and for treating an infection by one or more pathogenic Discard organisms on the basis of herein disclosed clonotypes and clonotype-generating methods.
FILED Monday, May 06, 2019
APPL NO 17/053727
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1089 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/30 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/689 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214773 HE et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) The University of Chicago (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Chuan HE (Chicago, Illinois);  Xiaocheng WENG (Chicago, Illinois);  Tong WU (Chicago, Illinois)
ABSTRACT Embodiments are directed to N3-kethoxal reagents and derivatives thereof, and related methods that allow fast and reversible labeling of single-stranded nucleic acids in live cells. By way of example, one aspect is directed to a process for reversible labeling of single-stranded guanine bases in live cells, which results in an effective in vivo method for transcriptome-wide RNA secondary structure mapping and RNA G-quadruplex prediction.
FILED Wednesday, May 08, 2019
APPL NO 17/250023
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 69/003 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214778 Makrigiorgos et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Gerassimos Makrigiorgos (Chestnut Hill, Massachusetts);  Cloud P. Paweletz (Boston, Massachusetts)
ABSTRACT Disclosed herein are methods to improve the efficiency of absolute quantification of nucleic acid targets such as digital PCR and digital isothermal amplification, and/or reduce the amount of nucleic acid sample required to determine the absolute quantity of target sequences in the sample.
FILED Friday, May 24, 2019
APPL NO 17/057936
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101)
C12Q 1/6848 (20130101) Original (OR) Class
C12Q 2600/156 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214781 Patel
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
APPLICANT(S) Abhijit Ajit Patel (Madison, Connecticut)
ASSIGNEE(S)
INVENTOR(S) Abhijit Ajit Patel (Madison, Connecticut)
ABSTRACT The current document is directed to methods and compositions that enable simplified, sensitive, and accurate quantification of nucleic acids, including sequence variations and epigenetic modifications. Some methods enable highly sensitive measurement of low-abundance nucleic acid variants from a complex mixture of nucleic acid molecules.
FILED Wednesday, November 25, 2020
APPL NO 17/105188
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
C12Q 1/6869 (20130101) Original (OR) Class
C12Q 1/6883 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215471 Lipson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Michal Lipson (New York, New York);  Xingchen Ji (New York, New York);  Alexander Klenner (New York, New York);  Xinwen Yao (Baltimore, Maryland);  Yu Gan (Harriston, New Jersey);  Alexander L. Gaeta (New York, New York);  Christine P Hendon (Bronx, New York)
ABSTRACT A method of providing optical coherence tomography (OCT) imaging may comprise using an on-chip frequency comb source interfaced with an OCT system by a circulator as an imaging source and reconstructing OCT images from resulting spectral data from target tissue illuminated by the imaging source.
FILED Friday, August 10, 2018
APPL NO 16/100401
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0066 (20130101)
A61B 5/7257 (20130101)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02083 (20130101)
G01B 9/02091 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215672 Teitell et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Michael A. Teitell (Tarzana, California);  Thomas A. Zangle (Salt Lake City, Utah);  Owen M. Witte (Sherman Oaks, California);  Daina Burnes Linton (Marina Del Rey, California)
ABSTRACT In certain embodiments methods of identifying T cell receptors that respond to specific target cell antigens are provided, where the methods comprise providing a substrate bearing a plurality of target cells (e.g., mammalian cells); contacting the target cells on the substrate with CD8+ T cells; and using label-free optical imaging to identify an increase in mass of a T-cell and/or a decrease in mass of a target cell, where an increase in mass of a T cell and/or a decrease in mass of a target cell is an indicator that said T cell bears a T cell receptor activated by antigens presented on said target cell.
FILED Thursday, December 17, 2020
APPL NO 17/125855
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02015 (20130101)
G01B 11/06 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/505 (20130101) Original (OR) Class
G01N 2333/70517 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215679 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey);  Sogang University (Seoul, South Korea)
ASSIGNEE(S)
INVENTOR(S) Ki-Bum Lee (Piscataway, New Jersey);  Jin-Ho Lee (Piscataway, New Jersey);  Jeong-Woo Choi (Seoul, South Korea);  Jin-Ha Choi (Seoul, South Korea)
ABSTRACT Nanorod devices for isolating and characterizing target cellular components are provided. Methods of isolating, detecting, and/or characterizing the components are also provided. Methods of use and treatment are further disclosed, such as treating diseases identified using the nanorods and/or using differentiated stem cells identified using the provided nanorods.
FILED Wednesday, January 06, 2021
APPL NO 17/142950
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 25/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6428 (20130101)
G01N 33/533 (20130101) Original (OR) Class

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 1/40 (20130101)
H01F 3/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215684 Beebe et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) David J. Beebe (Monona, Wisconsin);  Scott M. Berry (Madison, Wisconsin)
ABSTRACT A device and a method for isolating a target from a sample are provided. The target is bound to solid phase substrate to form a target bound solid phase substrate. The device includes a first plate having a first region for receiving at least a portion of the sample. A second plate is spaced from the first plate by a distance and has a first region for receiving a reagent. A force attracts the target bound solid phase substrate toward the first region of the second plate such that the target bound solid phase substrate in the portion of the sample are drawn through the air gap and into the reagent by the force.
FILED Wednesday, March 10, 2021
APPL NO 17/197243
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/5085 (20130101)
B01L 3/5088 (20130101)
B01L 2200/16 (20130101)
B01L 2300/161 (20130101)
B01L 2300/0819 (20130101)
B01L 2400/043 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/34 (20130101)
G01N 1/405 (20130101)
G01N 33/54326 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 436/25375 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215696 Weiss et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Emory University (Atlanta, Georgia)
ASSIGNEE(S)
INVENTOR(S) David Weiss (Decatur, Georgia);  Victor Band (Decatur, Georgia);  David Hufnagel (Atlanta, Georgia)
ABSTRACT This disclosure contemplates detecting antimicrobial heteroresistance to guide antibiotic or other antimicrobial therapy. In certain embodiments, this disclosure contemplates avoiding a monotherapy with antibiotics to which an individual bacterial isolate is heteroresistant, because this can lead to treatment failure. Thus, in certain embodiments, one uses a combination of antibiotics to which a bacterium is individually heteroresistant.
FILED Friday, March 26, 2021
APPL NO 17/214332
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56961 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215700 Hughes
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Steven J. Hughes (Gainesville, Florida)
ABSTRACT Disclosed herein is a soluble protein signature from the tumor microenvironment that can predict overall survival post-surgery in pancreatic adenocarcinoma. The disclosed protein signatures provide a precision approach to surgical therapy for patients with pancreatic cancer. Also disclosed herein is a soluble protein signature from the tumor microenvironment that can diagnose pancreatic ductal adenocarcinoma (PDAC). Also disclosed herein are proteins that can be used to accurately normalize protein levels in a pancreatic sample.
FILED Friday, May 31, 2019
APPL NO 17/059727
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57438 (20130101) Original (OR) Class
G01N 33/57484 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215703 McDevitt et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) NEW YORK UNIVERSITY (New York, New York)
ASSIGNEE(S)
INVENTOR(S) John T. McDevitt (New York, New York);  Michael P. McRae (Houston, Texas)
ABSTRACT The present disclosure is related to systems and methods to be used as aids in the diagnosis of risk for oral cancer, potentially malignant oral lesion (PMOL), and/or oral epithelial dysplasia (OED) by identifying cellular phenotype characteristics of cell samples, including percentage of mature squamous cells, presence or absence of nuclear actin in mature squamous cells, percentage of non-mature squamous cells, percentage of small round cells, percentage of white blood cells, and percentage of lone nuclei.
FILED Wednesday, January 13, 2021
APPL NO 17/147681
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57492 (20130101) Original (OR) Class

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 10/40 (20180101)
G16H 10/60 (20180101)
G16H 50/20 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215706 MARCOTTE et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Office of the Director (NIHOD)
APPLICANT(S) Board of Regents, The University of Texas System (Austin, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Edward MARCOTTE (Austin, Texas);  Eric ANSLYN (Austin, Texas);  Jagannath SWAMINATHAN (Austin, Texas);  Angela M. BARDO (Austin, Texas);  Caroline M. HINSON (Austin, Texas);  Cecil HOWARD (Austin, Texas);  Brendan FLOYD (Austin, Texas)
ABSTRACT The present disclosure provides methods of selectively label an amino acid residue on a peptide by replacing a post translational modification with a labeling moiety and sequencing the peptide to obtain the location of the amino acid residue and the identity of the post translational modification. In some aspects, the disclosure also provides methods of identifying the position, quantity, the identity of a post translational modification, or any combination thereof, in peptides which may be used for therapeutic purposes.
FILED Friday, January 22, 2021
APPL NO 17/155298
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/582 (20130101)
G01N 33/6818 (20130101) Original (OR) Class
G01N 2440/10 (20130101)
G01N 2440/12 (20130101)
G01N 2440/14 (20130101)
G01N 2440/18 (20130101)
G01N 2440/26 (20130101)
G01N 2440/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215707 MARCOTTE et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Office of the Director (NIHOD)
APPLICANT(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
ASSIGNEE(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Edward MARCOTTE (Austin, Texas);  Eric ANSLYN (Austin, Texas);  Alexander BOULGAKOV (Austin, Texas);  Angela M. BARDO (Austin, Texas);  Siyuan Stella WANG (Austin, Texas);  Jagannath SWAMINATHAN (Austin, Texas);  Fan TU (Austin, Texas)
ABSTRACT The present disclosure provides methods of identifying and quantifying the peptides displayed by the major histocompatibility complex (MHC). Such methods may comprise the ability to determine the type, identity, and quantity of each peptide displayed by the MHC. In some embodiments, these methods may be used to develop an anti-cancer therapy or type the HLA of a patient. Also provided herein are compositions comprising peptides from the MHC which have been prepared for sequencing.
FILED Wednesday, August 14, 2019
APPL NO 17/268162
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/582 (20130101)
G01N 33/6818 (20130101) Original (OR) Class
G01N 33/54306 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 50/00 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215708 Shu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Xiaokun Shu (San Francisco, California);  Qiang Zhang (Daly City, California);  Chan-I Chung (San Francisco, California)
ABSTRACT The invention is a novel reporter system for measuring protein-protein interactions. The system uses a pair of functionalized coiled coil subunits that spontaneously form two separate homo-oligomers when expressed in cells. The coiled coil subunits are functionalized with fluorescent proteins and complementary interacting proteins. Upon an activation stimulus which promotes the protein-protein interaction, the interacting proteins drive the formation of multivalent aggregates of the homo-oligomers in phase-shifted droplets. The highly concentrated fluorescent proteins in these structures provide high brightness over background fluorescence and a readily observed, quantitative and dynamic indicator of the protein-protein interaction. The reporters and assay methods are amenable to cells and whole organisms.
FILED Tuesday, October 02, 2018
APPL NO 16/838023
CURRENT CPC
Peptides
C07K 14/4705 (20130101)
C07K 14/4746 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/12 (20130101)
C12N 9/0028 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/542 (20130101)
G01N 33/582 (20130101)
G01N 33/6845 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215720 O\'Bryant
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) University of North Texas Health Science Center at Fort Worth (Fort Worth, Texas)
ASSIGNEE(S)
INVENTOR(S) Sid E. O\'Bryant (Aledo, Texas)
ABSTRACT The present disclosure relates to a method of treating a subject having a proinflammatory endophenotype profile with celecoxib or naproxen to improve cognition or to prevent cognitive decline or dysfunction in the subject. In another aspect, the present disclosure relates to a method of screening a subject for inclusion an NSAID or a PPAR-γ agonist clinical trial. In another aspect, the present disclosure relates to a method of determining a surrogate outcome of an NSAID or a PPAR-γ agonist clinical trial. In yet another aspect, the present disclosure relates to a method of treating an Alzheimer\'s disease patient having both a proinflammatory endophenotype profile and a metabolic endophenotype profile with a PPAR-γ agonist to improve cognition or to prevent cognitive decline or dysfunction in the patient.
FILED Friday, March 05, 2021
APPL NO 17/193907
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6896 (20130101) Original (OR) Class
G01N 2800/52 (20130101)
G01N 2800/60 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216351 Chaterji et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Somali Chaterji (West Lafayette, Indiana);  Saurabh Bagchi (West Lafayette, Indiana);  Ashraf Mahgoub (West Lafayette, Indiana)
ABSTRACT A system may forecast a workload for a cluster of nodes in a database management system. The system may generate a reconfiguration plan based on the forecasted workload. The system may obtain a heterogenous configuration set. The heterogenous configuration set may include respective configuration sets for the complete sets of nodes. The system may forecast, based on a first machine learning model, respective performance metrics for nodes in each of the complete sets. The system may forecast a cluster performance metric for the entire cluster of nodes based on a second machine learning model. The system may include, in response to satisfaction of an acceptance criterion, the heterogenous configuration set in the reconfiguration plan. The system may cause the cluster of nodes to be reconfigured based on the reconfiguration plan.
FILED Thursday, December 31, 2020
APPL NO 17/139958
CURRENT CPC
Electric Digital Data Processing
G06F 9/3891 (20130101)
G06F 9/44505 (20130101)
G06F 9/45558 (20130101) Original (OR) Class
G06F 16/182 (20190101)
G06F 2009/4557 (20130101)
G06F 2009/45583 (20130101)

Computer Systems Based on Specific Computational Models
G06N 20/00 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217213 Cole et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Elizabeth K. Cole (Stanford, California);  Shreyas S. Vasanawala (Stanford, California);  Frank Ong (Los Altos, California);  John M. Pauly (Stanford, California)
ABSTRACT A method of magnetic resonance imaging acquires undersampled MRI data and generates by an adversarially trained generative neural network MRI data having higher quality without using any fully-sampled data as a ground truth. The generative neural network is adversarially trained using a discriminative neural network that distinguishes between undersampled MRI training data and candidate undersampled MRI training data produced by applying an MRI measurement function containing an undersampling mask to generated MRI training data produced by the generative neural network from the undersampled MRI training data.
FILED Monday, January 13, 2020
APPL NO 16/740655
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101)

Image Data Processing or Generation, in General
G06T 5/10 (20130101)
G06T 11/006 (20130101) Original (OR) Class
G06T 2207/10088 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/20084 (20130101)
G06T 2210/41 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217490 MISHRA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Science Foundation (NSF)
APPLICANT(S) NEW YORK UNIVERSITY (New York, New York)
ASSIGNEE(S) NEW YORK UNIVERSITY (, None)
INVENTOR(S) Bhubaneswar MISHRA (Great Neck, New York);  Giuseppe NARZISI (New York, New York)
ABSTRACT Exemplary methods, procedures, computer-accessible medium, and systems for base-calling, aligning and polymorphism detection and analysis using raw output from a sequencing platform can be provided. A set of raw outputs can be used to detect polymorphisms in an individual by obtaining a plurality of sequence read data from one or more technologies (e.g., using sequencing-by-synthesis, sequencing-by-ligation, sequencing-by-hybridization, Sanger sequencing, etc.). For example, provided herein are exemplary methods, procedures, computer-accessible medium and systems, which can include and/or be configured for obtaining raw output from a sequencing platform configured to be used for reading fragment(s) of genomes, obtaining reference sequences for the genomes obtained independently from the raw output, and generating a base-call interpretation and/or alignment using the raw output and the reference sequences. For example, a score function can be determined based on information associated with the sequencing platform that can be used to analyze polymorphisms based on the base-call interpretation and/or alignment.
FILED Monday, March 29, 2021
APPL NO 17/216000
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 30/00 (20190201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218485 KOVACH
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) UNIVERSITY OF IOWA RESEARCH FOUNDATION (IOWA CITY, Iowa)
ASSIGNEE(S)
INVENTOR(S) CHRISTOPHER K. KOVACH (IOWA CITY, Iowa)
ABSTRACT The invention addresses the problem of recovering an unknown signal from multiple records of brief duration which are presumed to contain the signal at mutually random delays in a background of independent noise. The scenario is relevant to many applications, among which are the recovery of weak transients from large arrays of sensors and the identification of recurring patterns through a comparison of sequential intervals within a single record of longer duration. A simple and practical approach is provided by solving this problem through higher-order spectra is developed. Applying the method to the third-order spectrum, the bispectrum, leads to filters derived from cross bicoherence.
FILED Wednesday, July 03, 2019
APPL NO 17/058727
CURRENT CPC
Transmission
H04B 7/0842 (20130101)
H04B 17/318 (20150115)
H04B 17/336 (20150115)
H04B 17/364 (20150115) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218998 Ong et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California);  The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Frank Ong (Los Altos, California);  John M. Pauly (Stanford, California);  Shreyas S. Vasanawala (Stanford, California);  Michael Lustig (Moraga, California);  Nien Sin Cedric Yue Sik Kin (San Carlos, California)
ABSTRACT A method of medical imaging includes performing a medical imaging scan to produce acquired imaging data; reconstructing from the acquired imaging data a multi-dimensional medical imaging dataset in the form of a sliceable compressed representation where the reconstruction does not at any stage create full decompressed images; and producing from the sliceable compressed representation a selected image slice by decompressing only a subset of the sliceable compressed representation. The sliceable compressed representation may be stored in a lossless format, and the selected image slice may be displayed on a viewer for visualization.
FILED Monday, January 11, 2021
APPL NO 17/146355
CURRENT CPC
Pictorial Communication, e.g Television
H04N 19/63 (20141101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 20210213101 Chen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) The Schepens Eye Research Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Dong Feng Chen (Newtonville, Massachusetts);  Chenying Guo (Malden, Massachusetts)
ABSTRACT Disclosed is a method of promoting neuronal growth by administering IGFBPL-1, or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need thereof, e.g., a subject in need of treating optic nerve degeneration.
FILED Wednesday, October 14, 2020
APPL NO 17/070596
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/352 (20130101)
A61K 31/708 (20130101)
A61K 31/711 (20130101)
A61K 31/713 (20130101)
A61K 31/7004 (20130101)
A61K 31/7088 (20130101)
A61K 31/7105 (20130101)
A61K 38/18 (20130101) Original (OR) Class
A61K 38/22 (20130101)
A61K 38/30 (20130101)
A61K 38/1738 (20130101)
A61K 38/1841 (20130101)
A61K 38/2278 (20130101)
A61K 45/06 (20130101)
A61K 49/0056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213115 PEOPLES
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USU)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
APPLICANT(S) The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
ASSIGNEE(S)
INVENTOR(S) George E. PEOPLES (Spring Branch, Texas)
ABSTRACT Provided are methods for inducing and maintaining protective immunity against a tumor expressing FRα in a subject, comprising the administration of one or more peptide vaccines according to a particular dosages or particular dosage regimens.
FILED Monday, November 23, 2020
APPL NO 17/101985
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/08 (20130101)
A61K 39/0011 (20130101) Original (OR) Class
A61K 2039/54 (20130101)
A61K 2039/545 (20130101)
A61K 2039/55522 (20130101)

Peptides
C07K 14/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213159 Kudela et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Army Research Office (ARO)
APPLICANT(S) The Regents of the University of California (Oakland, California);  The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S)
INVENTOR(S) Damien Kudela (Santa Barbara, California);  Galen D. Stucky (Santa Barbara, California);  Anna May-Masnou (Barcelona, Spain);  Gary Bernard Braun (San Diego, California);  James H. Morrissey (Champaign, Illinois);  Stephanie A. Smith (Urbana, Illinois)
ABSTRACT A hemostatic composition is provided. The hemostatic composition includes a hemostatically effective amount of a hemostatic agent that includes a nanoparticle and a polyphosphate polymer attached to the nanoparticle. Also provided are medical devices and methods of use to promote blood clotting.
FILED Monday, November 16, 2020
APPL NO 17/099400
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/595 (20170801)
A61K 47/6923 (20170801)
A61K 47/6935 (20170801)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 24/02 (20130101)
A61L 24/046 (20130101) Original (OR) Class
A61L 2300/404 (20130101)
A61L 2300/418 (20130101)
A61L 2400/04 (20130101)
A61L 2400/12 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2982 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213170 Taboas et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Juan M. Taboas (Pittsburgh, Pennsylvania);  Alejandro Jose Almarza (Pittsburgh, Pennsylvania);  Jingming Chen (Chicago, Illinois)
ABSTRACT Biomaterials disclosed herein can comprise a hydrogel comprising PEG, gelatin, and a glycosaminoglycan with sulfated moiety; and chondrogenic, osteogenic, and immunomodulatory cytokines; wherein the biomaterial is capable of potentiating bone regeneration in a compromised wound while reducing inflammatory response. The glycosaminoglycan with sulfated moiety can comprise heparin, heparan sulfate, keratin sulfate, chondroitin sulfate, dermatan sulfate, and/or similar materials. The biomaterial can further comprise mesenchymal stem cells (MSCs), a crosslinking initiator, microparticles and nanoparticles, and or other materials. The biomaterial can be injectable into a wound, or the biomaterial can be loaded in, or further comprise a porous scaffold providing mechanical support for other components of the biomaterial, such that it can be implanted into a wound.
FILED Thursday, June 13, 2019
APPL NO 17/055046
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/52 (20130101)
A61L 27/54 (20130101)
A61L 27/3834 (20130101)
A61L 27/3847 (20130101) Original (OR) Class
A61L 2300/236 (20130101)
A61L 2300/252 (20130101)
A61L 2300/414 (20130101)
A61L 2300/426 (20130101)
A61L 2400/06 (20130101)
A61L 2430/02 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/19 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213191 BRUGGER et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) NxStage Medical, Inc. (Lawrence, Massachusetts)
ASSIGNEE(S) NxStage Medical, Inc. (Lawrence, Massachusetts)
INVENTOR(S) James M. BRUGGER (Newburyport, Massachusetts);  David DESOUZA (Essex, Massachusetts)
ABSTRACT Simple-to-use systems, methods, and devices for priming replacement blood treatment devices, for swapping the blood treatment devices out, for replacing swapped-out blood treatment devices, and other related operations are described. In embodiments, a blood treatment device can be primed while a therapy is still running. When the replacement blood treatment device is needed, the therapy can be stopped momentarily (less than a minute) for the rapid and safe swap of the blood treatment device. Blood loss can be minimized. The down time from therapy can be minimized.
FILED Wednesday, March 31, 2021
APPL NO 17/218860
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/3629 (20140204)
A61M 1/3643 (20130101) Original (OR) Class
A61M 1/3644 (20140204)
A61M 1/3646 (20140204)
A61M 1/3652 (20140204)
A61M 1/3672 (20130101)
A61M 39/10 (20130101)
A61M 2205/702 (20130101)
A61M 2205/705 (20130101)
A61M 2205/707 (20130101)
A61M 2205/3331 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213523 Peterson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Research Office (ARO)
United States Army (USA)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Office of Experimental Program To Stimulate Competitive Research (EPSCOR)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia);  South Dakota School of Mines (Rapid City, South Dakota)
ASSIGNEE(S)
INVENTOR(S) G. P. "Bud" Peterson (Atlanta, Georgia);  Haiping Hong (Rapid City, South Dakota)
ABSTRACT Disclosed herein is a method of homogeneously mixing solids, comprising: mixing, in a fluid medium, at least a first Got nanoparticle material and a surfactant, wherein the surfactant causes the first nanoparticle material to distribute uniformly in the fluid medium and have a specific charge; adding, to the fluid medium, a second nanoparticle material, wherein the surfactant has a charge of opposite polarity to the zeta potential of the second nanoparticle material; attaching the second nanoparticle material to the first Nnanoparticle material using the charge attraction of the surfactant and the second nanoparticle material to obtain a homogeneous material; and removing the attached first and second nanoparticle materials from the fluid medium to obtain a solid homogeneous material.
FILED Friday, May 10, 2019
APPL NO 17/054202
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 1/0022 (20130101) Original (OR) Class
B22F 1/0074 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/174 (20170801)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214101 Hoffman
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) United States of America as Represented by The Secretary of The Army (Alexandria, Virginia)
ASSIGNEE(S)
INVENTOR(S) Nolan R. Hoffman (Vicksburg, Mississippi)
ABSTRACT In one embodiment, tie-down assembly is provided for securing a parked aircraft to a slab of an aircraft mooring area. The assembly includes a support structure having a first side wall, a second side wall, a first end cover coupled with the first side wall and the second side wall, and a second end cover coupled with the first side wall and the second side wall. The assembly also includes a connector rod coupled with the first side wall and the second side wall, a talon pivot rod coupled with the first side wall and the second side wall, a first talon rotatably coupled with the talon pivot rod, a second talon rotatably coupled with the talon pivot rod, a first depth adjustment mechanism coupled with the first talon, and a second depth adjustment mechanism coupled with the second talon.
FILED Tuesday, January 14, 2020
APPL NO 16/742841
CURRENT CPC
Ground or Aircraft-carrier-deck Installations Specially Adapted for Use in Connection With Aircraft; Designing, Manufacturing, Assembling, Cleaning, Maintaining or Repairing Aircraft, Not Otherwise Provided For; Handling, Transporting, Testing or Inspecting Aircraft Components, Not Otherwise Provided for
B64F 1/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214303 ZARE et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
United States Air Force (USAF)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California);  UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (Cludad de Mexico, Coyacan, Mexico);  INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN (Cludad de Mexico, Alcaldia Tlalpan, Mexico)
ASSIGNEE(S)
INVENTOR(S) Richard Neil ZARE (Stanford, California);  Jose Ignacio VEYTIA-BUCHELI (San Luis Potosi, Mexico);  Edson Norberto Carcamo NORIEGA (Cuernavaca, Mexico);  Gnanamani ELUMALAI (Stanford, California);  Shyam SATHYAMOORTHI (Stanford, California);  Lourival Domingos POSSANI POSTAY (Cuernavaca, Mexico);  Shibdas BANERJEE (Howrah, India);  Rogelio Enrique HERNANDEZ PANDO (Ciudad de Mexico, Mexico)
ABSTRACT Provided are colored 1,4-benzoquinone compounds obtained by oxidation of precursor molecules from the venom of the scorpion Diplocentrus melici (Diplocentridae family). Schemes for the chemical synthesis of these compounds using reagents commercially available are also provided. Biological assays show that the red compound (3,5-dimethoxy-2-(methylthio)cyclohexa-2,5-diene-1,4-dione) is very effective at killing Staphylococcus aureus and that the blue compound (5-methoxy-2,3-bis(methylthio)cyclohexa-2,5-diene-1,4-dione) has remarkable activity against Mycobacterium tuberculosis. The blue compound is effective against multi-drug-resistant tuberculosis (MDR-TB) and is not detrimental to lung epithelium. Both compounds were found to be cytotoxic to human neoplastic cell lines and to mononuclear cells (PBMCs).
FILED Monday, May 20, 2019
APPL NO 17/058962
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)
A61P 35/02 (20180101)

Acyclic or Carbocyclic Compounds
C07C 319/20 (20130101)
C07C 323/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214469 Chen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Research Foundation of the City University of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Xi Chen (New York, New York);  Rein V. Ulijn (New York, New York);  Zhi-Lun Liu (New York, New York);  Yi-Ren Wang (San Jose, California);  Daniela Kroiss (New York, New York);  Haozhen Wang (New York, New York)
ABSTRACT A rotary engine that generates electricity using differences in relative humidity. A water-responsive material expands and contracts as water evaporates which drives the rotation of two wheels. The rotary motion drives an electrical generator which produces electricity. In another embodiment, the water-responsive material is used to actuate an artificial muscle of a robotic device.
FILED Friday, March 26, 2021
APPL NO 17/214132
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/0015 (20130101)

Polysaccharides; Derivatives Thereof
C08B 37/0081 (20130101) Original (OR) Class

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 105/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214505 WAGENER et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Research Office (ARO)
APPLICANT(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Kenneth B. WAGENER (Gainesville, Florida);  Taylor W. GAINES (Chandler, Arizona);  Michael BELL (North East, Maryland);  Julia Grace PRIBYL (Gainesville, Florida)
ABSTRACT A polysulfone has sulfone units that are separated by alkylene units in a polymer chain or a copolymer chain where the alkylene units have at least four carbons between sulfone units. The alkylene units can include an ethenylene unit separated from the sulfone units by at least one methylene units. The polysulfones can be crosslinked for enhanced thermal stability. Membranes can be formed from the polysulfones.
FILED Tuesday, January 19, 2021
APPL NO 17/152164
CURRENT CPC
Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 75/22 (20130101) Original (OR) Class

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 3/242 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214664 RAO et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (BALTIMORE, Maryland)
ASSIGNEE(S)
INVENTOR(S) GOVIND RAO (ELLICOTT CITY, Maryland);  YORDAN KOSTOV (COLUMBIA, Maryland);  ABHAY ANDAR (GAITHERSBURG, Maryland);  MUSTAFA AL-ADHAMI (SILVER SPRING, Maryland)
ABSTRACT The present invention provides for a fully integrated microfluidic system capable of producing single-dose amounts of biotherapeutics at the point-of-care wherein protein production, purification and product harvest are all integrated as a single microfluidic device which is portable and capable of continuous-flow production of biotherapeutics at the microscale using a cell-free reaction system.
FILED Thursday, June 07, 2018
APPL NO 16/618473
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 23/16 (20130101) Original (OR) Class
C12M 23/44 (20130101)
C12M 27/00 (20130101)
C12M 29/20 (20130101)
C12M 33/14 (20130101)
C12M 41/12 (20130101)
C12M 41/26 (20130101)
C12M 41/28 (20130101)
C12M 41/40 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214698 Liu et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) David R. Liu (Cambridge, Massachusetts);  John Paul Guilinger (Cambridge, Massachusetts);  David B. Thompson (Cambridge, Massachusetts)
ABSTRACT Some aspects of this disclosure provide compositions, methods, and kits for improving the specificity of RNA-programmable endonucleases, such as Cas9. Also provided are variants of Cas9, e.g., Cas9 dimers and fusion proteins, engineered to have improved specificity for cleaving nucleic acid targets. Also provided are compositions, methods, and kits for site-specific nucleic acid modification using Cas9 fusion proteins (e.g., nuclease-inactivated Cas9 fused to a nuclease catalytic domain or a recombinase catalytic domain). Such Cas9 variants are useful in clinical and research settings involving site-specific modification of DNA, for example, genomic modifications.
FILED Tuesday, November 24, 2020
APPL NO 17/103233
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 38/465 (20130101)

Peptides
C07K 14/315 (20130101)
C07K 2319/80 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 9/1241 (20130101)
C12N 15/01 (20130101)
C12N 15/907 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214713 Bashor et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Molecular and Cellular Biosciences (MCB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Trustees of Boston University (Boston, Massachusetts)
INVENTOR(S) Caleb J. Bashor (Boston, Massachusetts);  Jason Hung-Ying Yang (Watertown, Massachusetts);  Arnaud Gutierrez (Somerville, Massachusetts);  Wooseok Steven Ahn (Tenafly, New Jersey);  James J. Collins (Newton, New Jersey);  Brandon Gei-Chin Wong (Brighton, Massachusetts);  Ahmad S. Khalil (Lexington, Massachusetts)
ABSTRACT Disclosed herein are a high-throughput continuous culture system and novel methodologies for the experimental evolution of natural and synthetic microbes using the continuous culture system. The microbial culture is exposed to a stress ramp function which is overlaid on top of a culture fitness function. The amount of stress applied to the culture is increased in response to increased fitness of the microbial culture.
FILED Saturday, February 17, 2018
APPL NO 16/081975
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 41/36 (20130101)
C12M 41/46 (20130101)
C12M 41/48 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/36 (20130101)
C12N 15/01 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214724 CHOUDHARY et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Army Research Office (ARO)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE BROAD INSTITUTE, INC. (Cambridge, Massachusetts);  THE BRIGHAM AND WOMEN\'S HOSPITAL, INC. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Amit CHOUDHARY (Boston, Massachusetts);  Donghyun LIM (Cambridge, Massachusetts);  Kurt COX (Cambridge, Massachusetts);  Soumyashree Ashok GANGOPADHYAY (Boston, Massachusetts)
ABSTRACT The present inventions generally relate to site-specific delivery of nucleic acid modifiers and includes novel DNA-binding proteins and effectors that can be rapidly programmed to make site-specific DNA modifications. The present inventions also provide a synthetic all-in-one genome editor (SAGE) systems comprising designer DNA sequence readers and a set of small molecules that induce double-strand breaks, enhance cellular permeability, inhibit NHEJ and activate HDR, as well as methods of using and delivering such systems.
FILED Tuesday, October 23, 2018
APPL NO 16/758840
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5153 (20130101)
A61K 31/18 (20130101)
A61K 31/336 (20130101)
A61K 31/655 (20130101)
A61K 31/7088 (20130101)
A61K 38/465 (20130101)
A61K 47/60 (20170801)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101)
C12N 15/11 (20130101) Original (OR) Class
C12N 15/902 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214776 Henley et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
ASSIGNEE(S)
INVENTOR(S) William Hampton Henley (Chapel Hill, North Carolina);  Elizabeth Ann Dethoff (Chapel Hill, North Carolina);  John Michael Ramsey (Chapel Hill, North Carolina)
ABSTRACT Provided are compounds, compositions, kits, systems, devices, and methods for improving an assay such as, for example, a multiplexed PCR assay (e.g., a multiplexed immuno-PCR assay). A solid support (e.g., a bead) may be provided according to some embodiments of the present invention. The solid support may comprise an encoding agent (e.g., a dye), a nucleic acid sequence (e.g., an oligonucleotide and/or primer); and a molecular recognition element (e.g., an antibody). A detection reagent may be provided according to some embodiments of the present invention. The detection reagent may comprise a molecular recognition element (e.g., an antibody) and a nucleic acid tag. In some embodiments, at least a portion of the nucleic acid sequence of the solid support and at least a portion of the nucleic acid target tag of the detection reagent are configured to participate in a nucleic acid amplification process. A solid support and detection reagent may bind to the same target, thereby forming a reagent pair.
FILED Tuesday, September 24, 2019
APPL NO 17/048115
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6818 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214856 Grotjohn et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
U.S. Air Force
APPLICANT(S) BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (East Lansing, Michigan);  Fraunhofer USA (Plymouth, Michigan)
ASSIGNEE(S)
INVENTOR(S) Timothy A. Grotjohn (Okemos, Michigan);  Ramon Diaz (East Lansing, Michigan);  Aron Hardy (East Lansing, Michigan)
ABSTRACT The disclosure relates to large area single crystal diamond (SCD) surfaces and substrates, and their methods of formation. Typical large area substrates can be at least about 25 mm, 50 mm, or 100 mm in diameter or square edge length, and suitable thicknesses can be about 100 μm to 1000 μm. The large area substrates have a high degree of crystallographic alignment. The large area substrates can be used in a variety of electronics and/or optics applications. Methods of forming the large area substrates generally include lateral and vertical growth of SCD on spaced apart and crystallographically aligned SCD seed substrates, with the individual SCD growth layers eventually merging to form a composite SCD layer of high quality and high crystallographic alignment. A diamond substrate holder can be used to crystallographically align the SCD seed substrates and reduce the effect of thermal stress on the formed SCD layers.
FILED Thursday, May 16, 2019
APPL NO 17/055943
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 25/04 (20130101)
C30B 25/08 (20130101)
C30B 25/12 (20130101)
C30B 25/16 (20130101)
C30B 25/20 (20130101)
C30B 25/025 (20130101) Original (OR) Class
C30B 29/04 (20130101)
C30B 29/68 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215168 Greene et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
United States Air Force (USAF)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) Christopher Britton Greene (East Hartford, Connecticut);  Dustin Joseph Frohnapfel (Bloomfield, Connecticut)
ABSTRACT A boost compressor assembly may comprise an outer annular structure and a plurality of blades. Each blade in the plurality of blades may be moveably coupled to the outer annular structure. The plurality of blades may be configured to deploy in response to the boost compressor assembly rotating. The plurality of blades may be configured to retract when the boost compressor assembly stops rotating.
FILED Tuesday, January 14, 2020
APPL NO 16/742591
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 7/02 (20130101)

Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 3/06 (20130101)

Jet-propulsion Plants
F02K 3/06 (20130101)

Non-positive-displacement Pumps
F04D 29/366 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215235 O\'BRIEN et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
APPLICANT(S) Cornell University (Ithaca, New York)
ASSIGNEE(S)
INVENTOR(S) Kevin W. O\'BRIEN (Ithaca, New York);  Robert F. SHEPHERD (Ithaca, New York)
ABSTRACT A transmission is presented, including a spool having a bore. An outer member disposed on the spool, and a cord is configured to at least partially wrap around the outer member. The outer member is configured to constrict and unconstrict to a force applied to the outer member. In this way, rotation of the spool causes a tension force to be applied to the cord, and a greater tension force in the cord will cause the outer member to constrict more than a lower tension force in the cord.
FILED Wednesday, September 19, 2018
APPL NO 16/648610
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/104 (20130101)

Gearing
F16H 19/08 (20130101) Original (OR) Class
F16H 55/54 (20130101)
F16H 2019/085 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215461 Hoemann et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) United States of America as Represented by The Secretary of The Army (Alexandria, Virginia)
ASSIGNEE(S)
INVENTOR(S) John M. Hoemann (Vicksburg, Mississippi);  Justin M. Roberts (Florence, Mississippi)
ABSTRACT Enclosed structures, such as guard towers, are provided which are designed to be easily transportable, constructed easily onsite and erected in a manner which produces an exceptionally blast resistant structure that is also advantageously designed for positioning within a perimeter wall. In particular, in some embodiments, the guard towers have a pentagon shape and are comprised of a plurality of composite panels. Each panel is able to be constructed onsite. The panels typically have a rectangular shape with at least one half of the panel constructed as a solid composite of concrete and metal. Once the panels are constructed, the panels are erected and arranged in a pentagon shape. The panels are bolted together with the use of vertical face connections. These connections provide better structural integrity, retained over time, particularly after subjection to a blast. In addition, the pentagon shape provides improved safety when positioned along a perimeter wall.
FILED Tuesday, January 14, 2020
APPL NO 16/742813
CURRENT CPC
General Building Constructions; Walls, e.g Partitions; Roofs; Floors; Ceilings; Insulation or Other Protection of Buildings
E04B 1/34321 (20130101)

Buildings or Like Structures for Particular Purposes; Swimming or Splash Baths or Pools; Masts; Fencing; Tents or Canopies, in General
E04H 12/08 (20130101)
E04H 12/12 (20130101)
E04H 12/18 (20130101)

Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 5/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215471 Lipson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Michal Lipson (New York, New York);  Xingchen Ji (New York, New York);  Alexander Klenner (New York, New York);  Xinwen Yao (Baltimore, Maryland);  Yu Gan (Harriston, New Jersey);  Alexander L. Gaeta (New York, New York);  Christine P Hendon (Bronx, New York)
ABSTRACT A method of providing optical coherence tomography (OCT) imaging may comprise using an on-chip frequency comb source interfaced with an OCT system by a circulator as an imaging source and reconstructing OCT images from resulting spectral data from target tissue illuminated by the imaging source.
FILED Friday, August 10, 2018
APPL NO 16/100401
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0066 (20130101)
A61B 5/7257 (20130101)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02083 (20130101)
G01B 9/02091 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215472 He et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Department of Energy (DOE)
UChicago Argonne, LLC (UCHICAGO)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Northwestern University (Evanston, Illinois);  UChicago Argonne, LLC (Chicago, Illinois);  The University of Chicago (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Kuan He (Evanston, Illinois);  Oliver Strider Cossairt (Evanston, Illinois);  Aggelos K. Katsaggelos (Chicago, Illinois);  Norbert Scherer (Chicago, Illinois);  Mark Hereld (Chicago, Illinois)
ABSTRACT A system to generate image representations includes a first objective that receives a first light beam emitted from a sample and a second objective that receives a second light beam emitted from the sample, where the first light beam and the second light beam have conjugate phase. The system also includes a first diffractive element to receive the first light beam and separate it into a first plurality of diffractive light beams that are spatially distinct, and a second diffractive element to receive the second light beam and separate it into a second plurality of diffractive light beams that are spatially distinct. The system further includes a detector that receives the first and second plurality of diffractive light beams. The first plurality of diffractive light beams and the second plurality of diffractive light beams are simultaneously directed and focused onto different portions of an image plane of the detector.
FILED Friday, June 21, 2019
APPL NO 15/734172
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/04 (20130101) Original (OR) Class
G01B 9/02041 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/4788 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/361 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215554 Araromi et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
APPLICANT(S) President and Follows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Follows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Oluwaseun A. Araromi (Cambridge, Massachusetts);  Conor J. Walsh (Cambridge, Massachusetts);  Robert J. Wood (Cambridge, Massachusetts)
ABSTRACT A strain sensor comprising a conductive member having a plurality of elements arranged adjacent to one another, and a non-conductive and elastically deformable material encapsulating the conductive member, wherein, in an equilibrium state, compressive forces cause at least one of the plurality of elements to contact at least a portion of an adjacent element, and wherein, when a strain is applied, a resulting elastic deformation causes at least one of the plurality of elements to space apart from an adjacent element such that the contacted portion decreases or is eliminated. A multi-axis force sensor comprising a sensing array comprising at least two planar sensors arranged radially on a planar substrate in antagonistic pairs, and a compressible member positioned between the substrate and a central portion of the sensing array, the compressible member acting to displace the central portion of the sensing array away from the substrate.
FILED Monday, May 20, 2019
APPL NO 17/056357
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 7/18 (20130101)

Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, or Fluid Pressure
G01L 1/2287 (20130101) Original (OR) Class
G01L 5/1627 (20200101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215642 Fincke et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
U.S. Air Force
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Jonathan Randall Fincke (Lincoln, Massachusetts);  Brian W. Anthony (Cambridge, Massachusetts)
ABSTRACT Systems and methods are provided for imaging of soft and hard tissues with ultrasound. Such systems and methods can provide for non-contact and quantitative ultrasound images of bone and soft tissue. A method for imaging a biological body segment of soft and hard tissues includes setting geometry and material properties according to a model of the biological body segment to thereby generate a simulated time series data set. The method further includes collecting reflective and transmissive time series data of the biological body segment to thereby form an experimental time series data set and minimizing a difference between the simulated time series data set and the experimental time series data set, thereby imaging the biological body segment. Regularizing travel-time and/or using full waveform tomographic techniques with level set methods enable recovery of cortical bone geometry.
FILED Wednesday, June 26, 2019
APPL NO 17/255410
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0095 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 29/0672 (20130101) Original (OR) Class
G01N 29/2418 (20130101)
G01N 33/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215737 MCLEOD et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOEOS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) ALEXANDER SWINTON MCLEOD (New York, New York);  LIN XIONG (Bronx, New York);  SHUAI ZHANG (New York, New York);  DIMITRI N. BASOV (New York, New York)
ABSTRACT An exemplary apparatus can provide radiation to a sample(s), which can include, for example, a radiation source arrangement configured to provide radiation, a beam splitter configured to split the radiation into (i) a first radiation, and (ii) a second radiation. An optical element can also be provided which, in operation, can, e.g., (a) receive the first radiation and the second radiation, (b) reflect the first radiation as a reference radiation, (c) provide the second radiation as illumination for the sample(s), (d) receive a resultant radiation from the sample(s) that can be based on the illumination from the second radiation, and (e) provide the reference radiation and the resultant radiation to be detected and used for interferometric imaging or spectroscopy.
FILED Thursday, January 14, 2021
APPL NO 17/149236
CURRENT CPC
Scanning-probe Techniques or Apparatus; Applications of Scanning-probe Techniques, e.g Scanning Probe Microscopy [SPM]
G01Q 20/02 (20130101) Original (OR) Class
G01Q 30/18 (20130101)
G01Q 60/24 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/0032 (20130101)
G02B 21/0056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215758 Jackson
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
Secretary of the Navy (SECNAV)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Crane, Indiana)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Dennis H Jackson (Riverside, California)
ABSTRACT The present invention relates to a system and method for calculating measurement uncertainty and determining measurement decision risk. Measurement uncertainty is calculated based on a plurality of error contributors. Measurement decision risk is evaluated using the measurement uncertainty, and mitigation strategies are applied to lower the probability of false acceptance and the probability of false rejection.
FILED Monday, January 11, 2021
APPL NO 17/145985
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/31718 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216500 YIN et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) DEEPBITS TECHNOLOGY INC. (Riverside, California);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) DEEPBITS TECHNOLOGY INC. (Riverside, California);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Heng YIN (Riverside, California);  Xunchao HU (Riverside, California);  Sheng YU (Riverside, California);  Yu ZHENG (Riverside, California)
ABSTRACT A novel high-throughput embedding generation and comparison system for executable code is presented in this invention. More specifically, the invention relates to a deep-neural-network based graph embedding generation and comparison system. A novel bi-directional code graph embedding generation has been proposed to enrich the information extracted from code graph. Furthermore, by deploying matrix manipulation, the throughput of the system has significantly increased for embedding generation. Potential applications such as executable file similarity calculation, vulnerability search are also presented in this invention.
FILED Thursday, March 11, 2021
APPL NO 17/198312
CURRENT CPC
Electric Digital Data Processing
G06F 16/148 (20190101) Original (OR) Class
G06F 17/16 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6202 (20130101)
G06K 9/6215 (20130101)
G06K 9/6247 (20130101)
G06K 9/6296 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217149 Fleizach
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
Secretary of the Navy (SECNAV)
APPLICANT(S) United States of America as represented by the Secretary of the Navy (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Gregory Knowles Fleizach (San Diego, California)
ABSTRACT Method and system for improved contrast enhancement. The method includes receiving, from at least one imaging system, first and second component chiral images, the first component chiral image being captured by a first filter that is polarized in a first direction, the second component chiral image being captured by a second filter that is polarized in a second direction, the second direction being substantially orthogonal to the first direction. The method also includes pre-enhancing, by a processor, one or both of said first component chiral image and said second component chiral image. Then the processor weights and sums at least a portion of the first and second component chiral images. Weighting and summing may be repeated until an optimal weight is reached. A contrast enhanced image may be generated after the optimal weight is reached.
FILED Thursday, January 09, 2020
APPL NO 16/738871
CURRENT CPC
Image Data Processing or Generation, in General
G06T 5/007 (20130101) Original (OR) Class
G06T 5/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217185 MUHLEMAN
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
Secretary of the Navy (SECNAV)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) DANIEL H. MUHLEMAN (EL CAJON, California)
ABSTRACT Method comprises receiving, by at least one memory, from at least one imaging system, at least two input images. The method includes comparing, by a processor, the at least two input images to each other such that nonstationary portions of the at least two input images are determined by either separating, by the at least one processor, each of the two input images into multiple pixel regions, and generating an error matrix for each of said multiple pixel regions. If an error value in the error matrix falls within a predetermined range, the pixel region is a nonstationary portion of the input images; or identifying, by a machine learning system, nonstationary portions of the input images. The pixels from nonstationary portions are removed from the at least two input images.
FILED Friday, January 10, 2020
APPL NO 16/739351
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/32 (20170101) Original (OR) Class
G06T 7/97 (20170101)
G06T 2207/10032 (20130101)
G06T 2207/20081 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217402 Wynn et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
U.S. Air Force
APPLICANT(S) Charles Wynn (Groton, Massachusetts);  Yaron Rachlin (Newton, Massachusetts);  Ryan Sullenberger (Somerville, Massachusetts);  Sumanth KAUSHIK (Belmont, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Charles Wynn (Groton, Massachusetts);  Yaron Rachlin (Newton, Massachusetts);  Ryan Sullenberger (Somerville, Massachusetts);  Sumanth KAUSHIK (Belmont, Massachusetts)
ABSTRACT The ability to communicate with a specific subject at a prescribed location who lacks any communications equipment opens up many intriguing possibilities. Communications across noisy rooms, hail and warn applications, and localized communications directed at only the intended recipient are a few possibilities. We disclose and show localized acoustic communications, which we call photoacoustic communications, with a listener at long standoff distances using a modulated laser transmitted toward the receiver\'s ear. The optically encoded information is converted into acoustic messages via the photoacoustic effect. The photoacoustic conversion of the optical information into an audible signal occurs via the absorption of the light by ambient water vapor in the near area of the receiver\'s ear followed by airborne acoustic transmission to the ear. The recipient requires no external communications equipment to receive audible messages.
FILED Tuesday, January 07, 2020
APPL NO 16/736212
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/1702 (20130101)
G01N 2021/1704 (20130101)

Sound-producing Devices; Methods or Devices for Protecting Against, or for Damping, Noise or Other Acoustic Waves in General; Acoustics Not Otherwise Provided for
G10K 15/046 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217474 Whitesides et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
Army Research Office (ARO)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) George M. Whitesides (Newton, Massachusetts);  Brian J. Cafferty (Cambridge, Massachusetts);  Alexei S. Ten (Evanston, Illinois);  Michael J. Fink (Cambridge, Massachusetts);  Daniel J. Preston (Cambridge, Massachusetts);  Milan M. Mrksich (Hinsdale, Illinois);  Amit A. Nagarkar (Cambridge, Massachusetts)
ABSTRACT A machine-readable medium and methods of reading and writing same are disclosed. The machine-readable medium comprises a substrate having an array of addressable locations thereon, each addressable location adapted to be physically associated with a collection of non-polymeric molecules. The molecules in each collection are selected from a set of unambiguously identifiable molecules, each molecule uniquely associated with a predetermined position in a numerical value, wherein the presence of the molecule in the collection indicates a predetermined digit at the associated position and the absence of said molecule in the collection indicates a zero at said associated position.
FILED Friday, March 26, 2021
APPL NO 17/214664
CURRENT CPC
Nanostructures Formed by Manipulation of Individual Atoms, Molecules, or Limited Collections of Atoms or Molecules as Discrete Units; Manufacture or Treatment Thereof
B82B 1/008 (20130101)
B82B 3/009 (20130101)
B82B 3/0019 (20130101)
B82B 3/0047 (20130101)

Static Stores
G11C 13/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217598 VRIJSEN et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Geert VRIJSEN (Durham, North Carolina);  Jungsang KIM (Chapel Hill, North Carolina);  Robert SPIVEY (Durham, North Carolina);  Ismail INLEK (Durham, North Carolina);  Yuhi AIKYO (Durham, North Carolina)
ABSTRACT Systems and methods for loading microfabricated ion traps are disclosed. Photo-ablation via an ablation pulse is used to generate a flow of atoms from a source material, where the flow is predominantly populated with neutral atoms. As the neutral atoms flow toward the ion trap, two-photon photo-ionization is used to selectively ionize a specific isotope contained in the atom flow. The velocity of the liberated atoms, atom-generation rate, and/or heat load of the source material is controlled by controlling the fluence of the ablation pulse to provide high ion-trapping probability while simultaneously mitigating generation of heat in the ion-trapping system that can preclude cryogenic operation. In some embodiments, the source material is held within an ablation oven comprising an electrically conductive housing that is configured to restrict the flow of agglomerated neutral atoms generated during photo-ablation toward the ion trap.
FILED Tuesday, November 17, 2020
APPL NO 16/950703
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)

Electric Discharge Tubes or Discharge Lamps
H01J 49/0018 (20130101) Original (OR) Class
H01J 49/161 (20130101)
H01J 49/422 (20130101)
H01J 49/0463 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217617 Robinson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
Army Research Office (ARO)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE PENN STATE RESEARCH FOUNDATION (University Park, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Joshua A. Robinson (Spring Mills, Pennsylvania);  Natalie Briggs (Benton City, Washington)
ABSTRACT This disclosure relates to methods of growing crystalline layers on amorphous substrates by way of an ultra-thin seed layer, methods for preparing the seed layer, and compositions comprising both. In an aspect of the invention, the crystalline layers can be thin films. In a preferred embodiment, these thin films can be free-standing.
FILED Thursday, March 25, 2021
APPL NO 17/301117
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02568 (20130101) Original (OR) Class
H01L 21/02631 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217952 Jarillo-Herrero et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Energy (DOE)
Ames Laboratory (AL)
Office of Science (DOEOS)
APPLICANT(S) Pablo Jarillo-Herrero (Cambridge, Massachusetts);  Qiong MA (Cambridge, Massachusetts);  Nuh GEDIK (Watertown, Massachusetts);  Suyang XU (Cambridge, Massachusetts);  Zhiren ZHENG (Cambridge, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Pablo Jarillo-Herrero (Cambridge, Massachusetts);  Qiong MA (Cambridge, Massachusetts);  Nuh GEDIK (Watertown, Massachusetts);  Suyang XU (Cambridge, Massachusetts);  Zhiren ZHENG (Cambridge, Massachusetts)
ABSTRACT An ultrathin, carbon-based memristor with a moiré superlattice potential shows prominent ferroelectric resistance switching. The memristor includes a bilayer material, such as Bernal-stacked bilayer graphene, encapsulated between two layers of a layered material, such as hexagonal boron nitride. At least one of the encapsulating layers is rotationally aligned with the bilayer to create the moiré superlattice potential. The memristor exhibits ultrafast and robust resistance switching between multiple resistance states at high temperatures. The memristor, which may be volatile or nonvolatile, may be suitable for neuromorphic computing.
FILED Tuesday, November 10, 2020
APPL NO 17/094141
CURRENT CPC
Static Stores
G11C 13/0069 (20130101)
G11C 2213/35 (20130101)
G11C 2213/53 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 45/10 (20130101) Original (OR) Class
H01L 45/142 (20130101)
H01L 45/143 (20130101)
H01L 45/148 (20130101)
H01L 45/149 (20130101)
H01L 45/1206 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218153 Chapman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
U.S. Air Force
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Adam J. Chapman (Medford, Massachusetts);  Alan J. Fenn (Wayland, Massachusetts);  Pierre Dufilie (Marlborough, Massachusetts)
ABSTRACT A compact shallow cavity-backed discone antenna array for conformal omnidirectional antenna applications is disclosed. The antenna array comprises a plurality of discone antennas arranged in a ring array within a circular contoured conical cavity. The cavity is covered with an electrically transparent radome. The individual discone antenna elements are fed with coaxial transmission lines. Good performance is demonstrated by simulation and by experiment in terms of reflection coefficient and omnidirectional gain radiation patterns from about 960 MHz to 1220 MHz. In one embodiment, the shallow cavity-backed discone antenna array may be used as a flush-mounted antenna that conforms to the outer mold line of an aircraft.
FILED Thursday, April 16, 2020
APPL NO 16/850372
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/286 (20130101)
H01Q 1/421 (20130101)
H01Q 13/18 (20130101)
H01Q 21/0056 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218350 WEST et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) James WEST (Baltimore, Maryland);  Ugur ERTURUN (Baltimore, Maryland);  Sung Hoon KANG (Lutherville-Timonium, Maryland);  Adebayo EISAPE (Baltimore, Maryland)
ABSTRACT Disclosed are device implementations for a hybrid energy harvesting device and methods for harvesting mechanical energy from the ambient. The various device implementations utilize a combination of electrostatic energy conversion and piezoelectric energy conversion elements. The method simultaneously converts mechanical energy into electrical charge by electrostatic and piezoelectric energy harvesting. The devices include a piezoelectric harvester including a pair of electrodes and piezoelectric nanocomposite polymer, an electrostatic harvester including an electret film and a pair of electrostatic electrodes.
FILED Tuesday, June 11, 2019
APPL NO 17/059735
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 41/113 (20130101)
H01L 41/183 (20130101)
H01L 41/0472 (20130101)

Electric Machines Not Otherwise Provided for
H02N 1/08 (20130101)
H02N 2/181 (20130101)
H02N 2/186 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218382 Hickle
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
ASSIGNEE(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
INVENTOR(S) Mark D. Hickle (Merrimack, New Hampshire)
ABSTRACT Techniques are disclosed for filtering a radio frequency (RF) signal using an N-path bandstop filter with an extended, spurious-free upper passband. In an embodiment, a bandstop filter includes a bank of three switched capacitors in series with the RF signal path through the filter, in contrast to 4- or 8-capacitor banks or other bandstop filters where N is a power of 2. In this 3-path example configuration, an undesirable spurious bandstop notch at the 3rd and 5th harmonics of the clock frequency are eliminated or substantially reduced, improving performance of the filter in the desired passbands while preserving the notch in the desired stopband at high RF signal frequencies. Another N-path bandstop filter embodiment includes a bridged T-coil circuit, which absorbs a shunt capacitance of the bandstop filter into the bridged T-coil circuit.
FILED Thursday, January 09, 2020
APPL NO 16/738441
CURRENT CPC
Impedance Networks, e.g Resonant Circuits; Resonators
H03H 7/004 (20130101)
H03H 7/0153 (20130101) Original (OR) Class
H03H 11/0466 (20130101)
H03H 2007/013 (20130101)
H03H 2011/0488 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218408 Hong et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
U.S. Air Force
APPLICANT(S) Brian Daffern Hong (, None)
ASSIGNEE(S)
INVENTOR(S) Brian Daffern Hong (Sierra Madre, California);  Seyed Ali Hajimiri (Pasadena, California)
ABSTRACT The present disclosure includes a frequency divider circuit that includes a superharmonically injection-locked ring oscillator, injection circuitry, and various switches. The input can include a collection of signal components at different phases that are all at the same, but changeable, frequency. The divider\'s division ratio can be changed during the divider\'s operation by, for example, utilizing one or more switches to change: the number of stages in the ring oscillator, and/or which stage(s) of the ring oscillator are injected into by which input signal components.
FILED Monday, January 11, 2021
APPL NO 17/145886
CURRENT CPC
Generation of Oscillations, Directly or by Frequency-changing, by Circuits Employing Active Elements Which Operate in a Non-switching Manner; Generation of Noise by Such Circuits
H03B 5/1228 (20130101)

Pulse Technique
H03K 3/0322 (20130101)

Automatic Control, Starting, Synchronisation, or Stabilisation of Generators of Electronic Oscillations or Pulses
H03L 7/24 (20130101) Original (OR) Class
H03L 7/183 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 20210212657 GAO et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Technology Transfer (STTR)
APPLICANT(S) Cardiac Motion, LLC (Truckee, California);  The Regents of The University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Xiaomeng GAO (Dublin, California);  Xiaonan JIANG (Davis, California);  Xiaoguang LIU (Davis, California);  Dennis MATTHEWS (Meadow Vista, California);  Saul SCHAEFER (Davis, California)
ABSTRACT The present disclosure describes systems, methods, and devices to infer changes in pulmonary artery pressure in a subject using Doppler radar. A portable, non-invasive device for non-invasively measuring right ventricular cardiac motion that can be used in a subject\'s home can infer pulmonary artery pressure changes to increase patient compliance and mitigate the likelihood of heart decompensation. A mobile pulmonary artery pressure monitor can be especially useful to patients with congestive heart failure who are elderly, incapacitated, or do not have easy access to a clinic, doctor\'s office, or hospital.
FILED Tuesday, November 24, 2020
APPL NO 17/102838
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/02 (20130101)
A61B 8/04 (20130101) Original (OR) Class
A61B 8/08 (20130101)
A61B 8/488 (20130101)
A61B 8/5207 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213041 Ting et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Science Foundation (NSF)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts);  Icahn School of Medicine at Mount Sinai (New York, New York)
ASSIGNEE(S)
INVENTOR(S) David T. Ting (Dover, Massachusetts);  Miguel N. Rivera (Belmont, Massachusetts);  Vikram Deshpande (Belmont, Massachusetts);  Kshitij Arora (North Quincy, Massachusetts);  Benjamin Dylan Greenbaum (New York, New York);  Alexander V. Solovyov (New York, New York)
ABSTRACT Methods for predicting response to immunotherapy and selecting immunotherapy for treating cancer, e.g., cancer of epithelial origin, in a subject.
FILED Wednesday, February 06, 2019
APPL NO 16/967497
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7105 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/122 (20130101)
C12N 2310/141 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213168 BONASSAR et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) CORNELL UNIVERSITY (Ithaca, New York)
ASSIGNEE(S)
INVENTOR(S) Lawrence J. BONASSAR (Ithaca, New York);  Roger HARTL (New York, New York);  Robert D. BOWLES (Ithaca, New York);  Harry H. GEBHARD (Tuebingen, Germany)
ABSTRACT The present invention relates to a tissue-engineered intervertebral disc (IVD) suitable for total disc replacement in a mammal and methods of fabrication. The IVD comprises a nucleus pulposus structure comprising a first population of living cells that secrete a hydrophilic protein and an annulus fibrosis structure surrounding and in contact with the nucleus pulposus structure, the annulus fibrosis structure comprising a second population of living cells and type I collagen. The collagen fibrils in the annulus fibrosis structure are circumferentially aligned around the nucleus pulposus region due to cell-mediated contraction in the annulus fibrosis structure. Also disclosed are methods of fabricating tissue-engineered intervertebral discs.
FILED Wednesday, November 25, 2020
APPL NO 17/105154
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/442 (20130101)
A61F 2002/444 (20130101)
A61F 2002/445 (20130101)
A61F 2002/4435 (20130101)
A61F 2002/4445 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 35/32 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/20 (20130101)
A61L 27/22 (20130101)
A61L 27/24 (20130101)
A61L 27/44 (20130101)
A61L 27/52 (20130101)
A61L 27/3658 (20130101) Original (OR) Class
A61L 27/3691 (20130101)
A61L 27/3817 (20130101)
A61L 27/3856 (20130101)
A61L 27/3886 (20130101)
A61L 2430/38 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213264 LIU et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) UNIVERSITY OF MARYLAND, COLLEGE PARK (COLLEGE PARK, Maryland)
ASSIGNEE(S)
INVENTOR(S) SANWEI LIU (SAN JOSE, California);  SANGWOOK CHU (SAN JOSE, California);  REZA GHODSSI (POTOMAC, Maryland);  LUKE BEARDSLEE (ATLANTA, Georgia);  ASHLEY AUGUSTINY CHAPIN (WASHINGTON, District of Columbia)
ABSTRACT A microneedle system includes an ingestible structure and one or more microneedle units secured to a surface of the structure. Each microneedle unit has a plurality of barb members extending from the outer surface of a microneedle. The microneedle unit is secured to the structure by a displacement member, which displaces the microneedle unit when in a released state. The displacement member may be held in a compressed state by a dissolvable coating.
FILED Thursday, January 14, 2021
APPL NO 17/149277
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 31/10 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 37/0015 (20130101) Original (OR) Class
A61M 2037/0053 (20130101)
A61M 2205/0238 (20130101)
A61M 2210/1042 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/30 (20170801)
B29C 64/135 (20170801)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2031/7546 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 80/00 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213297 Yan et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The George Washington University (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Dayun Yan (Ashburn, Virginia);  Michael Keidar (Baltimore, Maryland);  Eda GJIKA (Washington, District of Columbia)
ABSTRACT A method and system of adaptive cold atmospheric based treatment for diseased tissues, such as an area with cancerous cells, is disclosed. A gas such as helium is ionized via supplying power between and anode and a cathode to create an initial cold atmospheric plasma jet. The initial plasma jet is directed toward the area for a sufficient time, such as 10 seconds, to sensitize the cells via a reactive species. A reactive treatment, such as H2O2 or TMZ, is directed to the sensitized cells. The effectiveness of the reactive treatment is increased by the process of sensitizing the cells.
FILED Friday, May 31, 2019
APPL NO 15/734149
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4188 (20130101)
A61K 33/40 (20130101)
A61K 41/00 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/44 (20130101) Original (OR) Class

Electric Discharge Tubes or Discharge Lamps
H01J 37/32366 (20130101)
H01J 37/32449 (20130101)
H01J 37/32825 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213329 Wechsler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute on Drug Abuse (NIDA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Trustees of Dartmouth College (Hanover, New Hampshire)
ASSIGNEE(S)
INVENTOR(S) Emily Wechsler (Dallas, Texas);  Ryan Halter (Lyme, New Hampshire);  John A. Batsis (Hanover, New Hampshire)
ABSTRACT Devices and methods are disclosed for remote clinical monitoring performance of exercises using an instrumented resistance device (100). An example device (100) includes a resistance band (120) having a first end (122) and a second end (124). A first handle (130) connected to the first end (122) and a second handle (140) connected to the second end (124) of the resistance band (120). The device (100) further includes a force sensing assembly (150) positioned between the first handle (130) and the first end (122). The force sensing assembly (150) includes a force sensor (156) connected to the resistance band (120), a microcontroller (182) connected to the force sensor (156) to receive a set of load force measurements from the force sensor (156), and a communication module (184) connected to the microcontroller (182) to transmit the set of load force measurements to a local data receiving device (170).
FILED Friday, May 17, 2019
APPL NO 17/055412
CURRENT CPC
Apparatus for Physical Training, Gymnastics, Swimming, Climbing, or Fencing; Ball Games; Training Equipment
A63B 21/00043 (20130101)
A63B 21/0552 (20130101)
A63B 21/4035 (20151001)
A63B 24/0062 (20130101) Original (OR) Class
A63B 2220/17 (20130101)
A63B 2220/51 (20130101)
A63B 2220/62 (20130101)
A63B 2220/833 (20130101)
A63B 2225/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213419 Anyanwu et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S)
INVENTOR(S) John-Timothy Anyanwu (Ann Arbor, Michigan);  Yiren Wang (Ann Arbor, Michigan);  Ralph T. Yang (Ann Arbor, Michigan)
ABSTRACT A method of grafting a silica support includes adding the silica support to a solvent, resulting in a first solution, adding an amount of silane to the first solution, resulting in a second solution, filtering grafted silica support from the second solution, and drying the grafted silica support.
FILED Friday, January 15, 2021
APPL NO 17/150376
CURRENT CPC
Separation
B01D 53/02 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/283 (20130101) Original (OR) Class
B01J 20/3259 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213424 Sofranko et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
National Science Foundation (NSF)
APPLICANT(S) John A. Sofranko (Weston, Massachusetts);  Fanxing Li (Raleigh, North Carolina);  Luke Michael Neal (Raleigh, North Carolina);  Yunfei Gao (Raleigh, North Carolina);  Seif Yusuf (Raleigh, North Carolina);  Ryan Dudek (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) John A. Sofranko (Weston, Massachusetts);  Fanxing Li (Raleigh, North Carolina);  Luke Michael Neal (Raleigh, North Carolina);  Yunfei Gao (Raleigh, North Carolina);  Seif Yusuf (Raleigh, North Carolina);  Ryan Dudek (Raleigh, North Carolina)
ABSTRACT Redox catalysts having surface medication, methods of making redox catalysts with surface modification, and uses of the surface modified redox catalysts are provided. In some aspects, the redox catalysts include a core oxygen carrier region and an outer shell having an average thickness of about 1-100 monolayers surrounding the outer surface of the core region.
FILED Tuesday, December 08, 2020
APPL NO 17/115115
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 21/14 (20130101)
B01J 23/002 (20130101) Original (OR) Class
B01J 23/02 (20130101)
B01J 23/005 (20130101)
B01J 23/30 (20130101)
B01J 35/002 (20130101)
B01J 35/0006 (20130101)
B01J 35/10 (20130101)
B01J 37/06 (20130101)
B01J 37/0081 (20130101)
B01J 37/088 (20130101)
B01J 37/0215 (20130101)

Acyclic or Carbocyclic Compounds
C07C 4/06 (20130101)
C07C 5/48 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213523 Peterson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Research Office (ARO)
United States Army (USA)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Office of Experimental Program To Stimulate Competitive Research (EPSCOR)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia);  South Dakota School of Mines (Rapid City, South Dakota)
ASSIGNEE(S)
INVENTOR(S) G. P. "Bud" Peterson (Atlanta, Georgia);  Haiping Hong (Rapid City, South Dakota)
ABSTRACT Disclosed herein is a method of homogeneously mixing solids, comprising: mixing, in a fluid medium, at least a first Got nanoparticle material and a surfactant, wherein the surfactant causes the first nanoparticle material to distribute uniformly in the fluid medium and have a specific charge; adding, to the fluid medium, a second nanoparticle material, wherein the surfactant has a charge of opposite polarity to the zeta potential of the second nanoparticle material; attaching the second nanoparticle material to the first Nnanoparticle material using the charge attraction of the surfactant and the second nanoparticle material to obtain a homogeneous material; and removing the attached first and second nanoparticle materials from the fluid medium to obtain a solid homogeneous material.
FILED Friday, May 10, 2019
APPL NO 17/054202
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 1/0022 (20130101) Original (OR) Class
B22F 1/0074 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/174 (20170801)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214079 Chilson et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Board of Regents of the University of Oklahoma (Oklahoma City, Oklahoma)
ASSIGNEE(S) The Board of Regents of the University of Oklahoma (Oklahoma City, Oklahoma)
INVENTOR(S) Phillip B. Chilson (Norman, Oklahoma);  Antonio R. Segales Espinosa (Norman, Oklahoma);  William J. Doyle (Norman, Oklahoma);  Tyler M. Bell (Norman, Oklahoma);  Brian R. Greene (Norman, Oklahoma);  Joshua J. Martin (Norman, Oklahoma);  Elizabeth A. Pillar-Little (Norman, Oklahoma);  Gustavo Britto Hupsel de Azevedo (Norman, Oklahoma)
ABSTRACT An unmanned aerial system (UAS) adapted to measure one or more atmospheric conditions has a frame and a plurality of motorized rotors suspended on arms extending outward from the frame. The UAS further includes a flight control module that includes a computer programmable flight control board and a sensor package that has an air sampling scoop, a first sensor positioned inside the air sampling scoop, and a ducted fan inside the air sampling scoop. The ducted fan is configured to draw air through the air sampling scoop in contact with the first sensor. The ducted fan can be configured to operate only when the UAS is above a predetermined altitude. The UAS may also be configured to operate in a “wind vane” mode in which wind speed and direction is determined based on the pitch and heading of the UAS.
FILED Monday, January 11, 2021
APPL NO 17/146352
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101) Original (OR) Class
B64C 2201/027 (20130101)
B64C 2201/108 (20130101)
B64C 2201/125 (20130101)
B64C 2201/141 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214282 Temme et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Pivot Bio, Inc. (Berkeley, California)
ASSIGNEE(S)
INVENTOR(S) Karsten Temme (Oakland, California);  Alvin Tamsir (San Francisco, California);  Sarah Bloch (Emeryville, California);  Rosemary Clark (Berkeley, California);  Emily Tung (Millbrae, California)
ABSTRACT Disclosed herein are methods of increasing nitrogen fixation in a non-leguminous plant. The methods can comprise exposing the plant to a plurality of bacteria. Each member of the plurality comprises one or more genetic variations introduced into one or more genes or non-coding polynucleotides of the bacteria\'s nitrogen fixation or assimilation genetic regulatory network, such that the bacteria are capable of fixing atmospheric nitrogen in the presence of exogenous nitrogen. The bacteria are not intergeneric microorganisms. Additionally, the bacteria, in planta, produce 1% or more of the fixed nitrogen in the plant.
FILED Wednesday, January 13, 2021
APPL NO 17/148173
CURRENT CPC
Nitrogenous Fertilisers
C05C 1/00 (20130101)
C05C 3/005 (20130101)
C05C 5/005 (20130101)
C05C 11/00 (20130101)

Organic Fertilisers Not Covered by Subclasses C05B, C05C, e.g Fertilisers From Waste or Refuse
C05F 11/08 (20130101) Original (OR) Class

Peptides
C07K 14/195 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)
C12N 9/80 (20130101)
C12N 9/93 (20130101)
C12N 9/0095 (20130101)

Enzymes
C12Y 118/06001 (20130101)
C12Y 305/01002 (20130101)
C12Y 603/01002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214325 Bond et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Jesse Quentin Bond (Syracuse, New York);  Ran Zhu (Boston, Massachusetts)
ASSIGNEE(S) SYRACUSE UNIVERSITY (SYRACUSE, New York)
INVENTOR(S) Jesse Quentin Bond (Syracuse, New York);  Ran Zhu (Boston, Massachusetts)
ABSTRACT A process for forming protoanemonin from an amount of levulinic acid or an amount of α-Angelica lactone using oxidative dehydrogenation. Biomass-derived levulinic acid (LA) is a green platform chemical and, using an oxidative scission pathway can be transformed into cyclic intermediates, namely angelicalactones to form protoanemonin. The oxidative dehydrogenation may be heterogeneously catalyzed in a gas-phase to perform aerobic oxidation using a solid oxide such as vanadium oxide. Protoanemonin is an intriguing polyfunctional molecule that is uniquely suited to bio-based production, and can be synthesized in yields from 50%-75% during periods of transient reactor operation.
FILED Thursday, January 14, 2021
APPL NO 17/148615
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 23/22 (20130101)

Heterocyclic Compounds
C07D 307/20 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214397 LY et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
ASSIGNEE(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
INVENTOR(S) Danith H. LY (Pittsburgh, Pennsylvania);  Srinivas RAPIREDDY (Pittsburgh, Pennsylvania);  Bichismita SAHU (Pittsburgh, Pennsylvania)
ABSTRACT The present invention relates to γ-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
FILED Wednesday, August 26, 2020
APPL NO 17/003131
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/60 (20170801)

Acyclic or Carbocyclic Compounds
C07C 229/12 (20130101)
C07C 271/20 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101)
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101)

Peptides
C07K 1/04 (20130101)
C07K 1/08 (20130101)
C07K 14/003 (20130101) Original (OR) Class

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 69/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214507 Sumerlin et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Brent S. Sumerlin (Gainesville, Florida);  William L.A. Brooks (Jacksonville, Florida);  Christopher Deng (Goleta, California)
ABSTRACT Boronic acid monomers, methods of making boronic acid monomer, and the like, are provided. Embodiments of the present disclosure are advantageous in that the boronic acid monomers are water soluble at a neutral pH, which is uncommon for boronic acids. As a result, the boronic acid monomers can be used in aqueous polymerization reactions with other hydrophilic monomers to yield polymers including boronic acids and esters.
FILED Wednesday, March 24, 2021
APPL NO 17/211255
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/025 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 79/08 (20130101) Original (OR) Class

Compositions of Macromolecular Compounds
C08L 85/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214508 Rawashdeh-Omary et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Texas Woman\'s University (Denton, Texas)
ASSIGNEE(S)
INVENTOR(S) Manal A. Rawashdeh-Omary (Denton, Texas);  Ruaa M. Almotawa (Denton, Texas);  Mohammad A. Omary (Denton, Texas)
ABSTRACT The embodiments described herein pertains to a new design method to produce copper, silver or gold based metal functional coordination polymers with excellent potential towards optoelectronic devices, gas storage and separation, optical sensors, and other applications.
FILED Tuesday, July 09, 2019
APPL NO 17/058764
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 1/08 (20130101)
C07F 1/10 (20130101)
C07F 1/12 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 83/001 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214611 Bawendi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts)
ASSIGNEE(S) MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts)
INVENTOR(S) Moungi Bawendi (Cambridge, Massachusetts);  Daniel Franke (Cambridge, Massachusetts);  Matthias Ginterseder (Cambridge, Massachusetts)
ABSTRACT A semiconductor nanocrystal can be made by an in situ redox reaction between an M donor and an E donor.
FILED Tuesday, January 12, 2021
APPL NO 17/147057
CURRENT CPC
Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/0883 (20130101)
C09K 11/883 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/0665 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214613 Jákli et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Kent State University (Kent, Ohio);  The University of Akron (Akron, Ohio)
ASSIGNEE(S) Kent State University (Kent, Ohio);  The University of Akron (Akron, Ohio)
INVENTOR(S) Antal Jákli (Kent, Ohio);  Chenrun Feng (Kent, Ohio);  Chathuranga Prageeth Hemantha Rajapaksha (Kent, Ohio);  Vikash Kaphle (Kent, Ohio);  Thein Kyu (Akron, Ohio)
ABSTRACT An ionic liquid crystal elastomer composition includes a liquid crystal elastomer; and an ionic liquid.
FILED Monday, January 11, 2021
APPL NO 17/248127
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/12 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 2/14 (20130101)
C08F 2/50 (20130101)
C08F 20/30 (20130101)
C08F 22/20 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 5/07 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 19/02 (20130101) Original (OR) Class
C09K 19/542 (20130101)
C09K 2019/0448 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214713 Bashor et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Defense Threat Reduction Agency (DTRA)
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Molecular and Cellular Biosciences (MCB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Trustees of Boston University (Boston, Massachusetts)
INVENTOR(S) Caleb J. Bashor (Boston, Massachusetts);  Jason Hung-Ying Yang (Watertown, Massachusetts);  Arnaud Gutierrez (Somerville, Massachusetts);  Wooseok Steven Ahn (Tenafly, New Jersey);  James J. Collins (Newton, New Jersey);  Brandon Gei-Chin Wong (Brighton, Massachusetts);  Ahmad S. Khalil (Lexington, Massachusetts)
ABSTRACT Disclosed herein are a high-throughput continuous culture system and novel methodologies for the experimental evolution of natural and synthetic microbes using the continuous culture system. The microbial culture is exposed to a stress ramp function which is overlaid on top of a culture fitness function. The amount of stress applied to the culture is increased in response to increased fitness of the microbial culture.
FILED Saturday, February 17, 2018
APPL NO 16/081975
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 41/36 (20130101)
C12M 41/46 (20130101)
C12M 41/48 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/36 (20130101)
C12N 15/01 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214857 Wang et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Haiyan Wang (West Lafayette, Indiana);  Xuejing Wang (West Lafayette, Indiana);  Xinghang Zhang (West Lafayette, Indiana)
ABSTRACT A method of the fabricating a metal-nitride vertically aligned nanocomposites is disclosed which includes applying a pulsed laser onto a composite target, the composite target including a two-phase metal-nitride plasmonic nanostructure, depositing adatoms of the composite target onto a substrate, and nucleating metal over the substrate and growing metal and nitride thereover until a predetermined size of vertically aligned metal nitride nanocomposite is achieved including metal nanorods embedded in nitride.
FILED Saturday, December 26, 2020
APPL NO 17/134340
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 23/025 (20130101)
C30B 23/066 (20130101)
C30B 29/02 (20130101)
C30B 29/38 (20130101)
C30B 29/605 (20130101) Original (OR) Class

Optical Elements, Systems, or Apparatus
G02B 1/002 (20130101)
G02B 5/008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215471 Lipson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Michal Lipson (New York, New York);  Xingchen Ji (New York, New York);  Alexander Klenner (New York, New York);  Xinwen Yao (Baltimore, Maryland);  Yu Gan (Harriston, New Jersey);  Alexander L. Gaeta (New York, New York);  Christine P Hendon (Bronx, New York)
ABSTRACT A method of providing optical coherence tomography (OCT) imaging may comprise using an on-chip frequency comb source interfaced with an OCT system by a circulator as an imaging source and reconstructing OCT images from resulting spectral data from target tissue illuminated by the imaging source.
FILED Friday, August 10, 2018
APPL NO 16/100401
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0066 (20130101)
A61B 5/7257 (20130101)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/02083 (20130101)
G01B 9/02091 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215472 He et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Department of Energy (DOE)
UChicago Argonne, LLC (UCHICAGO)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Northwestern University (Evanston, Illinois);  UChicago Argonne, LLC (Chicago, Illinois);  The University of Chicago (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Kuan He (Evanston, Illinois);  Oliver Strider Cossairt (Evanston, Illinois);  Aggelos K. Katsaggelos (Chicago, Illinois);  Norbert Scherer (Chicago, Illinois);  Mark Hereld (Chicago, Illinois)
ABSTRACT A system to generate image representations includes a first objective that receives a first light beam emitted from a sample and a second objective that receives a second light beam emitted from the sample, where the first light beam and the second light beam have conjugate phase. The system also includes a first diffractive element to receive the first light beam and separate it into a first plurality of diffractive light beams that are spatially distinct, and a second diffractive element to receive the second light beam and separate it into a second plurality of diffractive light beams that are spatially distinct. The system further includes a detector that receives the first and second plurality of diffractive light beams. The first plurality of diffractive light beams and the second plurality of diffractive light beams are simultaneously directed and focused onto different portions of an image plane of the detector.
FILED Friday, June 21, 2019
APPL NO 15/734172
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/04 (20130101) Original (OR) Class
G01B 9/02041 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/4788 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/361 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215508 Watson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) College of William and Mary (Williamsburg, Virginia)
ASSIGNEE(S) College of William and Mary (Williamsburg, Virginia)
INVENTOR(S) Amanda Watson (Williamsburg, Virginia);  Andrew Lyubovsky (Williamsburg, Virginia);  Gang Zhou (Williamsburg, Virginia)
ABSTRACT A method is provided for monitoring relative positions of two objects sharing a common joint during motion between the two objects. An electromagnet is positioned on a first object and a magnetic sensor is positioned on a second object. The electromagnet\'s power or polarity is cycled during a monitoring session in accordance with a periodic schedule of alternating power-on/power-off periods or alternating-polarity periods, respectively. The magnetic sensor\'s output during one or more of the power-off periods or the alternating-polarity periods is used to remove environmental magnetic interference to dynamically determine the distance between the electromagnet and the magnetic sensor where the determined distance and the north pole orientation of the electromagnet are indicative of relative positions of the first object and the second object.
FILED Wednesday, January 15, 2020
APPL NO 16/743502
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/1126 (20130101)
A61B 2562/0223 (20130101)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 7/30 (20130101)

Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 5/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215636 Claussen et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Iowa State University Research Foundation, Inc. (Ames, Iowa);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Jonathan Claussen (Ames, Iowa);  Kshama Parate (Ames, Iowa);  Mark C. Hersam (Willmette, Illinois);  Sonal V. Rangnekar (Chicago, Illinois)
ABSTRACT Methods and systems of fabrication of high resolution, high-throughput electrochemical sensing circuits on a substrate. High resolution electrochemical sensing circuits are printed by an effective additive technique to the substrate. Optionally, post-print annealing converts electrochemically inactive printed graphene into one that is electrochemically active. The printing can be by aerosol jet printing, but is not necessarily limited thereto. An example is inkjet printing and then the post-print annealing. Ink formulation would be adjusted for effectiveness with inkjet printing. Optionally biorecognition agents can be covalently bonded to the printed graphene for the purpose of electrochemical biosensing. High throughput fabrication of high-resolution graphene circuits (feature sizes in the tens of microns <50 μm) for electrochemical biosensing is possible by chemical functionalization of the graphene surface with a biological agent.
FILED Thursday, January 14, 2021
APPL NO 17/248211
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/112 (20170801)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2001/08 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 40/20 (20200101)
B33Y 80/00 (20141201)

Printing, Duplicating, Marking, or Copying Processes; Colour Printing,
B41M 3/006 (20130101)
B41M 5/0023 (20130101)
B41M 7/009 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4145 (20130101)
G01N 27/4148 (20130101) Original (OR) Class
G01N 33/5438 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215679 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey);  Sogang University (Seoul, South Korea)
ASSIGNEE(S)
INVENTOR(S) Ki-Bum Lee (Piscataway, New Jersey);  Jin-Ho Lee (Piscataway, New Jersey);  Jeong-Woo Choi (Seoul, South Korea);  Jin-Ha Choi (Seoul, South Korea)
ABSTRACT Nanorod devices for isolating and characterizing target cellular components are provided. Methods of isolating, detecting, and/or characterizing the components are also provided. Methods of use and treatment are further disclosed, such as treating diseases identified using the nanorods and/or using differentiated stem cells identified using the provided nanorods.
FILED Wednesday, January 06, 2021
APPL NO 17/142950
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 25/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6428 (20130101)
G01N 33/533 (20130101) Original (OR) Class

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 1/40 (20130101)
H01F 3/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215769 Chow et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Mo-Yuen Chow (Raleigh, North Carolina);  Habiballah Rahimi Eichi (Raleigh, North Carolina);  Cong Sheng Huang (Raleigh, North Carolina);  Bharat Balagopal (Raleigh, North Carolina)
ABSTRACT Battery parameters, state of charge, and state of health co-estimation are disclosed. According to an aspect, a method includes determining a terminal current and a terminal voltage of a battery. The method also includes maintaining a battery model that defines a relationship between a parameter of the battery, the terminal current, and the terminal voltage. Further, the method includes determining the parameter of the battery based on the battery model and the acquired terminal current and the terminal voltage. Temperature effects can also be accounted for by the co-estimation.
FILED Friday, January 10, 2020
APPL NO 16/740366
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/367 (20190101)
G01R 31/3835 (20190101) Original (OR) Class

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 10/48 (20130101)
H01M 10/425 (20130101)
H01M 10/0525 (20130101)
H01M 2010/4271 (20130101)
H01M 2220/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216020 Magnusson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) BOARD OF REGENTS, THE UNIVERITY OF TEXAS SYSTEM (Austin, Texas)
ASSIGNEE(S)
INVENTOR(S) Robert Magnusson (Arlington, Texas);  Kyu Lee (Euless, Texas);  Hafez Hemmati (Arlington, Texas);  Pawarat Bootpakdeetam (Arlington, Texas)
ABSTRACT A method of fabricating a metasurface comprises coating a photoresist film onto a substrate and loading the coated substrate into a laser interference lithography setup, exposing the photoresist film via a laser with a first interference pattern, the first interference pattern having a first period and a first exposure energy, subsequently exposing the coated substrate with a second interference pattern, the second interference pattern having a second period and a second exposure energy, developing the exposed portions of the photoresist film to form a periodic pattern in the photoresist, and transferring the periodic pattern into the substrate, the substrate supporting an appropriate film system that embodies the final metasurface device.
FILED Friday, January 15, 2021
APPL NO 17/150171
CURRENT CPC
Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0035 (20130101)
G03F 7/094 (20130101)
G03F 7/162 (20130101)
G03F 7/70408 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216500 YIN et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) DEEPBITS TECHNOLOGY INC. (Riverside, California);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) DEEPBITS TECHNOLOGY INC. (Riverside, California);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Heng YIN (Riverside, California);  Xunchao HU (Riverside, California);  Sheng YU (Riverside, California);  Yu ZHENG (Riverside, California)
ABSTRACT A novel high-throughput embedding generation and comparison system for executable code is presented in this invention. More specifically, the invention relates to a deep-neural-network based graph embedding generation and comparison system. A novel bi-directional code graph embedding generation has been proposed to enrich the information extracted from code graph. Furthermore, by deploying matrix manipulation, the throughput of the system has significantly increased for embedding generation. Potential applications such as executable file similarity calculation, vulnerability search are also presented in this invention.
FILED Thursday, March 11, 2021
APPL NO 17/198312
CURRENT CPC
Electric Digital Data Processing
G06F 16/148 (20190101) Original (OR) Class
G06F 17/16 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6202 (20130101)
G06K 9/6215 (20130101)
G06K 9/6247 (20130101)
G06K 9/6296 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217490 MISHRA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Science Foundation (NSF)
APPLICANT(S) NEW YORK UNIVERSITY (New York, New York)
ASSIGNEE(S) NEW YORK UNIVERSITY (, None)
INVENTOR(S) Bhubaneswar MISHRA (Great Neck, New York);  Giuseppe NARZISI (New York, New York)
ABSTRACT Exemplary methods, procedures, computer-accessible medium, and systems for base-calling, aligning and polymorphism detection and analysis using raw output from a sequencing platform can be provided. A set of raw outputs can be used to detect polymorphisms in an individual by obtaining a plurality of sequence read data from one or more technologies (e.g., using sequencing-by-synthesis, sequencing-by-ligation, sequencing-by-hybridization, Sanger sequencing, etc.). For example, provided herein are exemplary methods, procedures, computer-accessible medium and systems, which can include and/or be configured for obtaining raw output from a sequencing platform configured to be used for reading fragment(s) of genomes, obtaining reference sequences for the genomes obtained independently from the raw output, and generating a base-call interpretation and/or alignment using the raw output and the reference sequences. For example, a score function can be determined based on information associated with the sequencing platform that can be used to analyze polymorphisms based on the base-call interpretation and/or alignment.
FILED Monday, March 29, 2021
APPL NO 17/216000
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 30/00 (20190201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217606 JARROLD et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana)
ASSIGNEE(S)
INVENTOR(S) Martin F. JARROLD (Bloomington, Indiana);  Daniel BOTAMANENKO (Bloomington, Indiana)
ABSTRACT An electrostatic linear ion trap (ELIT) array includes multiple elongated charge detection cylinders arranged end-to-end and each defining an axial passageway extending centrally therethrough, a plurality of ion mirror structures each defining a pair of axially aligned cavities and an axial passageway extending centrally therethrough, wherein a different ion mirror structure is disposed between opposing ends of each cylinder, and front and rear ion mirrors each defining at least one cavity and an axial passageway extending centrally therethrough, the front ion mirror positioned at one end of the arrangement of charge detection cylinders and the rear ion mirror positioned at an opposite end of the arrangement of charge detection cylinders, wherein the axial passageways of the charge detection cylinders, the ion mirror structures, the front ion mirror and the rear ion mirror are coaxial to define a longitudinal axis passing centrally through the ELIT array. In a second aspect, an ELIT array comprises a plurality of non-coaxial ELIT regions, wherein ions are selectively guided into each of the ELIT regions.
FILED Friday, January 11, 2019
APPL NO 17/058561
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 49/022 (20130101)
H01J 49/025 (20130101)
H01J 49/0031 (20130101)
H01J 49/4245 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217617 Robinson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
Army Research Office (ARO)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE PENN STATE RESEARCH FOUNDATION (University Park, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Joshua A. Robinson (Spring Mills, Pennsylvania);  Natalie Briggs (Benton City, Washington)
ABSTRACT This disclosure relates to methods of growing crystalline layers on amorphous substrates by way of an ultra-thin seed layer, methods for preparing the seed layer, and compositions comprising both. In an aspect of the invention, the crystalline layers can be thin films. In a preferred embodiment, these thin films can be free-standing.
FILED Thursday, March 25, 2021
APPL NO 17/301117
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02568 (20130101) Original (OR) Class
H01L 21/02631 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217974 SCHMEDAKE et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The University of North Carolina at Charlotte (Charlotte, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Thomas Andrew SCHMEDAKE (Charlotte, North Carolina);  Michael George WALTER (Charlotte, North Carolina);  Yong ZHANG (Charlotte, North Carolina);  Margaret KOCHERGA (Charlotte, North Carolina)
ABSTRACT A variety of hexacoordinate pincer complexes are described herein having electronic structure advantageous for electronic and/or optoelectronic applications. In some embodiments, the pincer complexes are luminescent, exhibiting fluorescence and/or phosphorescence. Briefly, a hexacoordinate complex comprises a central atom selected from the group consisting of silicon, germanium, and tin, and two pincer ligands bound to the central atom, wherein the hexacoordinate complex is luminescent. In another aspect, a hexacoordinate complex comprises a central atom selected from the group consisting of silicon, germanium and tin, and two pincer ligands bound to the central atom, wherein the difference between the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) of the hexacoordinate complex is at least 1.5 eV.
FILED Wednesday, May 29, 2019
APPL NO 17/057308
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/025 (20130101)

Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/06 (20130101)
C09K 2211/1018 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0067 (20130101)
H01L 51/0072 (20130101)
H01L 51/0094 (20130101) Original (OR) Class
H01L 51/5072 (20130101)
H01L 2251/552 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218028 Su et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Carnegie Mellon University (Pittsburgh, Pennsylvania)
ASSIGNEE(S) Carnegie Mellon University (Pittsburgh, Pennsylvania)
INVENTOR(S) Laisuo Su (Pittsburgh, Pennsylvania);  Baby Reeja-Jayan (Pittsburgh, Pennsylvania)
ABSTRACT Manufacturing technology to fabricate liquid metal-based soft and flexible electronics (sensors, antennas, etc.) in a high-throughput fashion, with fabrication rates that may approach that of the traditional integrated circuit components and circuits, are described. The technique allows creation of liquid-metal-only circuits, as well as seamless integration of solid IC chips into the circuits, in which liquid metal traces are used as flexible interconnects and/or as other circuit elements. The process may be applied at the wafer scale and may be integrated into the traditional microelectronics fabrication processes. Many sensors, antennas, and other circuit elements may be directly created using liquid metal, and when combined with the IC chips, a broad range of electronic functionality may be provided in a flexible, soft circuit that can be conformable, wearable.
FILED Friday, May 29, 2020
APPL NO 16/886948
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/386 (20130101)
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 4/583 (20130101)
H01M 4/606 (20130101) Original (OR) Class
H01M 10/0525 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218366 Naing et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) MUMEC, INC. (Oakland, California)
ASSIGNEE(S) MUMEC, INC. (Oakland, California)
INVENTOR(S) Thura Lin Naing (Union City, California);  Tristan Orion Rocheleau (Berkeley, California)
ABSTRACT The present disclosure provides a super-regenerative transceiver with a feedback element having a controllable gain. The super-regenerative transceiver utilizes the controllable gain to improve RF signal data sensitivity and improve RF signal data capture rates. Super-regenerative transceivers described herein permit signal data capture over a broad range of frequencies and for a range of communication protocols. Super-regenerative transceivers described herein are tunable, consume very little power for operation and maintenance, and permit long term operation even when powered by very small power sources (e.g., coin batteries).
FILED Sunday, January 24, 2021
APPL NO 17/248411
CURRENT CPC
Generation of Oscillations, Directly or by Frequency-changing, by Circuits Employing Active Elements Which Operate in a Non-switching Manner; Generation of Noise by Such Circuits
H03B 5/30 (20130101)
H03B 5/32 (20130101) Original (OR) Class
H03B 5/323 (20130101)
H03B 5/1215 (20130101)

Demodulation or Transference of Modulation From One Carrier to Another
H03D 11/04 (20130101)
H03D 11/08 (20130101)
H03D 2200/0074 (20130101)

Impedance Networks, e.g Resonant Circuits; Resonators
H03H 3/02 (20130101)
H03H 9/02259 (20130101)
H03H 9/02393 (20130101)
H03H 9/2447 (20130101)
H03H 9/2457 (20130101)

Transmission
H04B 1/16 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 27/127 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218392 Carrigan
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Joseph T. Carrigan (Columbia, Maryland)
ABSTRACT An embodiment in accordance with the present invention provides a system and method of physically modulating a digital signal across a medium. A signal is sent one bit at a time (serially) as a period of high voltage followed by a period of low voltage. The present invention includes several major advantages. One advantage is that the code to execute the method is very lightweight. Another advantage is that the signals require no synchronization source. The signals of the present invention function as their own synchronization.
FILED Monday, February 20, 2017
APPL NO 15/999841
CURRENT CPC
Pulse Technique
H03K 7/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218423 Barton et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Taylor Wallis Barton (Boulder, Colorado);  William Sear (Aurora, Colorado)
ABSTRACT Systems and methods for controlling power amplifier (PA) performance metrics such as linearity and stability based on out-of-band feedback are presented. Various embodiments provide for synthesizing negative baseband termination using a feedback network between the drain and gate bias paths of the PA, so that the intermodulation distortion (IMD) is suppressed without an increase in system complexity. Other embodiments include a feedback network topology between the drain and gate bias paths of the PA that provides stability enhancement of the PA without the need for conventional stability networks in the radio frequency (RF) path. The out-of-band feedback nature of the approach means that the continuous wave (CW) RF performance is not perturbed, enabling conventional design techniques to be used for the input and output matching networks while enhancing aspects of the PA performance.
FILED Tuesday, January 12, 2021
APPL NO 17/146965
CURRENT CPC
Transmission
H04B 1/0057 (20130101) Original (OR) Class
H04B 1/0458 (20130101)
H04B 1/0475 (20130101)
H04B 1/1036 (20130101)
H04B 2001/0433 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218498 Effros et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Michelle Effros (Pasadena, California);  Yuxin Liu (Pasadena, California)
ABSTRACT Systems and methods in accordance with various embodiments of the invention enable communicating using nested Low Density Parity Check (LDPC) codes. A nested LDPC code is an LDPC code having a full blocklength, where shorter blocklengths of the nested LDPC code can be utilized as shorter blocklength LDPC codes. In certain embodiments, a transmitter utilizes a nested LDPC code to communicate via a point-to-point connection. In several embodiments, multiple transmitters utilize nested LDPC codes to communicate simultaneously via a Random Access Channel. One embodiment includes a transmitter capable of encoding a message as symbols using a nested LDPC code until a feedback message indicating an end of epoch message is received. A receiver can determine whether a decoding rule is satisfied at predetermined decode times and transmit an end of epoch message when the decoder can decode a message based upon the nested LDPC code.
FILED Monday, January 11, 2021
APPL NO 17/146343
CURRENT CPC
Coding; Decoding; Code Conversion in General
H03M 13/1105 (20130101)
H03M 13/1148 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 1/0041 (20130101)
H04L 1/0057 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218499 Yavas et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Recep Can Yavas (Pasadena, California);  Victoria Kostina (Pasadena, California);  Michelle Effros (Pasadena, California)
ABSTRACT Communication systems and methods in accordance with various embodiments of the invention employ a rateless coding strategy in which an encoder utilizes codewords located within a restricted subset of a multi-dimensional sphere. In one embodiment, a transmitter is configured to encode message data as symbols using a rateless code until an end of epoch message is received, where the rateless code comprises a set of codewords characterized in that they are located within a restricted subset of a multi-dimensional sphere. A receiver receives observed symbols and at each of a predetermined set of decode times, determines whether a decoding rule is satisfied. When the decoding rule is satisfied, the receiver decodes at least one message using the rateless code and transmits an end of epoch message.
FILED Monday, January 11, 2021
APPL NO 17/146462
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 1/0643 (20130101)
H04L 1/0687 (20130101) Original (OR) Class
H04L 12/1868 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 20210213424 Sofranko et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
National Science Foundation (NSF)
APPLICANT(S) John A. Sofranko (Weston, Massachusetts);  Fanxing Li (Raleigh, North Carolina);  Luke Michael Neal (Raleigh, North Carolina);  Yunfei Gao (Raleigh, North Carolina);  Seif Yusuf (Raleigh, North Carolina);  Ryan Dudek (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) John A. Sofranko (Weston, Massachusetts);  Fanxing Li (Raleigh, North Carolina);  Luke Michael Neal (Raleigh, North Carolina);  Yunfei Gao (Raleigh, North Carolina);  Seif Yusuf (Raleigh, North Carolina);  Ryan Dudek (Raleigh, North Carolina)
ABSTRACT Redox catalysts having surface medication, methods of making redox catalysts with surface modification, and uses of the surface modified redox catalysts are provided. In some aspects, the redox catalysts include a core oxygen carrier region and an outer shell having an average thickness of about 1-100 monolayers surrounding the outer surface of the core region.
FILED Tuesday, December 08, 2020
APPL NO 17/115115
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 21/14 (20130101)
B01J 23/002 (20130101) Original (OR) Class
B01J 23/02 (20130101)
B01J 23/005 (20130101)
B01J 23/30 (20130101)
B01J 35/002 (20130101)
B01J 35/0006 (20130101)
B01J 35/10 (20130101)
B01J 37/06 (20130101)
B01J 37/0081 (20130101)
B01J 37/088 (20130101)
B01J 37/0215 (20130101)

Acyclic or Carbocyclic Compounds
C07C 4/06 (20130101)
C07C 5/48 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213501 SMITH et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOEOS)
APPLICANT(S) Keystone Tower Systems, Inc. (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Eric D. SMITH (Boulder, Colorado);  Rosalind K. TAKATA (Denver, Colorado);  Alexander H. SLOCUM (Bow, New Hampshire);  Samir A. NAYFEH (Shrewsbury, Massachusetts)
ABSTRACT Feeding stock used to form a tapered structure into a curving device such that each point on the stock undergoes rotational motion about a peak location of the tapered structure; and the stock meets a predecessor portion of stock along one or more adjacent edges.
FILED Thursday, March 11, 2021
APPL NO 17/199019
CURRENT CPC
Rolling of Metal
B21B 39/02 (20130101) Original (OR) Class

Manufacture of Metal Sheets, Wire, Rods, Tubes or Profiles, Otherwise Than by Rolling; Auxiliary Operations Used in Connection With Metal-working Without Essentially Removing Material
B21C 37/124 (20130101)
B21C 37/126 (20130101)
B21C 37/185 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213753 Secor
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
National Technology and Engineering Solutions of Sandia, LLC (NTESS)
Sandia National Laboratories (SNL)
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Ethan Benjamin Secor (Albuquerque, New Mexico)
ABSTRACT Aerosol jet printing offers a versatile, high-resolution capability for flexible and hybrid electronics. By integrating a flow-through ink cartridge with an ink recirculation system, ink composition and level within the cartridge are better maintained. This invention enables extended duration printing with improved deposition stability. This provides an important tool for extending the duration and improving reliability for aerosol jet printing, a key factor for integration of aerosol jet printing in practical manufacturing operations.
FILED Wednesday, January 15, 2020
APPL NO 16/743720
CURRENT CPC
Typewriters; Selective Printing Mechanisms,, i.e Mechanisms Printing Otherwise Than From a Forme; Correction of Typographical Errors
B41J 2/18 (20130101) Original (OR) Class
B41J 2/17566 (20130101)
B41J 2/17596 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213932 AGGOUNE et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
APPLICANT(S) DELPHI TECHNOLOGIES IP LIMITED (ST. MICHAEL, Barbados)
ASSIGNEE(S)
INVENTOR(S) KARIM AGGOUNE (AUBURN HILLS, Michigan);  PETER M. OLIN (ANN ARBOR, Michigan);  ZHAOXUAN ZHU (UPPER ARLINGTON, Ohio)
ABSTRACT A method for controlling vehicle propulsion includes identifying at least one route characteristic of a portion of a route being traversed by a vehicle. The method further includes determining a profile for a target vehicle speed based on the at least one route characteristic and a vehicle energy consumption profile. The method further includes selectively adjusting a vehicle speed control input based on the target vehicle speed profile. The method further includes communicating the vehicle speed control input to a vehicle propulsion controller to achieve the target vehicle speed profile.
FILED Tuesday, January 14, 2020
APPL NO 16/742204
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 20/12 (20160101) Original (OR) Class
B60W 30/143 (20130101)
B60W 30/18072 (20130101)
B60W 40/09 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213933 Borrelli et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California);  HYUNDAI AMERICA TECHNICAL CENTER INC. (Superior Township, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California);  HYUNDAI AMERICA TECHNICAL CENTER INC. (Superior Township, Michigan)
INVENTOR(S) Francesco Borrelli (Kensington, California);  Yongkeun Choi (Berkeley, California);  Jacopo Guanetti (Berkeley, California);  Yeojun Kim (Berkeley, California);  Ryan Miller (Chino, California)
ABSTRACT Systems, apparatus and methods for controlling a plug-in hybrid electric vehicles (PHEVs) to improve energy utilization based on vehicle-to-internet cloud (V2C) connectivity. An automated driving system is trained for predicting vehicle motion trajectories based on historical vehicle and environmental trip data. An automated powertrain control system is trained to provide a parametric approximation of long-term energy cost about the remainder of a given vehicle trip. During the trip the automated driving system plans estimated trajectories based on forecasts of power allocation, while the powertrain control system forecasts and controls the fuel burning engine, electric drive motor(s), and powertrain mode, to minimize energy-wasteful motion trajectories.
FILED Thursday, December 10, 2020
APPL NO 17/118320
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 20/11 (20160101)
B60W 20/12 (20160101) Original (OR) Class
B60W 20/13 (20160101)

Indexing Scheme Relating to Aspects Cross-cutting Vehicle Technology
B60Y 2400/214 (20130101)

Wireless Communication Networks
H04W 4/44 (20180201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214287 Kothandaraman et al.
FUNDED BY
Department of Energy (DOE)
Battelle Memorial Institute (BATTELLE)
Pacific Northwest National Laboratory (PNNL)
APPLICANT(S) Battelle Memorial Institute (Richland, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) Jotheeswari Kothandaraman (Richland, Washington);  David J. Heldebrant (Richland, Washington);  Robert A. Dagle (Richland, Washington);  Yuan Jiang (Richland, Washington);  Johnny Saavedra Lopez (Richland, Washington)
ABSTRACT A process for producing methane or methanol includes combining a hydrogenation catalyst, hydrogen, and CO2 with a condensed phase solution comprising an amine under conditions effective to form methane or methanol, and water. A process for coproduction of methanol and a glycol includes combining an epoxide, a hydrogenation catalyst, hydrogen, and CO2 with a condensed phase solution comprising an amine under conditions effective to form methanol and a glycol.
FILED Monday, March 29, 2021
APPL NO 17/215415
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 1/12 (20130101) Original (OR) Class
C07C 29/1512 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214633 Thorson et al.
FUNDED BY
Department of Energy (DOE)
Battelle Memorial Institute (BATTELLE)
Pacific Northwest National Laboratory (PNNL)
APPLICANT(S) Battelle Memorial Institute (Richland, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) Michael R. Thorson (Richland, Washington);  Lesley J. Snowden-Swan (Ellensburg, Washington);  Andrew J. Schmidt (Richland, Washington);  Todd R. Hart (Kennewick, Washington);  Justin M. Billing (Richland, Washington);  Daniel B. Anderson (Pasco, Washington);  Richard T. Hallen (Richland, Washington)
ABSTRACT A hydrothermal liquefaction (HTL) system can comprise a biomass slurry source, a first pump in fluid communication with the slurry source and configured to pressurize a biomass slurry stream from the slurry source to a first pressure, a first heat exchanger in fluid communication with the first pump and configured to heat a slurry stream received from the first pump to a first temperature, a second pump in fluid communication with the first heat exchanger and configured to pressurize a slurry stream received from the first heat exchanger to a second pressure higher than the first pressure, a second heat exchanger in fluid communication with the second pump and configured to heat a slurry stream received from the second pump to a second temperature higher than the first temperature, and a HTL reactor configured to produce biocrude from a slurry stream received from the second heat exchanger.
FILED Friday, January 10, 2020
APPL NO 16/740339
CURRENT CPC
Fuels Not Otherwise Provided for; Natural Gas; Synthetic Natural Gas Obtained by Processes Not Covered by Subclasses C10G, C10K; Liquefied Petroleum Gas; Adding Materials to Fuels or Fires to Reduce Smoke or Undesirable Deposits or to Facilitate Soot Removal; Firelighters
C10L 3/08 (20130101)
C10L 9/086 (20130101) Original (OR) Class
C10L 2200/0469 (20130101)
C10L 2290/06 (20130101)
C10L 2290/46 (20130101)
C10L 2290/543 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214756 Stephanopoulos
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Gregory Stephanopoulos (Winchester, Massachusetts)
ABSTRACT Some aspects of this invention provide methods and bioreactors for converting a carbon source into a lipid. In some embodiments, lipid production is carried out in an aerobic fermentor and carbon dioxide generated during lipid production is converted into a carbon substrate by CO2 fixation in an anaerobic fermentor. In some embodiments, the carbon substrate generated by CO2 fixation is used as the carbon source for lipid production, thus achieving total carbon utilization in lipid production.
FILED Tuesday, October 20, 2020
APPL NO 17/074682
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 23/58 (20130101)
C12M 43/00 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/10 (20130101)
C12P 7/16 (20130101)
C12P 7/54 (20130101)
C12P 7/649 (20130101) Original (OR) Class
C12P 7/6463 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/10 (20130101)
Y02E 50/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214757 Sun et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Berkeley National Laboratory (LBNL)
National Nuclear Security Administration (NNSA)
National Technology and Engineering Solutions of Sandia, LLC (NTESS)
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Jian Sun (Albany, California);  Jian Shi (Albany, California);  Blake A. Simmons (San Francisco, California);  Seema Singh (Mountain House, California)
ABSTRACT The present invention provides for a method of fermenting or saccharifying a biomass comprising: (a) (i) contacting a biomass comprising a polysaccharide, and an ionic liquid (IL) to form a first solution, or (ii) providing the first solution comprising the biomass and the IL, (b) contacting the first solution and carbon dioxide such that the first solution results in a lower pH, (c) introducing (i) an enzyme capable of enzymatically to breakdown at least one bond in the polysaccharide or a breakdown product of the polysaccharide, and/or (ii) a microorganism that capable of producing the enzyme and/or fermenting the polysaccharide or a breakdown product of the polysaccharide, such that the polysaccharide is at least partially broken down and the first solution is transformed into a second solution.
FILED Monday, November 16, 2020
APPL NO 17/099488
CURRENT CPC
Polysaccharides; Derivatives Thereof
C08B 1/003 (20130101)

Derivatives of Natural Macromolecular Compounds
C08H 8/00 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/10 (20130101)
C12P 7/065 (20130101)
C12P 7/649 (20130101)
C12P 19/02 (20130101)
C12P 19/14 (20130101) Original (OR) Class
C12P 2201/00 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214823 Allard, JR. et al.
FUNDED BY
Department of Energy (DOE)
Pacific Northwest National Laboratory (PNNL)
UT-Battelle, LLC (UT-BATTELLE)
Oak Ridge National Laboratory (ORNL)
APPLICANT(S) Lawrence Allard, JR. (Knoxville, Tennessee);  Sumit Bahl (Knoxville, Tennessee);  Ryan Dehoff (Knoxville, Tennessee);  Hunter Henderson (Knoxville, Tennessee);  Michael Kesler (Knoxville, Tennessee);  Scott McCall (Livermore, California);  Peeyush Nandwana (Oak Ridge, Tennessee);  Ryan Ott (Ames, Iowa);  Alex Plotkowski (Knoxville, Tennessee);  Orlando Rios (Knoxville, Tennessee);  Amit Shyam (Knoxville, Tennessee);  Zachary Sims (Knoxville, Tennessee);  Kevin Sisco (Knoxville, Tennessee);  David Weiss (Manitowoc, Wisconsin);  Ying Yang (Knoxville, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Lawrence Allard, JR. (Knoxville, Tennessee);  Sumit Bahl (Knoxville, Tennessee);  Ryan Dehoff (Knoxville, Tennessee);  Hunter Henderson (Knoxville, Tennessee);  Michael Kesler (Knoxville, Tennessee);  Scott McCall (Livermore, California);  Peeyush Nandwana (Oak Ridge, Tennessee);  Ryan Ott (Ames, Iowa);  Alex Plotkowski (Knoxville, Tennessee);  Orlando Rios (Knoxville, Tennessee);  Amit Shyam (Knoxville, Tennessee);  Zachary Sims (Knoxville, Tennessee);  Kevin Sisco (Knoxville, Tennessee);  David Weiss (Manitowoc, Wisconsin);  Ying Yang (Knoxville, Tennessee)
ABSTRACT Disclosed herein are embodiments of an Al—Ce—Mn alloy for use in additive manufacturing. The disclosed alloy embodiments provide fabricated objects, such as bulk components, comprising a heterogeneous microstructure and having good mechanical properties even when exposed to conditions used during the additive manufacturing process. Methods for making and using alloy embodiments also are disclosed herein.
FILED Friday, June 05, 2020
APPL NO 16/894551
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/1055 (20130101)
B22F 2301/052 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 70/00 (20141201)

Alloys
C22C 21/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215472 He et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Department of Energy (DOE)
UChicago Argonne, LLC (UCHICAGO)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Northwestern University (Evanston, Illinois);  UChicago Argonne, LLC (Chicago, Illinois);  The University of Chicago (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Kuan He (Evanston, Illinois);  Oliver Strider Cossairt (Evanston, Illinois);  Aggelos K. Katsaggelos (Chicago, Illinois);  Norbert Scherer (Chicago, Illinois);  Mark Hereld (Chicago, Illinois)
ABSTRACT A system to generate image representations includes a first objective that receives a first light beam emitted from a sample and a second objective that receives a second light beam emitted from the sample, where the first light beam and the second light beam have conjugate phase. The system also includes a first diffractive element to receive the first light beam and separate it into a first plurality of diffractive light beams that are spatially distinct, and a second diffractive element to receive the second light beam and separate it into a second plurality of diffractive light beams that are spatially distinct. The system further includes a detector that receives the first and second plurality of diffractive light beams. The first plurality of diffractive light beams and the second plurality of diffractive light beams are simultaneously directed and focused onto different portions of an image plane of the detector.
FILED Friday, June 21, 2019
APPL NO 15/734172
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/04 (20130101) Original (OR) Class
G01B 9/02041 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/4788 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/361 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215737 MCLEOD et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOEOS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) ALEXANDER SWINTON MCLEOD (New York, New York);  LIN XIONG (Bronx, New York);  SHUAI ZHANG (New York, New York);  DIMITRI N. BASOV (New York, New York)
ABSTRACT An exemplary apparatus can provide radiation to a sample(s), which can include, for example, a radiation source arrangement configured to provide radiation, a beam splitter configured to split the radiation into (i) a first radiation, and (ii) a second radiation. An optical element can also be provided which, in operation, can, e.g., (a) receive the first radiation and the second radiation, (b) reflect the first radiation as a reference radiation, (c) provide the second radiation as illumination for the sample(s), (d) receive a resultant radiation from the sample(s) that can be based on the illumination from the second radiation, and (e) provide the reference radiation and the resultant radiation to be detected and used for interferometric imaging or spectroscopy.
FILED Thursday, January 14, 2021
APPL NO 17/149236
CURRENT CPC
Scanning-probe Techniques or Apparatus; Applications of Scanning-probe Techniques, e.g Scanning Probe Microscopy [SPM]
G01Q 20/02 (20130101) Original (OR) Class
G01Q 30/18 (20130101)
G01Q 60/24 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/0032 (20130101)
G02B 21/0056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215777 Marple
FUNDED BY
Department of Energy (DOE)
Lawrence Livermore National Laboratory (LLNL)
Lawrence Livermore National Security LLC (LLNS)
APPLICANT(S) LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (Livermore, California)
ASSIGNEE(S)
INVENTOR(S) Maxwell Marple (Berkeley, California)
ABSTRACT A magic angle sample spinning nuclear magnetic resonance system including a housing, a cryogenic fluid in the housing, a magnet in the housing, a probe in the housing, a magic angle sample spinning insert in the probe, a sample battery in the magic angle sample spinning insert, a photovoltaic cell in the magic angle sample spinning insert wherein the photovoltaic cell is connected to the sample battery, an optic fiber operatively connected to the photovoltaic cell, and a laser operatively connected to the optic fiber wherein the laser provides power to charge the sample battery during the magic angle sample spinning nuclear magnetic resonance.
FILED Tuesday, December 15, 2020
APPL NO 17/122233
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
G01R 33/307 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215843 Barajas-Olalde et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Energy and Environmental Research Center Foundation (Grand Forks, North Dakota)
ASSIGNEE(S)
INVENTOR(S) César Barajas-Olalde (Tampico, Mexico);  Kyle A. Glazewski (Grand Forks, North Dakota);  Nicholas W. Bosshart (Larimore, North Dakota)
ABSTRACT Methods are presented for determining the location of underground features (e.g., CO2). One method includes capturing, by sensors distributed throughout a region, seismic traces associated with seismic signals generated by a seismic source. For multiple sensors, active noise is identified or passive noise is measured within each seismic trace and values for attributes associated with the active or passive noise are determined. Further, an unsupervised machine-learning model, based on the values of the attributes, is utilized to determine noise characteristics for multiple sensors. The sensors are grouped in clusters based on the noise characteristics for each sensor. For multiple clusters, a noise filter is created based on the noise characteristics of the sensors in the cluster, and the noise filter of the cluster is applied, for multiple sensors, to the seismic traces of the sensor. Additionally, the filtered seismic traces are analyzed to determine a location of CO2 underground.
FILED Wednesday, December 09, 2020
APPL NO 17/116409
CURRENT CPC
Geophysics; Gravitational Measurements; Detecting Masses or Objects; Tags
G01V 1/288 (20130101)
G01V 1/301 (20130101)
G01V 1/364 (20130101) Original (OR) Class
G01V 2210/3246 (20130101)
G01V 2210/3248 (20130101)

Computer Systems Based on Specific Computational Models
G06N 5/04 (20130101)
G06N 20/00 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216368 GUTIERREZ et al.
FUNDED BY
Department of Energy (DOE)
Exascale Computing Project (ECP)
PathForward Project (PATHFORWARD)
Lawrence Livermore National Laboratory (LLNL)
APPLICANT(S) ADVANCED MICRO DEVICES, INC. (Santa Clara, California)
ASSIGNEE(S)
INVENTOR(S) Anthony GUTIERREZ (Bellevue, Washington);  Sooraj PUTHOOR (Austin, Texas)
ABSTRACT A processor core is configured to execute a parent task that is described by a data structure stored in a memory. A coprocessor is configured to dispatch a child task to the at least one processor core in response to the coprocessor receiving a request from the parent task concurrently with the parent task executing on the at least one processor core. In some cases, the parent task registers the child task in a task pool and the child task is a future task that is configured to monitor a completion object and enqueue another task associated with the future task in response to detecting the completion object. The future task is configured to self-enqueue by adding a continuation future task to a continuation queue for subsequent execution in response to the future task failing to detect the completion object.
FILED Monday, March 29, 2021
APPL NO 17/215171
CURRENT CPC
Electric Digital Data Processing
G06F 9/542 (20130101)
G06F 9/545 (20130101)
G06F 9/546 (20130101)
G06F 9/3877 (20130101)
G06F 9/4881 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210216387 LePera et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S)
INVENTOR(S) William P. LePera (Wappingers Falls, New York);  Sameh Sherif Sharkawi (Cypress, Texas);  Austen William Lauria (Fishkill, New York)
ABSTRACT Technology for determining whether an inter-process type message has been successfully sent from a first process to a second process running on a single computer with a single processor(s) set. A variable (for example, a bit value) is used to indicate whether the inter-process message has been communicated between the processes. A timer and a predetermined timeout threshold are used to determine if the inter-process message has been pending for too long without being successfully communicated.
FILED Friday, January 10, 2020
APPL NO 16/739613
CURRENT CPC
Electric Digital Data Processing
G06F 9/546 (20130101)
G06F 11/079 (20130101) Original (OR) Class
G06F 11/0724 (20130101)
G06F 11/0757 (20130101)
G06F 11/0772 (20130101)
G06F 2209/547 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217712 PAPAPOLYMEROU et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
APPLICANT(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
ASSIGNEE(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
INVENTOR(S) Ioannis PAPAPOLYMEROU (Okemos, Michigan);  Premjeet CHAHAL (Okemos, Michigan);  John D. ALBRECHT (Okemos, Michigan);  Michael Thomas CRATON (Lansing, Michigan);  Christopher OAKLEY (Lansing, Michigan)
ABSTRACT A method of manufacturing an interconnect packaging structure is provided. In one aspect, the method includes forming a first body defining a cavity around at least one integrated circuit using an additive manufacturing machine, depositing a conductive transmission line on the first body and electrically coupling the conductive transmission line and the at least one integrated circuit with a conductive interconnect.
FILED Wednesday, May 15, 2019
APPL NO 17/056188
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 30/00 (20141201)

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/028 (20210501)
G01S 7/282 (20130101)
G01S 13/931 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/66 (20130101) Original (OR) Class
H01L 24/06 (20130101)
H01L 24/19 (20130101)
H01L 24/24 (20130101)
H01L 2223/6627 (20130101)
H01L 2223/6644 (20130101)
H01L 2223/6677 (20130101)
H01L 2224/06131 (20130101)
H01L 2224/24227 (20130101)
H01L 2224/24247 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217943 REN et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOEOS)
APPLICANT(S) University of Houston System (Houston, Texas)
ASSIGNEE(S) University of Houston System (Houston, Texas)
INVENTOR(S) Zhifeng REN (Pearland, Texas);  Jing SHUAI (Houston, Texas)
ABSTRACT Systems and methods discussed herein relate to Zintl-type thermoelectric materials, including a p-type thermoelectric material according to the formula AMyXy, and includes at least one of calcium (Ca), europium (Eu), ytterbium (Yb), and strontium N (Sr), and has a ZT of the above about 0.60 above 675 K. The n-type thermoelectric component includes magnesium (Mg), tellurium (Te), antimony (Sb), and bismuth (Bi) according to the formula Mg3.2Sb1.5Bi0.5-xTex that has an average ZT above 0.8 from 400 K to 800 K. The p-type and n-type materials discussed herein may be used alone, in combination with other materials, or in combination with each other in various configurations.
FILED Friday, February 17, 2017
APPL NO 15/999846
CURRENT CPC
Alloys
C22C 1/04 (20130101)
C22C 12/00 (20130101)
C22C 28/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 35/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217952 Jarillo-Herrero et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Energy (DOE)
Ames Laboratory (AL)
Office of Science (DOEOS)
APPLICANT(S) Pablo Jarillo-Herrero (Cambridge, Massachusetts);  Qiong MA (Cambridge, Massachusetts);  Nuh GEDIK (Watertown, Massachusetts);  Suyang XU (Cambridge, Massachusetts);  Zhiren ZHENG (Cambridge, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Pablo Jarillo-Herrero (Cambridge, Massachusetts);  Qiong MA (Cambridge, Massachusetts);  Nuh GEDIK (Watertown, Massachusetts);  Suyang XU (Cambridge, Massachusetts);  Zhiren ZHENG (Cambridge, Massachusetts)
ABSTRACT An ultrathin, carbon-based memristor with a moiré superlattice potential shows prominent ferroelectric resistance switching. The memristor includes a bilayer material, such as Bernal-stacked bilayer graphene, encapsulated between two layers of a layered material, such as hexagonal boron nitride. At least one of the encapsulating layers is rotationally aligned with the bilayer to create the moiré superlattice potential. The memristor exhibits ultrafast and robust resistance switching between multiple resistance states at high temperatures. The memristor, which may be volatile or nonvolatile, may be suitable for neuromorphic computing.
FILED Tuesday, November 10, 2020
APPL NO 17/094141
CURRENT CPC
Static Stores
G11C 13/0069 (20130101)
G11C 2213/35 (20130101)
G11C 2213/53 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 45/10 (20130101) Original (OR) Class
H01L 45/142 (20130101)
H01L 45/143 (20130101)
H01L 45/148 (20130101)
H01L 45/149 (20130101)
H01L 45/1206 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218015 CHEN et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) GM GLOBAL TECHNOLOGY OPERATIONS LLC (Detroit, Michigan)
ASSIGNEE(S) GM GLOBAL TECHNOLOGY OPERATIONS LLC (Detroit, Michigan)
INVENTOR(S) Shuru CHEN (Troy, Michigan);  Fang DAI (Troy, Michigan);  Mei CAI (Bloomfield Hills, Michigan)
ABSTRACT The present disclosure relates to sulfur-containing electrodes and methods for forming the same. For example, the method may include disposing an electroactive material on or near a current collector to form an electroactive material layer having a first porosity and applying pressure and heat to the electroactive material layer so that the electroactive material layer has a second porosity. The first porosity is greater than the second porosity. The electroactive material may include a plurality of electroactive material particles and one or more salt additives. The method may further include contacting the electroactive material layer and an electrolyte such that the electrolyte dissolves the plurality of one or more salt particles so that the electroactive material layer has a third porosity. The third porosity may be greater than the second porosity and less than the first porosity.
FILED Wednesday, January 15, 2020
APPL NO 16/743650
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/38 (20130101)
H01M 4/62 (20130101)
H01M 4/139 (20130101) Original (OR) Class
H01M 4/0404 (20130101)
H01M 4/0435 (20130101)
H01M 10/0525 (20130101)
H01M 2004/021 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218055 Visco et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
APPLICANT(S) PolyPlus Battery Company (Berkeley, California)
ASSIGNEE(S)
INVENTOR(S) Steven J. Visco (Berkeley, California);  Vitaliy Nimon (San Francisco, California);  Yevgeniy S. Nimon (Danville, California);  Bruce D. Katz (Moraga, California)
ABSTRACT A sulfide glass solid electrolyte sheet can be protected from reaction with moisture by a thin metal layer coating converted to a thin electrochemically functional and protective compound layer. The converted protective compound layer is electrochemically functional in that it allows for through transport of lithium ions.
FILED Thursday, January 14, 2021
APPL NO 17/248225
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 10/0525 (20130101)
H01M 10/0562 (20130101) Original (OR) Class
H01M 50/403 (20210101)
H01M 50/437 (20210101)
H01M 50/451 (20210101)
H01M 50/457 (20210101)
H01M 2300/0068 (20130101)
H01M 2300/0094 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218062 Xu et al.
FUNDED BY
Department of Energy (DOE)
Battelle Memorial Institute (BATTELLE)
Pacific Northwest National Laboratory (PNNL)
APPLICANT(S) Battelle Memorial Institute (Richland, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) Wu Xu (Richland, Washington);  Ji-Guang Zhang (Richland, Washington);  Hao Jia (Richland, Washington);  Xianhui Zhang (Richland, Washington);  Xia Cao (Richland, Washington);  Sujong Chae (Richland, Washington);  Ran Yi (Richland, Washington);  Qiuyan Li (Richland, Washington);  Won-Jin Kwak (Richland, Washington);  Xiaolin Li (Richland, Washington)
ABSTRACT Electrolytes for lithium ion batteries with carbon-based, silicon-based, or carbon- and silicon-based anodes include a lithium salt; a nonaqueous solvent comprising at least one of the following components: (i) an ester, (ii) a sulfur-containing solvent, (iii) a phosphorus-containing solvent, (iv) an ether, (v) a nitrile, or any combination thereof, wherein the lithium salt is soluble in the solvent; a diluent comprising a fluoroalkyl ether, a fluorinated orthoformate, a fluorinated carbonate, a fluorinated borate, or a combination thereof, wherein the lithium salt has a solubility in the diluent at least 10 times less than a solubility of the lithium salt in the solvent; and an additive having a different composition than the lithium salt, a different composition than the solvent, and a different composition than the diluent.
FILED Friday, January 08, 2021
APPL NO 17/144600
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 10/0525 (20130101)
H01M 10/0567 (20130101)
H01M 10/0568 (20130101) Original (OR) Class
H01M 10/0569 (20130101)
H01M 2300/004 (20130101)
H01M 2300/0034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218230 BOWERS et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency Energy (ARPAE)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) John E. BOWERS (Santa Barbara, California);  Arthur GOSSARD (Santa Barbara, California);  Daehwan JUNG (Goleta, California);  Kunal MUKHERJEE (Goleta, California);  Justin NORMAN (Goleta, California);  Jenny SELVIDGE (Goleta, California)
ABSTRACT A quantum dot (QD) laser comprises a semiconductor substrate and an active region epitaxially deposited on the semi-conductor substrate. The active region includes a plurality of barrier layers and a plurality of QD layers interposed between each of the plurality of barrier layers. A net compressive strain associated with the plurality of QD layers is maintained below a maximum allowable strain to prevent formation of misfit dislocations within the active region of the QD laser.
FILED Friday, May 24, 2019
APPL NO 17/058012
CURRENT CPC
Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/3406 (20130101) Original (OR) Class
H01S 5/3412 (20130101)
H01S 5/3436 (20130101)
H01S 5/34353 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218805 Gonzalez et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOEOS)
National Aeronautics and Space Administration (NASA)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ASSIGNEE(S) Intellectual Property Systems, LLC (Weston, Florida)
INVENTOR(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ABSTRACT Systems and methods for reducing data movement in a computer system. The systems and methods use information or knowledge about the structure of an algorithm, operations to be executed at a receiving processing unit, variables or subsets or groups of variables in a distributed algorithm, or other forms of contextual information, for reducing the number of bits transmitted from at least one transmitting processing unit to at least one receiving processing unit or storage device.
FILED Thursday, March 25, 2021
APPL NO 17/213012
CURRENT CPC
Electric Digital Data Processing
G06F 9/46 (20130101)

Coding; Decoding; Code Conversion in General
H03M 7/24 (20130101)
H03M 7/30 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/10 (20130101)
H04L 67/104 (20130101)
H04L 67/1095 (20130101) Original (OR) Class
H04L 69/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 20210214049 Cardenas et al.
FUNDED BY
Department of Commerce (DOC)
National Oceanic and Atmospheric Administration (NOAA)
APPLICANT(S) Boston Engineering Corporation (Waltham, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Robert Lee Cardenas (Framingham, Massachusetts);  Michael Conry (Beverly, Massachusetts);  Michael Rufo (Hanover, Massachusetts)
ABSTRACT A technique for managing an attachment between first and second portions of a device. The technique includes a retaining component having a first state in which the retaining component maintains the attachment between the first and second portions by virtue of a rigid characteristic and a second state in which the retaining component loses the rigid characteristic and no longer maintains the attachment. The retaining component transitions from the first state to the second state upon exposure to liquid water.
FILED Tuesday, April 21, 2020
APPL NO 16/854533
CURRENT CPC
Ships or Other Waterborne Vessels; Equipment for Shipping
B63B 22/003 (20130101)
B63B 22/08 (20130101) Original (OR) Class

Launching, Hauling-out, or Dry-docking of Vessels; Life-saving in Water; Equipment for Dwelling or Working Under Water; Means for Salvaging or Searching for Underwater Objects
B63C 7/26 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215353 Yashar
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Government of the United States of America, as represented by the Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) David Anthony Yashar (Dunn Loring, Virginia)
ABSTRACT A bacteria abatement water heater abates bacterial growth and includes a fluid-isolated heat exchanger; a water heating container that heats water to a high water temperature that is greater than or equal to a kill temperature for bacteria; a hot water delivery conduit including a transitional cooling zone in thermal communication with the fluid-isolated heat exchanger and that provides bacteria-free water from the water heating container at a safe temperature.
FILED Monday, January 11, 2021
APPL NO 17/146330
CURRENT CPC
Domestic- or Space-heating Systems, e.g Central Heating Systems; Domestic Hot-water Supply Systems; Elements or Components Therefor
F24D 17/0073 (20130101) Original (OR) Class
F24D 19/1051 (20130101)
F24D 2220/06 (20130101)

Fluid Heaters, e.g Water or Air Heaters, Having Heat Generating Means, in General
F24H 1/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215518 Rufo et al.
FUNDED BY
Department of Commerce (DOC)
National Oceanic and Atmospheric Administration (NOAA)
APPLICANT(S) Boston Engineering Corporation (Waltham, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Michael Rufo (Hanover, Massachusetts);  Michael Conry (Beverly, Massachusetts);  Robert Watson (Lowell, Massachusetts)
ABSTRACT A technique provides a modular sensing device having multiple separable modules attached end to end. The modules are selectable based on mission requirements, with different modules and combinations thereof selected for different mission types and/or requirements.
FILED Friday, January 08, 2021
APPL NO 17/144527
CURRENT CPC
Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 11/245 (20130101) Original (OR) Class
G01D 21/02 (20130101)

Electric Digital Data Processing
G06F 8/61 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215599 Forbes et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Government of the United States of America, as represented bythe Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Thomas Patrick Forbes (Elkridge, Maryland);  Matthew Edward Staymates (Damascus, Maryland)
ABSTRACT An infrared thermal desorber includes a desorption housing; an infrared source receiver that receives an infrared emission source; an infrared absorber receiver that receives an infrared absorber, such that the infrared absorber receiver produces thermal energy emission; an analyte target receiver that receives an analyte target, such that the analyte target receiver is in infrared communication with the infrared absorber disposed in the infrared source receiver so that the analyte target receives the thermal energy emission from the infrared absorber, desorbs the adsorbed analyte as volatilized analyte from the analyte target in response to receipt of the thermal energy emission from the infrared absorber, and communicates the volatilized analyte from the analyte target; and an effluent communicator that receives the volatized analyte.
FILED Friday, January 08, 2021
APPL NO 17/144232
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/405 (20130101)
G01N 21/35 (20130101) Original (OR) Class
G01N 21/71 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215636 Claussen et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Iowa State University Research Foundation, Inc. (Ames, Iowa);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Jonathan Claussen (Ames, Iowa);  Kshama Parate (Ames, Iowa);  Mark C. Hersam (Willmette, Illinois);  Sonal V. Rangnekar (Chicago, Illinois)
ABSTRACT Methods and systems of fabrication of high resolution, high-throughput electrochemical sensing circuits on a substrate. High resolution electrochemical sensing circuits are printed by an effective additive technique to the substrate. Optionally, post-print annealing converts electrochemically inactive printed graphene into one that is electrochemically active. The printing can be by aerosol jet printing, but is not necessarily limited thereto. An example is inkjet printing and then the post-print annealing. Ink formulation would be adjusted for effectiveness with inkjet printing. Optionally biorecognition agents can be covalently bonded to the printed graphene for the purpose of electrochemical biosensing. High throughput fabrication of high-resolution graphene circuits (feature sizes in the tens of microns <50 μm) for electrochemical biosensing is possible by chemical functionalization of the graphene surface with a biological agent.
FILED Thursday, January 14, 2021
APPL NO 17/248211
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/112 (20170801)

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2001/08 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 40/20 (20200101)
B33Y 80/00 (20141201)

Printing, Duplicating, Marking, or Copying Processes; Colour Printing,
B41M 3/006 (20130101)
B41M 5/0023 (20130101)
B41M 7/009 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4145 (20130101)
G01N 27/4148 (20130101) Original (OR) Class
G01N 33/5438 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215882 Khan et al.
FUNDED BY
Department of Commerce (DOC)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado);  Government of the United States of America as represented by the Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Saeed Khan (Lafayette, Colorado);  Jeffrey Shainline (Boulder, Colorado)
ABSTRACT A fiber-to-chip coupler includes a substrate, a waveguide on a top surface of the substrate, an optical fiber axially aligned to the waveguide, and a cap. The waveguide has a uniform region with uniform width and a tapered-waveguide region having a width that adiabatically increases from a minimum width to the uniform width. The optical fiber has a tapered fiber tip having a minimum core diameter, a cylindrical section having a maximum core diameter, and a tapered-fiber section therebetween. The optical fiber is located at least in part above the tapered-waveguide region, and has a core diameter that adiabatically decreases within a taper length of the tapered-fiber section. The cap extends from the tapered fiber tip toward the cylindrical section, is formed of a second material having a cap refractive index that exceeds a refractive index of the optical fiber, and includes a cap-region disposed on the tapered-waveguide region.
FILED Friday, January 08, 2021
APPL NO 17/144980
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/305 (20130101) Original (OR) Class
G02B 6/4214 (20130101)
G02B 6/4239 (20130101)
G02B 6/29335 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 20210213177 Cho
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The Research Foundation for The State University of New York (Binghamton, New York)
ASSIGNEE(S)
INVENTOR(S) Junghyun Cho (Vestal, New York)
ABSTRACT A substrate subject to degradation at temperatures above 100° C. is coated with a nanostructured ceramic coating having a thickness in excess of 100 nm, formed on a surface of the substrate, wherein a process temperature for deposition of the nanostructured coating does not exceed 90° C. The coating may be photocatalytic, photovoltaic, or piezoelectric. The coating, when moistened and exposed to ultraviolet light or sunlight, advantageously generates free radicals, which may be biocidal, deodorizing, or assist in degradation of surface deposits on the substrate after use. The substrate may be biological or organic, and may have a metallic or conductive intermediate layer.
FILED Monday, November 09, 2020
APPL NO 17/093382
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 29/16 (20130101)
A61L 29/106 (20130101)
A61L 31/16 (20130101)
A61L 31/088 (20130101) Original (OR) Class

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 35/004 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/325 (20130101)
C02F 1/725 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 7/06 (20130101)
C08J 7/14 (20130101)

Processes for the Electrolytic or Electrophoretic Production of Coatings; Electroforming; Apparatus Therefor
C25D 9/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213491 Edwards et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Kevin Scott Edwards (Roanoke, Virginia);  Mark Alan Mitchell (Decatur, Alabama);  Eric Townsend Fox (Huntsville, Alabama)
ABSTRACT A high flow differential cleaning system uses a source of pressurized compressed dry gas to pressurize a holding tank. A component to be cleaned is securely loaded and oriented against a blast plate designed specifically for the desired pressure, flow, and volume. A fast-actuated valve system opens to direct high volumes of pressurized gas from a holding tank through and around the component(s) held within the cleaning chamber for the removal of remnant powder and foreign particles from interior cavities as well as exterior component surfaces.
FILED Tuesday, June 23, 2020
APPL NO 16/909572
CURRENT CPC
Cleaning in General; Prevention of Fouling in General
B08B 9/0328 (20130101) Original (OR) Class

Servicing, Cleaning, Repairing, Supporting, Lifting, or Manoeuvring of Vehicles, Not Otherwise Provided for
B60S 3/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210213523 Peterson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Research Office (ARO)
United States Army (USA)
National Aeronautics and Space Administration (NASA)
National Science Foundation (NSF)
Office of Experimental Program To Stimulate Competitive Research (EPSCOR)
APPLICANT(S) Georgia Tech Research Corporation (Atlanta, Georgia);  South Dakota School of Mines (Rapid City, South Dakota)
ASSIGNEE(S)
INVENTOR(S) G. P. "Bud" Peterson (Atlanta, Georgia);  Haiping Hong (Rapid City, South Dakota)
ABSTRACT Disclosed herein is a method of homogeneously mixing solids, comprising: mixing, in a fluid medium, at least a first Got nanoparticle material and a surfactant, wherein the surfactant causes the first nanoparticle material to distribute uniformly in the fluid medium and have a specific charge; adding, to the fluid medium, a second nanoparticle material, wherein the surfactant has a charge of opposite polarity to the zeta potential of the second nanoparticle material; attaching the second nanoparticle material to the first Nnanoparticle material using the charge attraction of the surfactant and the second nanoparticle material to obtain a homogeneous material; and removing the attached first and second nanoparticle materials from the fluid medium to obtain a solid homogeneous material.
FILED Friday, May 10, 2019
APPL NO 17/054202
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 1/0022 (20130101) Original (OR) Class
B22F 1/0074 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/174 (20170801)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218368 Siles Perez et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Jet Propulsion Laboratory (JPL)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Jose Vicente Siles Perez (Pasadena, California);  Choonsup Lee (La Palma, California);  Robert H. Lin (Chino, California);  Alejandro Peralta (Pasadena, California)
ABSTRACT A solid-state device chip including diodes (generating a higher or lower frequency output through frequency multiplication or mixing of the input frequency) and a novel on-chip diplexing design that allows combination of two or more multiplier or mixer structures operating at different frequency bands within the 50-5000 GHz range within a same chip and/or waveguide. The on-chip diplexing design consists of a single-substrate multiplier chip with two or more multiplying structures each one containing 2 or more Schottky diodes. The diodes in each structure are tuned to one portion of the target frequency band, resulting in the two or more structures working together as a whole as a large broadband multiplier or mixer. Thus, an increase in bandwidth from 10-15% (current state-of-the-art) to at least 40% is achieved. Depending on the target frequencies, each subset of diodes within the chip can be designed to work either as a doubler or a tripler.
FILED Monday, November 09, 2020
APPL NO 17/093305
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/66 (20130101)
H01L 29/872 (20130101)
H01L 2223/6627 (20130101)
H01L 2223/6688 (20130101)

Generation of Oscillations, Directly or by Frequency-changing, by Circuits Employing Active Elements Which Operate in a Non-switching Manner; Generation of Noise by Such Circuits
H03B 19/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218805 Gonzalez et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOEOS)
National Aeronautics and Space Administration (NASA)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ASSIGNEE(S) Intellectual Property Systems, LLC (Weston, Florida)
INVENTOR(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ABSTRACT Systems and methods for reducing data movement in a computer system. The systems and methods use information or knowledge about the structure of an algorithm, operations to be executed at a receiving processing unit, variables or subsets or groups of variables in a distributed algorithm, or other forms of contextual information, for reducing the number of bits transmitted from at least one transmitting processing unit to at least one receiving processing unit or storage device.
FILED Thursday, March 25, 2021
APPL NO 17/213012
CURRENT CPC
Electric Digital Data Processing
G06F 9/46 (20130101)

Coding; Decoding; Code Conversion in General
H03M 7/24 (20130101)
H03M 7/30 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/10 (20130101)
H04L 67/104 (20130101)
H04L 67/1095 (20130101) Original (OR) Class
H04L 69/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 20210212657 GAO et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Technology Transfer (STTR)
APPLICANT(S) Cardiac Motion, LLC (Truckee, California);  The Regents of The University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Xiaomeng GAO (Dublin, California);  Xiaonan JIANG (Davis, California);  Xiaoguang LIU (Davis, California);  Dennis MATTHEWS (Meadow Vista, California);  Saul SCHAEFER (Davis, California)
ABSTRACT The present disclosure describes systems, methods, and devices to infer changes in pulmonary artery pressure in a subject using Doppler radar. A portable, non-invasive device for non-invasively measuring right ventricular cardiac motion that can be used in a subject\'s home can infer pulmonary artery pressure changes to increase patient compliance and mitigate the likelihood of heart decompensation. A mobile pulmonary artery pressure monitor can be especially useful to patients with congestive heart failure who are elderly, incapacitated, or do not have easy access to a clinic, doctor\'s office, or hospital.
FILED Tuesday, November 24, 2020
APPL NO 17/102838
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/02 (20130101)
A61B 8/04 (20130101) Original (OR) Class
A61B 8/08 (20130101)
A61B 8/488 (20130101)
A61B 8/5207 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210214282 Temme et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Pivot Bio, Inc. (Berkeley, California)
ASSIGNEE(S)
INVENTOR(S) Karsten Temme (Oakland, California);  Alvin Tamsir (San Francisco, California);  Sarah Bloch (Emeryville, California);  Rosemary Clark (Berkeley, California);  Emily Tung (Millbrae, California)
ABSTRACT Disclosed herein are methods of increasing nitrogen fixation in a non-leguminous plant. The methods can comprise exposing the plant to a plurality of bacteria. Each member of the plurality comprises one or more genetic variations introduced into one or more genes or non-coding polynucleotides of the bacteria\'s nitrogen fixation or assimilation genetic regulatory network, such that the bacteria are capable of fixing atmospheric nitrogen in the presence of exogenous nitrogen. The bacteria are not intergeneric microorganisms. Additionally, the bacteria, in planta, produce 1% or more of the fixed nitrogen in the plant.
FILED Wednesday, January 13, 2021
APPL NO 17/148173
CURRENT CPC
Nitrogenous Fertilisers
C05C 1/00 (20130101)
C05C 3/005 (20130101)
C05C 5/005 (20130101)
C05C 11/00 (20130101)

Organic Fertilisers Not Covered by Subclasses C05B, C05C, e.g Fertilisers From Waste or Refuse
C05F 11/08 (20130101) Original (OR) Class

Peptides
C07K 14/195 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)
C12N 9/80 (20130101)
C12N 9/93 (20130101)
C12N 9/0095 (20130101)

Enzymes
C12Y 118/06001 (20130101)
C12Y 305/01002 (20130101)
C12Y 603/01002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218805 Gonzalez et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOEOS)
National Aeronautics and Space Administration (NASA)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ASSIGNEE(S) Intellectual Property Systems, LLC (Weston, Florida)
INVENTOR(S) Juan Guillermo Gonzalez (Weston, Florida);  Santiago Andres Fonseca (Doral, Florida);  Rafael Camilo Nunez (Aventura, Florida)
ABSTRACT Systems and methods for reducing data movement in a computer system. The systems and methods use information or knowledge about the structure of an algorithm, operations to be executed at a receiving processing unit, variables or subsets or groups of variables in a distributed algorithm, or other forms of contextual information, for reducing the number of bits transmitted from at least one transmitting processing unit to at least one receiving processing unit or storage device.
FILED Thursday, March 25, 2021
APPL NO 17/213012
CURRENT CPC
Electric Digital Data Processing
G06F 9/46 (20130101)

Coding; Decoding; Code Conversion in General
H03M 7/24 (20130101)
H03M 7/30 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/10 (20130101)
H04L 67/104 (20130101)
H04L 67/1095 (20130101) Original (OR) Class
H04L 69/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Office of the Director of National Intelligence (ODNI) 

US 20210215882 Khan et al.
FUNDED BY
Department of Commerce (DOC)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado);  Government of the United States of America as represented by the Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Saeed Khan (Lafayette, Colorado);  Jeffrey Shainline (Boulder, Colorado)
ABSTRACT A fiber-to-chip coupler includes a substrate, a waveguide on a top surface of the substrate, an optical fiber axially aligned to the waveguide, and a cap. The waveguide has a uniform region with uniform width and a tapered-waveguide region having a width that adiabatically increases from a minimum width to the uniform width. The optical fiber has a tapered fiber tip having a minimum core diameter, a cylindrical section having a maximum core diameter, and a tapered-fiber section therebetween. The optical fiber is located at least in part above the tapered-waveguide region, and has a core diameter that adiabatically decreases within a taper length of the tapered-fiber section. The cap extends from the tapered fiber tip toward the cylindrical section, is formed of a second material having a cap refractive index that exceeds a refractive index of the optical fiber, and includes a cap-region disposed on the tapered-waveguide region.
FILED Friday, January 08, 2021
APPL NO 17/144980
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/305 (20130101) Original (OR) Class
G02B 6/4214 (20130101)
G02B 6/4239 (20130101)
G02B 6/29335 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217598 VRIJSEN et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Geert VRIJSEN (Durham, North Carolina);  Jungsang KIM (Chapel Hill, North Carolina);  Robert SPIVEY (Durham, North Carolina);  Ismail INLEK (Durham, North Carolina);  Yuhi AIKYO (Durham, North Carolina)
ABSTRACT Systems and methods for loading microfabricated ion traps are disclosed. Photo-ablation via an ablation pulse is used to generate a flow of atoms from a source material, where the flow is predominantly populated with neutral atoms. As the neutral atoms flow toward the ion trap, two-photon photo-ionization is used to selectively ionize a specific isotope contained in the atom flow. The velocity of the liberated atoms, atom-generation rate, and/or heat load of the source material is controlled by controlling the fluence of the ablation pulse to provide high ion-trapping probability while simultaneously mitigating generation of heat in the ion-trapping system that can preclude cryogenic operation. In some embodiments, the source material is held within an ablation oven comprising an electrically conductive housing that is configured to restrict the flow of agglomerated neutral atoms generated during photo-ablation toward the ion trap.
FILED Tuesday, November 17, 2020
APPL NO 16/950703
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101)

Electric Discharge Tubes or Discharge Lamps
H01J 49/0018 (20130101) Original (OR) Class
H01J 49/161 (20130101)
H01J 49/422 (20130101)
H01J 49/0463 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

United States Postal Service (USPS) 

US 20210216962 Lawson et al.
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Angela Dawn Lawson (Cambridge, Massachusetts);  Fatema Momenni Kennedy (Dumfries, Virginia);  Junghyun Hwang (Herndon, Virginia)
ABSTRACT A system and method for tracking and managing package delivery within a distribution network. Many events happen during the processing, moving, and delivery of a package. Systems and methods herein identify whether all expected events occur, whether scan locations are correct, whether delivery times are met, and other requirements. Problems or potential problems can be identified and corrected.
FILED Monday, January 11, 2021
APPL NO 17/145719
CURRENT CPC
Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/0633 (20130101)
G06Q 10/0833 (20130101) Original (OR) Class
G06Q 10/06393 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210218975 Simpson
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Ryan J. Simpson (Vienna, Virginia)
ABSTRACT Embodiments of a system and method for secure processing of image data are described. Image data included in image files may be encrypted and compressed in a single step using dynamically identified compression/encryption information such as code word tables.
FILED Wednesday, March 31, 2021
APPL NO 17/219353
CURRENT CPC
Electric Digital Data Processing
G06F 21/6209 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00456 (20130101)

Pictorial Communication, e.g Television
H04N 19/172 (20141101)
H04N 19/182 (20141101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 20210214383 Jackson et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) Michael A. Jackson (Morton, Illinois);  Neil P. Price (Edelstein, Illinois)
ABSTRACT Disclosed are C-glycoside amine derivatives of the formula:
R—CH2—C(CH3)—NH—R2 wherein R is a saccharide (e.g., as described in U.S. Pat. No. 8,314,219) and R2 is an acyl moiety derived from any ketone of the formula R3—C(O)—R3 wherein R3 is C1 to C22 straight or branched chain hydrocarbon which may be saturated or unsaturated. In addition, a method for making the C-glycoside amine derivatives involving (1) reacting a saccharide (e.g., glucose) C-glycoside ketone with a catalyst (e.g., Rh), about 10 to about 25 fold excess NH3, and an organic solvent (e.g., methanol) to form a saccharide C-glycoside amine, and (2) reacting said saccharide C-glycoside amine with a catalyst (e.g., Rh), an organic solvent (e.g., methanol), and an acyl moiety derived from any ketone of the formula R3—C(O)—R3 wherein R3 is C1 to C22 straight or branched chain hydrocarbon which may be saturated or unsaturated to form said C-glycoside amine derivative.
FILED Monday, January 04, 2021
APPL NO 17/140415
CURRENT CPC
Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/00 (20130101)
C07H 7/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 20210215599 Forbes et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Government of the United States of America, as represented bythe Secretary of Commerce (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Thomas Patrick Forbes (Elkridge, Maryland);  Matthew Edward Staymates (Damascus, Maryland)
ABSTRACT An infrared thermal desorber includes a desorption housing; an infrared source receiver that receives an infrared emission source; an infrared absorber receiver that receives an infrared absorber, such that the infrared absorber receiver produces thermal energy emission; an analyte target receiver that receives an analyte target, such that the analyte target receiver is in infrared communication with the infrared absorber disposed in the infrared source receiver so that the analyte target receives the thermal energy emission from the infrared absorber, desorbs the adsorbed analyte as volatilized analyte from the analyte target in response to receipt of the thermal energy emission from the infrared absorber, and communicates the volatilized analyte from the analyte target; and an effluent communicator that receives the volatized analyte.
FILED Friday, January 08, 2021
APPL NO 17/144232
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/405 (20130101)
G01N 21/35 (20130101) Original (OR) Class
G01N 21/71 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 20210213101 Chen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) The Schepens Eye Research Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Dong Feng Chen (Newtonville, Massachusetts);  Chenying Guo (Malden, Massachusetts)
ABSTRACT Disclosed is a method of promoting neuronal growth by administering IGFBPL-1, or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need thereof, e.g., a subject in need of treating optic nerve degeneration.
FILED Wednesday, October 14, 2020
APPL NO 17/070596
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/352 (20130101)
A61K 31/708 (20130101)
A61K 31/711 (20130101)
A61K 31/713 (20130101)
A61K 31/7004 (20130101)
A61K 31/7088 (20130101)
A61K 31/7105 (20130101)
A61K 38/18 (20130101) Original (OR) Class
A61K 38/22 (20130101)
A61K 38/30 (20130101)
A61K 38/1738 (20130101)
A61K 38/1841 (20130101)
A61K 38/2278 (20130101)
A61K 45/06 (20130101)
A61K 49/0056 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 20210215098 GREENE et al.
FUNDED BY
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) CHRISTOPHER BRITTON GREENE (Hebron, Connecticut);  Stuart S. Ochs (Coventry, Connecticut)
ABSTRACT A diffuser may comprise an inlet and an outlet. The inlet may comprise an arcuate shape. The outlet may comprise an annular shape. The diffuser may transition from the arcuate shape at the inlet to the annular shape at the outlet. The diffuser may comprise a radially inner wall and a radially outer wall disposed opposite the radially inner wall. The radially inner wall and the radially outer wall may partially define a duct.
FILED Wednesday, January 15, 2020
APPL NO 16/743966
CURRENT CPC
Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 33/02 (20130101)
B64D 2033/0273 (20130101)

Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/04 (20130101) Original (OR) Class

Jet-propulsion Plants
F02K 7/02 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2250/51 (20130101)
F05D 2250/71 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210215779 BULATOWICZ
FUNDED BY
APPLICANT(S) MICHAEL D. BULATOWICZ (SUN PRAIRIE, Wisconsin)
ASSIGNEE(S) NORTHROP GRUMMAN SYSTEMS CORPORATION (FALLS CHURCH, Virginia)
INVENTOR(S) MICHAEL D. BULATOWICZ (SUN PRAIRIE, Wisconsin)
ABSTRACT One embodiment includes a heater system. The system includes a current source configured to generate an input current and to receive a return current. The system also includes a heater configured to generate heat in response to the input current. The system further includes a plurality of current lead wires interconnecting the current source and the heater and being configured to provide the input current to the heater and to conduct the return current from the heater. Each of the plurality of current lead wires is arranged on a separate substrate layer such that each of the plurality of current lead wires are each spaced apart from each other. At least one of the input current and the return current is divided to be conducted on two or more of the plurality of current lead wires.
FILED Monday, January 13, 2020
APPL NO 16/741302
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/26 (20130101)
G01R 33/3804 (20130101) Original (OR) Class

Electric Heating; Electric Lighting Not Otherwise Provided for
H05B 3/03 (20130101)
H05B 3/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20210217949 KIRBY et al.
FUNDED BY
APPLICANT(S) CHRISTOPHER F. KIRBY (GAMBRILLS, Maryland);  MICHAEL RENNIE (ASHLAND, Virginia);  DANIEL J. O\'DONNELL (LINTHICUM, Maryland);  AURELIUS L. GRANINGER (SYKESVILLE, Maryland);  AARON A. PESETSKI (GAMBRILLS, Maryland)
ASSIGNEE(S) NORTHROP GRUMMAN SYSTEMS CORPORATION (FALLS CHURCH, Virginia)
INVENTOR(S) CHRISTOPHER F. KIRBY (GAMBRILLS, Maryland);  MICHAEL RENNIE (ASHLAND, Virginia);  DANIEL J. O\'DONNELL (LINTHICUM, Maryland);  AURELIUS L. GRANINGER (SYKESVILLE, Maryland);  AARON A. PESETSKI (GAMBRILLS, Maryland)
ABSTRACT A method of forming a superconductor structure is disclosed. The method comprises forming a superconductor line in a first dielectric layer, forming a resistor with an end coupled to an end of the superconductor line, and forming a second dielectric layer overlying the resistor. The method further comprises etching a tapered opening through the second dielectric layer to the resistor, and performing a contact material fill with a normal metal material to fill the tapered opening and form a normal metal connector coupled to the resistor.
FILED Thursday, January 09, 2020
APPL NO 16/738790
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/5228 (20130101)
H01L 23/53242 (20130101)
H01L 39/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT APPLICATION DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Thursday, July 15, 2021.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week's taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer-funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract is presented as it appears on the patent.

FILED
The date the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that the more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2021/details-patents-20210427.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital